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ABBEBVXATIOSS.
ADP - Adenosine diphosphate
A W  - Adenosine monophosphate
ATP - Adenosine triphosphate
POV w Packed cell volume
Platelet ccuht Platelet rich plasma platelet count,
SL
VJher© mo3:0 than one roference has been used the 
references ore given in alphabetical order#
oiiàPTm I.
Although the credit feu? the first observation of a blood platelet 
Is usually given to Alfred Donne (IS42)# the flrot drawings of 
platelets were made independently by two English practitioners, George 
Gulliver (IS41) and William Addison (I84O, I84I)#
In 1842, Donne stated that there are three elements in the blood; 
red cells, white colls and globules of chyle. Frans Simon in IB42 
treated antiooagulated blood with potassium ferrocyanide and saw 
numerous small bodies, almost certainly platelets, which he thoi%?ht 
wore the early stages of erythrocytes. Arnold (1845) the first 
professional anatomist to recognise and illustrate platelets which he 
called elementary grains* ï?,irmuermann (I846) repeated and confirmed 
Simon*0 work* Ho observed that if blood is rendered incoagulable it 
contained numerous small colourless bodies 2 to 4 U in diameter, which 
were refractlie and had a well defined contour* He called them 
'^ elementary bodies".
Wharton Jones (IB50) was the first to describe etEiges of 
thrombosis, using frogs as expo5?imental animals. He examined the 
web of a frog*s leg and observed that arteries became blocked by a 
mass composed apparently of colourless corpuscles and fibrin* In 
I864, there appeared the first clear drawing of a platelet (Boale). 
Sohultao in I865 using a warm stage, observed the coalescence of 
platelets in "granular masses"* This work was further extended by 
Osier (I874) who gave a dot Exiled account of individual platelets, of 
Schulte's granular masses, and the changes that take place in the 
peripheral portion of platelets* He observed that these peripheral 
parts become glassy, throw out pseudo-pods and are associated with 
fibrin formation. Unfortunately, Osier thought that these bodies were 
peculiar types of bacteria*
2Hanvier, in 1073# q papor on thé formation of fibrin in v/hroh 
he referred to its relationship to granules which ho believed were 
Ghemioally identical to fibrin# Fulpian (1873) oommentlng on this 
paper said that he found these oorpusoles in normal blood and that 
they adhered to glass# Hayera (1877)# calling the platelet a 
haemobXastf thought that it was an oar2y stage in the development 
of the erytteooyte# io was able to count platelets; ho studied their 
morphology and the part they played in coagulation and elot retraotiom
Bissoaero (1881) described the preaenoe of free platelets in 
omental vessels; ho damaged the vessel wall and saw that the first 
effect was th# adhesion of platelets to the point of Injm^# He 
also showed that it was platelets, not loucooytos as had previously 
been believed, that formed the first stage of a thrombus, and 
demonstrated their relationship to coagulation#
In 1885 Sohimmelbusch described the morphologloal changes that 
occur when plateleta come in contact with a foreign surface or a 
damaged vessel# Enhanced stickiness of platelets resulted and caused 
Individual platelets to adhere to one another as well as to foreign 
surface»# Ha believed that these changes occurred independent of, 
and before fibrin formation# Eberth and ^chimmalbusoh (1886) 
repeated and extended the work of BIzzozbtq and introduced the term 
"viscous metamorphosis" to describe the Biorphological and physical 
changes that enabled platelets to stidc to foreign surfaces and to one 
another# Later Wright and IHnot (XSH?) used the term viscous 
metamorphosie to describe the agglutination and fusion of platelets 
into "glassy masses" and strands, a phenomenon which they 
distinguished from simple agglutination without fusion#
The confusion as regarda the origin of platelets was settled in
1906 by Wrlglit wto fomid the tme- origin of platelete from the 
megakaryocyte•
Platelet tlltrfietmQtura#
% e  use of the electron iirlcroaoopa and the discovery of a new 
group of aldehyde fixatives have provided valuable information 
about the u3,W%otructure of blood plateleta* #%e electron 
miorosoope m e  first applied to the study of platelets by Wolpers 
and Hueka (X93p)* Binoe them several Studies have been made on 
blood platelets (mployimg a spreading teclmlque vMdi utilisas the 
ability of the platelet to spread when in contact with a solid 
surface. The introduction of the uXtratliin seotioning tec^n^que 
by vMcâ'i sections vdLth a thi#moss of about 5001 can be examined, 
end the use of suitab3,e embedding mediae allo%ved for better use 
of the electron microscope#
#%8 problem of fixing platelets vdthout the use of aati* 
caagulants and centrifugation vms solved by the Introâuotioïi of 
gtotaraMahyde (Babatini et al#, 1963) #ich permitb rapid fixation 
by teawing the blood directly into the fixative. Aldehyde fixation 
iB of special value in the loOE^l^ation of specific #omical 
components and enzymatic actions* àdenoaine triphoBphatase and 
acid phosphatase retain their activity in aldehyde^ fissod tissue and 
may be localised in tMe way*
Electron microscopy is also used with immunoohemioal staining 
where sufficient electron density must be associated with the antibody 
molecule* Autoradiography is another method adapted for the 
electron mloroscope in the study of the platelet iiltrastmoture in 
wMoh the position of the radioactive materlêil incorporated into the 
specimen can be observed* Hegativa staining of the rpeoimena io
4tiaed when very high resolution is required as in studies of isolated 
suboolltxlar components. The principle of negative staining is to 
surround the particles with an electron dense material, thus making 
them visible.
All the above methods have been used in electron microscopic 
studies of blood platelets their subeellular components and 
contributed to better understanding of the platelet morpholep and 
function.
Platelets which have been rapidl^ *^ fixed in glutaralclehydo and 
examined in ultrathin sections usually have an elliptical, rod like 
or disc shape. The longitudinal diameter of the disc form is 
usually between 1*5 to 4\^ and the transversal diameter la within the 
range of 0*5 to 2p. The blood platelet is formed of a oytoplaamic 
matrix which is surrounded by a membrane and contains various 
organelles* These include mltoohondria, granules, vacuoles, Gogli 
complex, siderosomes, microtubules, ribosomes, glycogen and lipid 
inclusions.
Electron niicrosGopic studies have shown that the platelet is 
surrounded by a well defined membrane similar in structure to other 
cells. V&en potassium permanganate is used as a fixative the triple 
layered structure of the unit membrane can be easily demonstrated 
(Robertson, i960). The unit membrane is oomonly thought to be 
formed of a double layer of lipids and phospholipids covered on both 
sides by layers of proteins (stoeckenlm, 1962). The phospholipid 
fraction of the platelet membrane (platelet factor 3) becomes exposed 
on the platelet surface, and thereby capable of reacting with other 
clotting factors in the plasma (:Wcm et al., 1966).
In ultrathin sections a fluffy coat can be seen outside the 
platelet mmbram, which appears as aaiorphous subatame or as short 
threads extcndixig radially from the mei^rane. This extracellular
coat is thought by Marcus and Sucker (1965) to bo an inherent part 
of the membrgme structure, while Blsmîa imd Molenaar (196?) regard it 
as adsorbed plasma proteins# It is possible that this surface coat 
corresponds to what Hoskam (1923) described as the "plasmatic atmosphere" 
of the platelet* This coat is likely to be composed of niueopoly^  
sacchasides, proteins and muco-proteins and to contain many, if not all, 
the plasma coagulation factors* It has been stated by Adelson et al 
(1961) that platelets adsorb and concentrate coagulation and other 
factors and transport them in the circulation, the ability of the 
platelet to act as a sponge being one of its basic functions# The 
plasma coagulation factors stated by various authors to be present 3*n 
the plasmatic atmosphere include fibrinogen, prothrombin, factors If, VII, 
VIII, IX, X, surface factors (XI, XII) and factor XIII* Some of these 
feetors are tightly bound to the platelet whilst others can easily be 
removed by washing* Prothrombin, factors VII, IX and X are loosely 
bound and may easily be eluted (Bounanieaux, 1957a)# Fibrjiiogen, 
factors V, VIII and XIII as well as surface factors are more tightly 
bound and resist repeated washing (latridis ami Ferguson, 1965)#
Electron microscopic studies have shoim that during ADP-induced 
platelet aggregation, the fluffy coat appears to form bridges in the 
aones of contact between platelets (Hovig, I968)*
Eïiîsymatic reactions may also talce place on the platelet surface# 
Adenosine triphosphatase activity has been demonstrated by White and 
Krivit (1965) on the surface membrume $ however, this was not confirmed 
by Behnka (I96?) or Vetharaany and Laaarua (196?)♦
Blood platelets contain from 1 to 6 mitochondria, whose function 
is presumably similar to that in other cells being the principle site 
of oxidative reactions# Tîieee reactions are mediated by adenosine 
triphosphate (ATP)* It is of interest to note that platelets contain 
more ATP and fewer mitochondria than other cells indicating that the
6ATP may be iuvo3.ved In prooosses beoidoa cell metabolism.
Thore a m  between 2 and 20 aranules in the hxmm blood platelet. 
Although the nature of these granules la not quite clear, granules are 
auppoeed to contain lipid (platelet factor )), lyeooomaX en%yms# 
fibrinogen and nucleotides.
A variable number of vacuoleo and vesioleB of different sisea and 
shapes can be seen in sections of blood platelets* Platelets fixed in 
g3.utaraldehyde and post-fixed in oendum totroxido show cavities 
surrounded by a membrane, which appears to be continuous with the 
surface memibrane.
Btruotures similar to that of the Golgl complex can somotimes be 
found in normal platelets. These structures probably originate from 
the megakaryocytes and scorn to have no iînportaïit function in platelets.
A bundle of tubular filment.a can be observed along the inner 
circumference of the platelets when glutaraldoliyde is used as a fixative. 
In saggital sections of platelets the marginal band of tubules appears 
at the poles of the disc**shaped cells as loosely associated groupe of 
small circles. Althoiigh the function of the microtubialOB is still 
ut^nown, Bohiitco (1965) auggeets that tho tubules may ploy a role in 
maintaining the discoid shape of platelets* The microtubules may also - 
have a role in the formation of pseudopod-like projections of the 
cytoplasm (silver, 1966). It is possible that those mic3?otubules may 
represent a retractile element of the platelet cytoplasm.
Glycogen granules occumjzlng singly or in large aggeogates htiv© been 
demonstrated in platelets. Lipid inclusions may occasionally be found 
in normal human platelets suggesting that platelote phagocytose and 
transport lipids.
The presence of ribosomes in platelets has not been proved 
conclusively. Recent evidence suggests that platelets tire able to 
aynthegize proteins (Booyao end Rafelaon, 196'?), an activity known to
?
take place in ribosomes*
THE imNGTIONS OF PMTmUTS 
Platelets and Haemostasis
Recent advances in the fields of microphotography and 
Ginemicrophotograpliy (Kwaan et al*, 196?) have been applied to the 
study of platelet behaviour in small blood vessels in vivo* These 
techniques have been also applied to the study of the arrest of 
bleeding from transected small blood vessels and have established 
that bleeding is stopped by the formation of a platelet mass which 
occludes the gap In the vessel wall (Fmcker-,, 19^-?9 Jorgansen and 
Borchgrevink, I9631 Hovig ot al., 196?)# Platelets interact with the 
collagen in the connective tissue as one of the first steps in the 
formation of the haemostatic plug (Hovig et al*, 196?)• This results 
in the release of ADP from platelets (JSuoker and Borrelli, 1962?
Hovig, 19635 Bpaot and %ucker$ 1964) which causes the platelets to 
adhere to each other (Gaarder et al*, 196I5 Born, 1962b)*
According to the experiments made by Bounameaux (196I), fmcker 
and Borrelli (1962); Hugues and Lapiero (1964), Spaet and Erichson 
(1965) and to the observation in vivo by Hugues (I962), at the site of 
injury to a blood vessel, platelets adhere in preference if not exclusively 
to collagen* Platelets in contact with collagen show structural changes 
which include swelling and loss of platelet constituents (Hovig, 1963;
Hovig et al*, 196?)* Adherence of platelets to collagen does not 
requii'G the presence of divalent cations (%aet and 2ucker, 1964) and 
is independent of the blood clotting mechanism* However divalent cations 
are essential for oollagen-induoed release of platelet eonstituonte 
(Hovig, 1964). Together with the release of platelet nucleotides 
including ADP, collagen also induces the release of serotonin and 
histamine which influence vessel permeability and cause contraction of
smooth DMoelG (Packhaia et al., 1968). It is psasurascl that lysosoraal 
enzymes a m  also released at the site of W a r y  since the platelet grannies 
which contain them disappear during this proooss*
ADP is probably supplied by both the injured cells ift the area and 
by the platelets. It is doubtful whether red cells, which are rich in 
nucloatldeo, nWce a substantial contribution to extracellular ADP; 
detailed studies of the haemostatic plugs have not shown extensive 
accumulation of rod cells in the platelet mass (tucker, 1947;
Jorgenson and Borchgrevihk, 1963; Hovig et al., 19&7)# cells are
shown to be trapped :ln the fibrin around the periphery of haemostatic 
plugs, but their position suggeate that they are not involved in the early 
events of plug formation*
ADP has been found to bo the most potent compound for inducing 
platelet aggregation but other compounds like uridine diphosphate, 
oytidine diphosphate, Inosine diphosphate and guanosine diphosphate can 
also cause platelet aggregation (Spaot and tucker, 1964; Balsman,
1967)* Adenosine triphosphate has been found by some workers to cause 
platelet aggregation (îtotard at al., 1964b; lEtoholl and Oharp, I964). 
However, O'Briens(1964) reported that fresh solutions of ATP have little 
or no activity.
ADF can also cause platelet aggregation in vivo. ADP infusions cause 
intravasoular platelet aggregation which is associated with a fall in the 
platelet count. In most instances ABF-induced platelet aggregation 
appears to be reversible both in vitro and in vivo. It has been shown 
that adenosine inhibits ADF-induoed platelet aggregèîtion in vivo (Bom 
and Gross, 1963a) and probably acts by preventing the aceumlation of 
platelets at the site of lnji%ry by inhibiting the action of ADP released 
from damaged tissues or from the platelets.
The platelet mass formed in vivo in experimental situations is 
usually unstable* Stabilisation of the platelet masses in vivo requires
the action of thrombin; it has been demonstrated that when coagulation 
is inhibited, the platelet masses formed in the microcirculation are 
unstable (Fulton et al,, 1955; Berman, I96I), Thrombin will cause 
platelets to adhere to each other probably by inducing the release of 
platelet ADP (Haslam, I964; Mustard et al,, 1967b), Thrombin also 
catalyses the formation of fibrin which stabilizes the platelet mass 
by binding the platelets together. It is probably the formation of 
fibrin which is the main factor in stabilizing the platelet plug 
because if fibrin is lysed, platelet aggregates break up (Hirsh et
al,, 1968).
The sequence of steps by v/hich thrombin is generated in vivo 
has not yet been fully elucidated, but there is evidence to suggest 
that collagen may activate Factor XII thus activating the intrinsic 
coagulation pathway (Hiewiarowski et al,, I965). Tissue thrombo­
plastin released at the site of injury may be responsible for 
initiating coagulation through the extrinsic pathway (Biggs and 
MacFarlane, I962), The release of platelet factor 3 through platelet 
aggregation by ADP may also have a relationship to thrombin formation 
(Mustard et al,, 1964b; Castaldi et al,, I965; Hardisty and Hutton, 
1966b), Associated with the platelet membrane are some plasma 
coagulation factors as Factor V and Factor VIII which may be 
involved in the coagulation process.
Finally, to become an effective haemostatic plug, the fibrin 
around the platelet mass may undergo retraction; as in a blood clot 
tightening of the peripheral fibrin by concentration of the contractile 
protein of platelets may help to stabilize the platelet mass (Bettex- 
Galland and Duscher, 1959; 1965)* Figure 1 summarizes the functions
of platelets in haemostasis and figure 2 illustrates the mechanism of 
haemostasis schematically.
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m i m t M B  AMD mmomoaia#
The early work of Blasosero (1882); Eborth and Sohisimeltoch 
(1B85) and Welch (188?) hm eatabliehod much knowledge about the 
morphology and striiotura of a thrombm^
A th2?oiftb«s ooneiete of a head or white tlîrombus which is 
attached to the vessel wall# and a tail or red thrombus formed from 
coagulated blood (figure 3)# Hiatologioal sections of in vivo thrombi§ 
experimental in vivo thrombi (Eowntree and Shionoya, 1927; Shionoya, 
1927$ Bast et alf, 19381 Mason and Harrison, 1949) and experimental 
in vitro thmabi (Chandler* 1958; Poole* 1959; and i960) have shown 
that the white bead of a tWombus is formed almost exclusively of
tightly packed platelets (figure 4)* Flow is critical for the
development of such structures# These can develop on arteriosclerotic
plaques in arteries, and at sites of Injury in patent veins#
Thrombosis may however oodur in the absence of flow as in lower 
limb veins filled with stagnant blood* or in eddying pools of blood in 
the cardiac chambers# %n this situation* the thrombus closely
resembles a blood clot* beln^  ^% homogenous structure of red cells*
leucocytes and platelets enmeshed in a fibrin netv/ork*
There is considerable evidence to suggest that adherence of 
platelets to the injured vessel wall and to each other is a fundamental 
step in the formation of thrombi from flowing blood (Berman and Fulton* 
19615 llistard et al#, 1962)# The initial adherence of platelets 
to the subendothelial tissue appears to be independent of blood 
coagulation (Jorgensen and BorohgrevitA^ * 1964; Mistard et al#* 1964a) 
and may be initiated by the release of ADP from injured tissue (Honour
and Mitohell, I963# Born et al#* I964)# In regions of disturbed blood
11
flow m.Û vortex formation* the formed elements of blood may collide 
with one another and with the vessel wall* Such collisions may oause 
cellular jnjnry leading to the release of ADP, On the other hand it 
seema possible that accnmulatiom of platelets and leucocytes on the 
vessel surface may induce changes in the imderlying endothélium* Doth 
leucocytes and platelets contain lysosomal enzymes, wMoh when released 
during degraiiulation can cause tissue injury (Mustard et al** 19G?a)# 
Moreover focal Injury of the vessel wall may cause the accumulation of 
fo3?med elements with exaggeration of the effect of injury* particularly 
increased permeability of the endothelium (Mustard et al#* 196?a)#
ADP cannot maintain the platelet aggregate because it ie 
dephoaphorylated to AMP by an enisyme in the plasma (Ireland and Mills, 
1966? pÊAOldaam et al.g 196?)* The most important factor in atabilisisig 
the platelet aggregate is the formation of fibrin aroimd it* Thrombin 
converts some platelet ATP to ADP which escapes into the ambient fluid 
causing further platelet aggregation (Esi,aer*Glmzmaan m â  Xuscher, 
19625 Grette, 1962). It also induces eerotonin release (Euoker and 
Borrelli, 19535 Grette, 1962), and renders platelet phospholipid 
available for the formation of large amounts of tlirombin from the 
intrinsic coagulation mechanism (ICaiser-Glemzmann and Luschor, 1962; 
Schmid et al** I962)* When the rat© of thrombin formation is greater 
than the effect of dilution by flowing blood and neutralization by 
anti thrombin, fibrin is formed in the area surromidmg the platelet 
aggregate* Subsequently thrombdii on the surface of the thrombus is 
rapid^ ly depleted -Huough its absorption by fibrin (Beogera et al*,
1945), neutralisation of blood antlMirombin (IteMiouse et al#, 1955), 
and dilution in the blood stream#
If the blood flow is slowed or arrested distal to tho initial, 
thrombus, thrombin concentration will not diminish rapidly* TMs will 
result in extension of the fibrin formation giving the tlirombus the 
appearance of a white head and a red tail#
OEAFMI
G MEML imaomoTiom om ie tjimbmxa*
A generalised haesK>rrhagia state in uraemia has Xoiig been 
recognised* According to Rieeman (1907) $ itegagni early in the 
eighteenth century described a woman in whom "though she already had 
the odow of urine in her breath* vomiting of blood and bleeding from 
the nose proved beneficial"» A bleeding tendency in chronic renal 
failure has been described by Eieamn (1907)$ Davidson (1937) ê 
Xioeper and Leb2?et (l940)$ and more recently in acute uraemia by Bwami 
and Merrill (1953)$ Rbroney and Herndon (1954)$ Donner and 
Houwirtova (i960) and Kendall et al#, (I96I)# Although gastro­
intestinal bleeding has been moat frequently described* other miooaal 
euifaces and the skin may also be involved» At times $ serious or 
fatal haemorrhage has occurred into vital areas such as the 
mediastinum (Brown et al#$ 1953) or pericardial space (Guild ot al»$ 
1957)» Heed le biopsy of the liver and kidney in ,a uraemic patient 
has led to massive and fatal bleeding (Telman* 1954)»
Despite the clinical appreciation of the occurrence of a 
haemorrhagio state* the haemostatic mechanism in uraeraia received scant 
attention until recently# Earlier workers attempted to explain this 
haeaorrhagio tendency in uraemia on the basis of a vascular defect 
( GuaMi* 1935)* Rieeman postulated "a circulating substance in 
uraemic plasma that weakened the capillary wall" $ wheras Jaffe and 
Laing (1934) described a "toxic effect on the capillaries"# They 
noted marked dilatation of the capillaries and venules in the walls 
of the gaetrointestiml tract in association with narrowed 
arterioles#
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The Bleeding: Time m û  Oani Harz lity Testa#.
The bleeding time and capillary fragility tests were two of the 
first tests m#yed in an attempt to detoot and possibly to explain 
the haemostatic defect#
In fishherg's test (1954) it was reported that the tourniquet 
test was usually positive and it was suggested that decreased 
capillary resistance was the immediate mechanism of bleeding# A 
similar observation was also made by Kuhlbach (1957) in a study of 
30 patients with chronic renal failure; of a number of coagulation 
tests performed the-tojpel^Loede capillary fragility test #ae the 
most consistently abnormal#
î&roney and Herndon (1954) reported purpura in post «traumatic 
renal insufficiency resulting from battlefield casualties# Bleeding 
into the ekihf aasopharynsc and intestine appeared after 12 to 15 days 
and was related only to tho duration* not the severity of the uraemia# 
Unlike other manifestations, tho haemorrhagic tendency was entirely 
unaffected by haemodialysis or by diuresis; on the contrary, the 
most eevere bleeding oeourred several days after the onset of 
diuresis# A search for the cause of the bleeding revealed increased 
capillary fragility but no intrinsic clotting defect; the condition 
was unrelated to abnormalities of plasma electrolytes and was 
unaffected by the administration of Vitamin K, Vitamin G or fresh 
blood transfusion.
In a more detailed investigation by Rath ©t al#, (1957) of a
rated group of 45 uraemic patients "capillary fragility was the least
commonly seen abnormality"# terill (1955) reported that the bleeding
time and tourniquet test are m M o m  abnormal in patients with renal 
failure and purpura#
She bleeding time wag psolunged in 2 of 12 patients with ohronio 
uraemia studied by lewia @t al., (1956) and apparently la none of
14
ÎCuhXbaoh's (X95?) 30 ohronlo cases#
However, the bleeding time was prolonged in all 3 oasea of aomta 
renal failure studied by Iiarmin and Adelson (1956)# Bath et al#» 
(1957) also reported that the bloedlKig time \mB prolot%ed in 4 out of 
5 eases of acute renal failure duo to aouto glomerulonephritis* only 
3 out of 21 of the other acute oases and only 2 of I5 ohronie 
uraeiaio patients showed proloi%ation of the bleeding time#
In Kendall fs (196I) group of acute uraemia the capillary fragility 
was abnormal in only 6 of 21 cases tested# In those 6 patients there 
was prolonged bleeding time, and thromboeytopenia; in 5 ©f these the 
platelet count was below 30*000/o##n# Kendall ©t al»? (I96I) found 
that a prolonged bleeding time was a common finding* and was seen at 
some time in 27 of his 46 cases# Bleeding occurred in 24 of the 27 
and it therefore appears that a prolonged blooding time is a useful 
indication of likelihood of bleeding# In only 4 of these 27 oases 
was tho platelet count greater than 100*000/c#mia# and 3 of the 4 showed 
an impaired prothrombin consumption (Kendall et al#, I96I)#
Donnes? and leuwirtova (I96O) found tho bleeding tim to bo 
prolonged in only 4 out of 31 patients with acute uraemia and 3 out of 
23 with chronic uraemia#
Willoughby and Grouch (I96I) studied the Ivy bleeding time and 
the rate of blood loss from skin punoturee in this test; and found 
both to be increased in mar^ of the renal patients with a clinically 
manifested problem of haemostasis# However the capillary fragility 
test of Heas was seldom abnormal in the same group#
Oheney and Bonnin (1962) found the bleeding tieie to be prolonged in 
only 4 out of 33 cases of uraemia and only 4 were associated with severe 
haemorrhagio manifestations# However 11 other patients also showed 
haemorrhagio signa * sometimes of equal severity * yet had a normal
X5
bleeding time# The results of the tourniquet te%t did not 
however correlate well with the clinloal manifestât!one of bleeding 
nor with the levels of platelet thromboplastic function#
Salzman and Her! (l#6) determined the Ivy bleeding time on 29 
occasions in 24 patients and found this to be prolonged in 13.
Patients with a long bleeding time invariably had deficient platelet 
adhesiveness#
Oastaldi et al#» (1966) found abnormal capillary 'fragility in 
only 3 patients out of 19 of whom 2 had severe bleeding and one had 
no bleeding# Hone of the 3 had thrombocytopenia# A prolonged 
Blocs'3 bleeding time was found only in one patient who had a severe 
bleeding tendency# In contrast* all patients with evident bleeding 
had a aignificantly prolonged Ivy bleeding time but only one of the 
non«bleedera had a prolonged bleeding time#
Stewart and Oastaldi (196?) considered the Ivy bleeding time to 
be one of the most sensitive sBoaauras of impaired platelet functions 
and this was found to be abnormal in nearly all predialysis tests and 
waa frequently corrected by one or more dialysis treatments.
The, Platelet Gount.
Marked throBibooytopenia has been found to be an unusual finding 
in chronic uraemia althoti^ gh a slight reduotlom in platelet number is 
not uncommon (Favre-Gilly and Durand, 1950; Euhlbach* 1957; Rath 
et al.ÿ 1957? 0'Grady# 1959)$ In acuta renal failure thrombocytopenia 
m y  become more striking especially when other toxic factors* as 
hepatocellular jaundice» septicaemia or severe infection are present# 
Hath et al#? (1957) found platelet counts under 150*000/c.mm* !h 17 
of 26 acute cases including all 5 of their oases with acute
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glomerulonephritis. Larrain and Adelson (1956) noted mild to 
moderate thrombocytopenia at some time in their 3 acute oases.
Wursel (i960) found reduced platelet counts in 16 of 43 patients 
with acute uraemia. Kendall et al., (3.961) found tlirombocytopeaia 
in ïïïa>ny cases of acute uraemia; factors other than the uraemic 
process, such as septicaemia* most probably contributed to this.
Oastaldi et al.? (1966) found thrombocytopenia to be present in only 
2 patients with chronic renal failm?e both of whom had evident bleeding 
and prolonged Ivy bleeding time. All other patients however had 
platelet counts in the normal range even when there was severe bleeding.
Stewart (I967) estimated the platelet count in 225 patients with 
severe renal failure. Thrombocytopenia occurred in one quarter of all 
patients with renal tubular necrosis* acute or sub-acute 
glomerulonephritis or malignant hypertension* but only in one twelfth 
of those with severe uraemia due to chronic renal failure. Recovery 
of platelet numbers followed partial relief of uraemia by dialysis or 
return of renal function in 24 patients.
Whale Blood Plotting Time.
The whole bleed clotting tim? In glass tubes was stated to be 
prolonged (Allen* 1951) • Bonner and Heuv/irtova (3.960) found the
clotting time to be prolonged in 10 out of 46 cases of acute uraemia 
and 4 out of 26 cases of chronic uraemia# Willoughby and Grouch 
(1961) reported the clotting time to be normal except in 2 cases of
acute uraemia. However Larrain and Adelson (1956) showed a
prolongation of the clotting time in silicone tubes in their 3 patients*
and considered this to be one the earliest changes in acute
experimental canine uraemia. Bonner and Heupjirtova (196O) reported 
the silicone clotting time to be prol'«ged In B of 43 êÊcùte uraemic 
patients and in 4 out of 31 patients with chroni?. renal failure.
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One-Sta^e Prothrombin Time
The one-stage îæothrombin time has shovm no consistent prolongation 
in uraemic patients and when present such prolongation has rarely been 
sufficient to be a likely cause of bleeding* Lewis et al (1956) 
reported one-stage prothrombin times ranging from high normal to very 
lovf levels; this usually reflected abnormalities in prothrombin, factor V 
and factor VII, Similar 3?esuits were found by Donner* and Neuv/irtova (i960)* 
Factor V was deficient in 16 out of 43 patients with acute uraemia and in 
6 out of 18 patients with chronic renal failure* Factor VII was 
diminished in 29 out of 51 patients with acute uraemia and in 7 out of 21 
patients with chronic renal failure* However, Willoughby and Grough 
(1961) reported normal one-stage prothrombin times in all of their 56 
uraemic patients except two; the one-stage prothrombin time in these 
patients was promptly corrected to normal by vitamin K administration*
A slight or moderate prolongation of the one-stage prothrombin time was 
detected in almost every uraoDiio patient at or near the peak of azotaemia 
(Kendall et al*, I96I), They found that the abnormalities in the one- 
stage prothrombin time did not correlate with microscopic hepatic 
pathology in 29 oases examined at autopsy,
Cheney and Bomiin (I962) found a deficiency in factor VII which 
resulted in prolongation of the one-stage prothrombin time in I5 out of 
33 uraemic patients* Only two of their patients showed marked prolongation 
which was attributed to factor X deficiency in one and to factor VII 
deficiency in the other patient*
Other plasma coagulation factors were investigated*
Factor VIII levels were reported by Lewis et al (1956) to be normal; only 
two patients in their series showed reduced factor IX associated with 
factor VII and protheombin deficiency*
Fibrinogen
Plasma fibrinogen levels have been found by many workers to be 
elevated (Hath et al*, 1957» Donner and Heuwirtova, I96O5 Kendall et 
al,, 1961 and McMicoI et al*, 1965)* Gaetaldi et al*, (I966) reported
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factor XIII by a qualitative test to be normal* 
plasma Thrombin plotting Time
The plasma thrombin clotting time was prolonged in 6 of the 12 
oases of Lewis et al,, (1956) and in 9 of the I4 oases investigated by 
KendalLet al*, (I96I)* In several patients the addition of calcium 
with thrombin resulted in normalization of the thrombin time. No 
increased antithrombin activity could be detected in Kendall's oases*
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Clot Retraotion
Clot rétraction was impaired in al3. nraerniç patienta with 
isieidontal blooding and in many of those not bleeding (Caotaldi et al#*
1966)# Clot retraction was restored to normal in the majority of 
uraemic patients after dialysis treatment (Btewart and Gaataldi,
1967)*
3?rothrombin Oonaumntion Test
The protWombin eonsnmption test has often been reported to be 
abnormal in. patients with acmte and chronic uraemia (terrain and 
Adalson* 1956; tewio et al.* 1957? Hath et al#* 1957? Oahalane et 
al#* 19581 Geiger et al#* 1959? 0*Grady, 19591 Donner imâ Netiwirtova* 
I96O; Alsehiiler et al*, I960; Wurzel, I96O? Kendall et al#* I96I; 
Willoughby and Grouch* 19615 Castaldi ot al*, 1966; Salzmaa and 
Nori* 1966; Stewart and Castaldi* 1967)*
Oaîialane et al*, (1958) fomid abnormal protlirambin consumption 
in all 8 ohrcmio patients studied by him* while Lewis et al., (1936) 
noted this defect in 7 out of 12 cases* lath et al** (1937) found a 
similar abnormality in 38 out of 45 acute and chronic cases and mad© 
the ssmie observation in 2 out of 3 acute cases#
Wtozel (i960) reported abnormal pï'othrombln consumptioi'i in a high 
percentage of patients with both acute and chronic uraemia*
Of particular Interest was the finding of 0'Grady (1939) that 
prothrombin consumption abnormality was present in 6 ohz^ omlo uraemice 
with platelet comta greater t h m  150*000/c*mm*
Altschuler's (196Û) group when tîirombocytopenia was present iii 
some patients, protbrombj^ i consumption waa normal :u% some, but not-in
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others* Oa the other defective protîirombâai omsumptiüii uas
demonstrated in cases with normal platelet coimt* Willoughby and 
Groncli (19^ 1) fomid that prothrombin oonauriiption inde^  %ms the 
only test of blood coagulation to bo abnormal^  i.e# over 19#  ^in a 
signiflcamt number of patients with a clisiieal haemorrhagic state*
Kendall ot al*$ C196I) investigating cases of acute renal 
failure found the prothrombin consumption index to be abnormal ûn 
2? out of 34 cases at the pealc of asotemia although the abnormality 
was slight* Platelet counts carried out at the same time wore found 
to be below 190,000/o #m#* in 22 of these patients ^ but in several 
cases where the platelet counts were below 10Ûç0Q0/ç*mm# the prothrombin 
consumption index appeared to be normal*
iliese results suggest a poor correlation between the platelet 
count and the prothrombin consumption index*
Salsmen and Herl (I966) examined 16 patients using the technique 
of Merskey found the prothrombin consumption index to be abnormal in 
13 patients all of whom had a platelet count above l49 0^C0/c*mm* %ey 
also found that patienta with abnormal platelet adheaiveness tended 
to have a poor prothrombin consumption Index but the correlation was 
not perfect* Abnormal prothrombin consumption was found in 2 patients 
with normal platelet.adhesiveness and sufonorma3, platelet adhesiveness 
was seen in 3 patients with normal prothrombin conaumption, and in 4 
borderline values were obtained*
Castalcli et al*g (1966) found the test to be normal in the great 
majority of patients with no evidence of bleeding*
Stewart end Oaataldi C1967) found the prothrombin Gonsumption Indesi: 
to be more frequently abnormal before dialysis and also more readily 
corrected by treatment than other abnormalities of platelet function*
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PlatQlGt Tbrombonlastlo gaotor  ^Activity*.
Recently more attention haa been foeuseod on the qualitative 
chauîçes In the uraemic platelets* Lev/is et al*# (19£5S) reported 
reduced platelet throzaboplaetic factor 3 activity in 8 and reduced 
platelet accelerator factor I activity in ? of 12 uraemics (10 
chronic and 2 acute) 9 of whom had normal platelet counts*
Subsequently Gahalane et &!#* (1958) in their studies of 8 
patients with ote>nio uraemia and mr^ na,! platelet counts found 
reduced platelet thromhoplastic activity in a modified thrombo­
plastin generation test and this was confirmed by the discovery of 
marked reduction in their platelet factor 3 assay*
Cheney and Bonnin (1962) usins the platelet thromboplastid 
function test# showed reduced levels of platelet thromboplastie 
function in the majority of the uraemic patients examined by them* 
Recently» platelet factor 3 availability has been tested using intact 
platelet rich plasma# Activation of platelet factor 3 was achieved 
by addition of kaolin (Hardlsty and Hutton» 19651 8paet and Olntron 
1965)» or by k W  (Horowit# ot al.» 196?). Oaetaldi et al.» (1966) 
found reduced platelet factor 3 availability in 56 per cent of 
uraemic patients with bleeding while the majority of patients with 
no bleeding showed normal results. The effect of dialysis on 
platelet factor 3 availability was shown by Stewart and Oistaldi (1967)* 
Using the method of Hardisty and Hutton (1965) platelet factor 3 
availability was corrected to normal in 3 out of 6 occasions#
Horowitsî et al.» (1967) used âI)P to activate platelet factor 3 
and found that 16 out of I7 uraemlo patients showed prolonged "Stypven 
times"*
l‘ho most detailed studies of the haemostatic mechanism have been 
carried out in chronic uraemia. On’Jy recently has acute uraemia cos^ 
under investigation. ‘Phis has been possible through the prolongation
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of patients* lives by Improved medical management and the 
introduction of extracorporal haemodialyelB. Because of the 
rapidly changing clinical state and the effect of the uraemic 
process and other factors such as the admlnietration of heparin, 
adrenal and anabolic steroids and blood transfusion, the acute 
cases require serial studies* tethermore, the underlying disease 
procese causing the acute renal failure may have widespread systemic 
effects which may contribute to the observed abnosmaalities of 
haemostatic function teats.
therefore, although platelet count seems to be more reduced in 
acute than in chronic uraemia, this is not, however, a constant 
finding*
Rath et al,, (1957) suggested that disturbances of the haemostatic 
mechanism may differ in acute and chronic renal failure, and 
indicated that the nature of renal disease roe^* influence the type of 
the coagulation abnormality found* There seema to be a greater 
likelihood for bleeding to ooour in severe uraemia of acute onset than 
in ohronio, Thus Tesohan et al*, (1955) reported bleeding in 2? of 
55 oases of post-traimatio renal insufficiency, and Rath et al,,
(1957) in their study of 45 civilian oases noted a higher incidence of . 
clinical bleeding in those with acute renal failu37e than in chronic,
V/ursîel ( i960) applied screening procedures of the coagulation 
mechanism in his study of a considerable mtmbor of acute and chronic 
uraoraiosj ho compared "bleeders" with"non*bleeder8". Impaired 
thromboplastin generation time was noted in a high percentage of the 
former, but no appreciable difference in the tost results were 
noted between acute and chronic oases. However, no mention was made of 
the stage of acute renal failure nor on the duration of asotemia at the 
time the studies were undertaken*
Thr omboelastoi^mphio Pat terne .
Donner and Neu?/irtova (19SQ) described the thromboelastographio
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patterns in both aoute and chronic uraomia* In several oases, v^ raenda 
was suspected from thromboelastographio changes even before being 
ascertained by other laboratory methods. Although similar changes 
were found in other diseases such as chronic lymphatic Xeulcaemia, 
thrordbooythaomia, bronchopneumonia and post-splenQCtoiry, these changes 
were never so markod as in uraeidia. The patterns described were 
either narrowing of a bottle-neck or gradual joining or an onion- 
like pattern# They suggested that platelets take part in the 
development of those changes#
Platelet Adhesiveness.^
The earliest report on platelet adhesiveness in uraemia was 
described by Donnes? and Heuwirtova (i960), Using Bounameaux^s 
method (1957a) of exaialning platelet adhesiveness to yeast cells and 
Jurgen*8 platelet adhesion after rotation in a glass rotator (l959)? 
they found platelet adhesiveness to be diminished in some cases of 
acute and chronic uraemia.
Hellem et al*» (1964) using his own technique, found platelet 
adhesiveness in platelet-rich plasma induced by ADD to be diminished 
in uraemia.
Ralssman and Meri (1966) found in vitro platelet adhesiveness by 
his own technique to be diminished in 21 of 24 patients with chronic 
renal failure; the abnormality was strongly correlated with 
prolongation of Ivy bleedi^ ]g time, abnormal pa^ othrombin consumption 
and with clinical bleeding# In vivo j>latelet adhesiveness 
(Borchgrevink method) was found by Oastaldi ot al*, (1966) to be 
diminished below the lower lirait of noraml in 5 patients with 
prolonged Ivy blooding time but was normal in patients without bleeding 
tendency. Stewart and Oastaldi (I967) studied the effect of dialysis 
on impaired in vivo platelet adhesiveness; 7 patients were restored 
to normal and one showed an improvement# O’Brien (I967) found that 
in a fev/ patients with uraemia the glass bead column method showed 
abnormally low adhesiveness» while with Wright’s method (1941) results
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wero all within the normal range#
Bayer ot al#, (1966) investigated 25 patients with aaotomla due 
to primary chronic renal disease* ïti three patients with severe 
bleeding, platelet adheoivenees was very low. In the remaining 
patiente vdth minor or no bloeditig about one third ohowed 
abnormalities which uaually correlated with platelet thromboplaatio 
factor. Abnormal platelet adhesivenoss and platelet thromboplaatio 
factor were more frequently found in patients with blood urea 
elevated above 100 mg# per 100 ml.
BTaga and Cortellaro (196T) found no correlation between eerum 
urea levels and the dimunition in platelet adhesiveness by the 
rotating bulb method. However they found an inverse relationship 
between serum creatinine and platelet adhesiveness in patients with 
chronic uraemia. Pitney et al#, (i960) measured the adenino 
nuoleolides in platelets from normal and uraemic subjects before and 
after passage of blood through glass bead filters. They found 
uraemic platelets to contain normal amounts of ATP, ADP, AflP and 
total nucleotides. Bormal platelets which had passed through 
filters contained higher concentration of ATP, ABP and total 
nucleolides than platelets in control blood sample, indicating that 
either heterogenity of adenine and imoleolide content in normal 
platelets or adsorption of nucleotides onto platelets during their 
passage through the filters. This phenomenon was not observed \7ith 
platelets from uraemic patients.
ADP-lnduoed Blatelet; Agrégation.
ADP-induoed platelet aggregation in uraemia was recently studied 
by Oantaldi et al», 1966; flalsman and Heri, 1966; Boaenberg and 
Firkin, 1966; Stewart and Oastaldi, I967; O’Brien, 1967; Gan and 
Firkin, I968.
Oastaldi et al., (I966) found platelet ADP-induced platelet 
agsractttion to be nojsaal In  ^patients vdthcmt bleeding manifeatationa
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and impaired in 5 of the same group, but every patient with an 
established bleeding tendency and long bleeding time had grossly 
depressed or absent platelet aggregation,with ADP, whatever their 
soruïü urea concentration* There was also partial correction of 
impaired platelet aggregation in 2 patients with active bleeding after 
dialysis treatment*
Sal^man and Neri,, (1966) on the other hand found ADP platelet 
aggregation to be normiil, but thrombin induced platelet 
eggreg-itior* was diminished in uraema* They also found e significant 
diminution in ATP content of uraemic platelets*
Rosenberg and Firkin,(1966) found impaired platelet aggregation 
in 3 -ut of 3 cases of uraemia with blood urea about I50 mg* per 100 ml, 
They found a good correlation between prolonged bleeding times (Duke), 
impaired aggregation and reduction of platelet masses in the 
viscometer* The plasm of the 5 uraemic patients did not reduce the 
rate of aggregation of normal platelets and correlation between the 
level of urea and platelet function v/as not present* The âbP-induoed 
platelet aggregation was found by O’Bsîion (196?) to proceed at a normal 
rate but the time till disaggregation v/a» rather prolonged*
Stewart and Oastaldi (I96?) demonstrated the beneficial effect of 
dialysis on AbP-induoed platelet aggregation; 4 patients were restored 
to normal, ono improved and two showed no change*
Gan and fisicin, (I968) showed that ABF-induced platelet 
aggregation was diminished in six uraemic patients with a bleedxrîg 
diathesis and a prolonged bleeding time, while it v/as normal in two 
patients with no haemostatic defect*
Platelet serotonin was found by Lev/is et al#, (1956) and Weiner
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and llâoiitrieiid (199T) to bo reduced ia eevero anaemia* 'Lo?/is et al*, 
'(1956) found markedly reduced serum eerotlnin levels in 9 oat of 12 
uraemic patient#* . :
.. . Platelet iîife Bpaii
- ■ " 51 '  ^ :.
The life span of chromium labelled autologous platelet# wxa • ■
found by dastsldi et âl*@ (1966) to be normal in ?. uraemic.nationto*
Only two of these patients suffered from hoomorrhaglo manifestations*  ^
^hen ieoXogoUB platelets from ABO rhesus compatible dono'fs'waro used, . -, 
they found a shortended .survival in 4 out of 5 uraemic patients* .'
Similar roault# were reported by Stewart (1967)# The life.span 
of antoXogouo plataXato, or of compatiblo normal homologous platelets ■ '■ 
given to aubjeote who had never reeaivod blood tr^ uiefuelon was normal 
ill aovoro renal failaro* There wan no oignlflmnt difference between • 
patients with various types or different .severities of renal diseaso* 
The amvival of homologous platelets m s  slightly-or moderately reduced 
when given to patients who had received a previous.- transfusion# • .
- • A Variety of in vitro, s "Wiles have been carried out to determine 
the offeet of substanoee known to too raised in the blood or uraemic 
patients, m  the activity of blood coagulation faotcrs on the 
functions of platelets*
fhe studies of.platelet factor 3 by Cahalaue ot al*, (1956) 
suggested that uraemic plasma may induce a defect in n03?^ ial platelet 
fraipents after an - incubation period of 10 hours*
Uomier and Sauwirtova (i960) found that the addition in vitro of 
urea, phenol, oreatininc and guanidine did not definitely.influence the, 
activity of the. principal coagulation factors*
Ilellem at :al*.,. (I964) suggested that irma impaired ABF-indiicod 
platelet adheexveneoa and thus interfered with platelet function. .
On the other hand Salgmen and Hori (1966) found that the
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incubation of platolet-^ rloh plasma with urea (2OO-4OO mg* per 100 ml.) 
in vitro led to platelet aggregation mid the subsequent addition of 
ADP led to further aggregation which was limited only by the extent 
to which the platelets bad already been clumped by m:ea. Furthermore 
the addition of normal plasma to u3?aemio platelets did not improve the 
response to thrombin, and the addition of uraemic plasma to normal 
platelets did not impair the response to thrombin#
FantX (1966) reported on the effect of urea on ADP^induced 
platelet aggregation# He found that although at very high urea 
concentration, above a level ever encountered in vivo (lOOO m-oemolo), 
uroa inhibited ABP-intluoed aggregration, no effect on ADP.
Reactivity was produced by urea concentration at the upper limit of 
that encountered in vivo in uraemia (440 m-oemole).
Oastaldi ot al,, (1966) found that acute elevation of serum urea 
to about 200 mg# per 100 ml# by means of intravenous infusion of urea 
to two normal subjects, failed to cause any detectable abnormality to 
platelet function# Stewart and Oastaldi (196?) failed to produce a 
qualitative platelet defect as measured by platelet aggregation, factor 
3 availability, and clot retraction by in vitro addition of urea, 
dextrose, laannitol, creatinine, m?eate, phosphate, potassium or magnealum 
or by changes of pH or osmolality within the range which might be 
encountered in severely uraemic patients#
Jerushalïîy et al#, (1966) reported I-4 diguanldino diphenyl 
sulphone caused inhibition of AbP-induoed platelet aggregation# An 
analogous compound, guanldinosucoinic acid was found by Horowitz et al,, 
(1967} to be a powerful inhibitor of ADF-induoed platelet factor 3 
activa ti on o
Fraga and Oortellaro (1967) found that creatinine in vitro had a 
direct inhibitory effect on platelet adhesiveness to glass# Somer ot al#
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(i960) otudied the effect of urea on platelet aggregation and found 
that urea initially inhibits, and later onhanoee aggregation induced 
by ADF, thrombin, adrenaline and non-adrenaline*
The present study was undertaken to determine the presence of 
a platelet defect in uraemia, evaluate the effect of haornodlalysis on 
this defect, and to demonstrate by in vitro tests the effect of 
certain substances known to be elevated in uraemia on ADF-inducod 
platelet aggregation*
OHAFTER 3# 
m T m i A W  AED METHODS.
In this chapter is given an account of the materlale and 
methods used in the work for this thesis. A brief outline of the 
basis of each method and a discussion of some of the possible 
sources of error in the basic technique are given v/ith each method.
A short outline of the historical background to these 
techniques ia also presented.
Standard method# were used for the asseeement of platelet 
funotian. These include techniques for the estimation of the 
ability of platelets to aggregate in the presence of calcium ions 
and calcium plus ADF. Tests used were a Chandler tube system and 
the turbidimetrio method. ADF-induced platelet aggx*egation and its 
reversal was studied by the turbidimetrio method. The ability of 
platelets to adhere to glass surfaces was estimated by a modified 
Hellem’s glass bead coXimn method. Platelet factor 3 availability 
was determined by the method of Spaet and Cintron.
Experiments on the effect of factors influencing the results 
of some of the tests are presented.
Details of the method for collection and handling of blood used 
during the work for this thesis are also described.
Materials.
Adj3nQsiner5_rdiphoaphate was used in the form of the sodium salt 
ao supplied by the Sigma Ohemical Company, St bouis. This compound 
was prepared by dissolvin^ .^  the salt in a barbitone-buffered saline pH 
7,2. A stock solution was stored at -20^0 in a concentration of 
10 Mg per ml. in 0.3 ml. amounts. Just before use it was diluted
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with the saîîie buffer to give a final conceatmtioii of U.25 pg per ml 
of plasma for iiDF^ lnduced platelet aggregation* Iti the Chandler tube 
technique and the turbidimetrio modification it mis used ?ji a final 
concentration of 0.125 P-g per ml#
Barbitone^buffered ssilin© (pH 7#2) was made as followsî« 0#1M 
barbitone sodium, 5? ml# 0.1 H, liydrochlorio acid^ k3 ml# sodium chloride
0.56 gîB# 0.9 per coat sodium chloride to 200 ml. It was kept at 4^0 mid 
prepared freshly eirory week*
a stock solution
was prepared and used tM'oughout the study. The eoaoeatratioa was 
checked by titration (Douglas» 1961)#
(h^ tinime ^ solution. Creatinine supplied by Bigma Chemical Company,
St# Louie was dissolved in barbltone buffered saline to give a 
concentration of 0*2 gin per 100 ml.
Guaniditiosisecinio acid supplied
by Maim Heseareh Laboratorieog Hev; fork, H*Y#* was made up ‘Jia saline 
buffered to pH 7»33 with ono teagh volume of 0.09 molar imida'^ ole to 
give a concentration of 0*386 gm per 100 ml#
Ilidagple buffer. pH 7.2 * 1*72 gm@ imidazole (Koch-Light Xiaboratories,
Colnbrook, Bucks, ^ England) was dissolved ia approximately 90 ml 0,1 H 
hydrochloric acid; pH was adjusted to 7.2» diluted to 100 ml and stored
at »20®C,
S !^ â g 2 lS » S H S ^ lJ â 3 lM »  pH 7. 2. O.85 per cent <W/V) sodiina chloride
in distilled water was brought to pH 7*2 with one-tenth volume of imidazole 
buffer.
ImidaEipp.e^  ^buffered saline ^ pH‘7*35* 0.85 per cent (W/V) sodium
chloride in distilled water was buffered to pH 7*35 with one-tonth volume 
of 0*05 M imidazole (Kooh-Mght Laboratories, Oolnbrookg Bucks* sShgland)* 
Kaolin auspeiision* Kaolin (light) supplied by the British Drug House 
Ltd.* was washed in large volume of imidazole buffered saline pH 7*2 and 
3 per cent concentration was prepared in the same buffer,
O^phol^. 1 in 100 Bell and Alton platelet substitute (Diagnostic 
Reagents Ltd*, Thame, Oxon).
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Kaolfot 3 mgm per ml in 0*85 per cent (H/V) sodium chloride in 
dietiXled water*
Rucaell’fô viper venom (Btypvan, Burrougha, Wellcome and Company) 
was used at a concentration of 10 pg per ml in imidazole buffered 
saline (pH 7*2)*
Saline 0.86 per cent (W/V) sodium chloride in distilled water.
Urea stock solutiona. Urea supplied by Slgm Chemical Company, 
St. Louis, was made up in barbitone buffered saline pH 7.2 to give a
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conoetttrationof 20 gm» pez; 3.00 ml and 30 gai, per 100 ml.
Uric sold aolutioa 50 ms;, uric acid (Sigraa Chemical Company,inapt im 1 #1 ^
St Louie) woro dieoolvod In 100 ml, barbitono bufforod saline 
(pH 7.2) by gentle heating.
Tubing Transparent vinyl tubing Portland Plaotlce,
Kent) and plaetio adaptors (IOM/634? Portox) wore uaed in the Chandler 
tube method* For platelet adhoeivenose» transparent vinyl tubing 
(î^ /1 3  Portland Plastios, Kent) and translucent silicone tubing 
(Esco Rubber Ltd., London) were used in the preparation of the glass 
bead ooltumu,
[0 0*57 îiîiîî* diameter.
Collection of Blood.
All blood samples used in this thesis were collected by clean 
venepuncture using Zl G disposable needles and plastic disposable 
syringes. (Plastipaok, Beckon* Dickinson and Oompany* Ireland; and 
Grahams Medical Products Ltd., England)* Blood was withdrawn slowly 
and care was taken to avoid frothing. With the minimum delay* the 
blood was transferred from the syringe to graduated 10 ml. 
siliconized centrifuge tubes containing 3*8 per cent sodium citrate, . 
the relative proportions of blood to citrate being 9 to 1. The 
tubes were then covered with parafilm (Gallonlcamp, made by Lindsay 
and Williams Ltd.) and the blood and citrate were mixed gent3y by 
inversion 3 times.
FlMelet^rioh 4?la^ ma was prepared from citrated whole blood by 
centrifugation at 6OO $ for 5 minutes at room temperature in mi 
MBE major centrifuge (Hfeasiirlng and Boientifio Equipment Ltd.,
England). The blood was centrifuged within 10 minutes from vene­
puncture. The iilasma was gontîy pipetted off leaving the lower 1 ml* 
and transferred to another sllioonièod centrifuge tube* Experiments 
v/ero carried out immediately after separation of the plasma.
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Platelet poor nlaamg. GitsateA blQocl v/aa centzJifuged at 
3.200 e. for 10 Biinutes at 4°0 the supornatent two thirds o.f the 
plasffla vim cantidfugad again in a superspesd angle head at 10,000 g, 
for 5 tolnutos at 4®0. ïhe upper two thirds wore separated and
warmed to room temperature before use*
Slllconigc.a. was vm& for all oxporimento involving
study of platelet function* Two anethode were ueod to oiliconize 
the glasB ware* The fixot method used a water^ineoluble commercial 
silicone preparation Silicone I#4l (imporioal Chemical Induotrios 
Ltd*) as desoribed by Dade ( 1956b)* Later in this theais a water 
soluble comsioroial dlioone preparation v/ao used (Slliclad; 01^  
Adams Inc*, H.J*)*
Methods*
Ibaeurement of Platelet Aaÿ^ r^egatiûr^  in Vitro.
%  comparing the adheoivenees of whole blood and platelet-rich 
plasma, Hellem (i960) demonstrated that a factor present in the 
erythrocytes» was essential for platelet adhesion to glass* The 
subsequent identification of this factor as ADD (Gaardox* et al*»
1961) has led to the development of a method for estimating platelet 
aggregation in platelet-rich plasma (Born, 1962a; O’Brien, 1962b; 
Guthbertson and Mils, 1963; Born and Cross, 1963b; Mitchell and 
Sharpt 1964; Hardisty et al*, I964; Cook and Symons, 1965 and 
1966). The method depends on the observation that platelet
aggregation may be induced when ADP is added to platelet-rich plasma
which is being stirred (Born, 1962a)* The progress of platelet 
aggregation can be measured quantitativoîy by recording changes in
light transmission through the plasma sample, as the clumping of
platelets clumps occur (Born, 1962a)* The turbidimetrio method was 
first described by Born (1962a) and Born and Cross (1963b) and 
O’Brien (1962b)* Born (1962a), Dorn mid Cross (1963b) described a 
turbidimetrio method for studying platelet aggregation quantitatively in 
vitro* The mthod depends on the decrease in optical density
of plQDfâa which ocourrod when tho platelets aggregated* The 
initial optical denelty of piatelot-rioh plasma is found to ho 
proportional to the nuraher of platelets and vigorous stirring alono 
Causes only elicit decrease in optical density in 30 minutes# O’Brien 
(1962b) estimated platelet aggregation using a simple photo-electric 
colorimeter* He found that platelet aggregation is more rapid at 
37*^ 0, with rapid stirrii'îg, with high concentration of A #  and a high 
platelet count*
Outhbertson and Mils (1963) modified the turbidimetrio method 
of Born to permit temperature control and continuous recording of the 
state of aggregation in small samples of platelet suspensions*
A mininiuîii stirring speed is required to obtain aggregation for a 
given dose of ABF O’Brien (1962b)* Tho rate and extent of 
aggregation^  increased when stirring is increased from 100 to 600 r*p*m* 
but the of foot at 600 r*p*m* and 1000 r*p.m* was sirnilar (©’Brion, 
1962b; Born end Gross, 1963b)* Inoreaoing concentrations of ADP 
caused greater fall in optical density mid the logarithm of ABP 
concentration is proportional to the rate of fall in optical density 
during the first 30 seconds (Born mid Gross, 1963b; O’Brien» 1964)* 
Aggregation is more rapid for a high platelet count (O’Brien, 1962b; 
Bora and Gross, 1963b). The turbidimetrio method was further modified 
by Oook and Symons (1965) using a prottoombin meter (Evans 
EleatroseleniuiB Ltd.) described by Tooby and Cook (i960) ami later by 
another similar apparatus (Gook and Symons, 1966); these modifications 
also employ the principle of measurement of the decrease in optical 
density as a result of platelet aggregation* In these modifioatlone 
the assessment of platelet aggregation is Bieasured as the time in 
seconds taken by tho optical density to reach a pre-sot point on tho 
galvanometer scale. Optical density changes are also recorded 
graphically.
Simpler methods for estimating platelet aggregation are described
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by îtodisty ot al. (19^4) ««d by mtohell and Shisi-p (1964).
In the version described by Hardlslyet al# platelet aggregation 
is studied by adding the aggregating agent to platelet-rich 
plasma in a tube which is then shaken vigorously either by hand 
or on an automatic pipette shaker* The sample is then examined 
macrosooploally and niioroscopically for platelet aggregation.
Mitchell and Sharp (1964) estimated platelet clumping in glass tubes 
at room temperature# ADP is added to platelet-^ rioh citrated plasma 
and the mixture shaken gentJy and observed against a dark baekgTound 
under powerful oblique illumination. To determine the nttnimum 
effective concentration of an active agent» doublin.. dilutions of the 
agent in saline are prepared and the lowest concentration of the agent 
which would produce visible clumps within one minute is taken as the 
end point for that system# They found that the threshold 
concentration needed to produce visible clumping in 60 seconds is 
0*04 Mg. ADP per ml* Platelet aggregation in platelet-rich plasma 
can also be measured using an artificial circulation system 
(Cunningham et al.* I965)* In this technique» recalclfled platelet- 
rich plasim is rotated in a loop where it forms an artificial thrombus 
with a platelet head and a fibrin tail# The platelets clump together 
to form macroscopic aggregates before fibrin formation occurs; the 
time is recorded botwoen reoaloifioation and platelet aggregation.
Of those methods the following have been used;
1# The Ohanctler tube method#
2# The turbidimetrio method#
Me asur omen' ijtoecl Jby^ Q^alcijiffl
ÆMMleg-I&MJgoMfaue,.
This method is based on the observation made by Chandler (1958) 
that if blood is made to flm round a closed loop of plastic tubing, 
a thrombus is formed which resembles in vivo thrombus histologically*
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If whole blood is replaced by platslet-rioh plasms In this system, 
at an interval following rocalcifioation a "snov/ atorm" of platelet 
aggregates appears# Those aggregates eventually consolidate to form 
a white thrombus and 3ater the fibrin tail of the tlirombuo becomes 
visible (Ounningham ot aU, I965)*
In the present experiments, tho time interval between 
recalcifioation, or the addition of calcium plus ABP and tîie appearance 
of tho "snow storm'" effect » was used as a measure of platelet 
aggregation#
The method is a modifioation of that described by Gunningham 
et al*, (1965)* A length of vtïiÿtl tiibing (71 cm.) havi% a boro of 
5*5 mm. (®/l3 Portland Plastics, Kent) was siade into a loop by moans 
of a plastic adaptor (lOA%/634, Portex)# The loop was first washed in 
distilled water, then rinsed thoroughly in 0*9 par cent sodium 
chloride*
Two tubes were used in each fxperiinenti to each tube were added 
1 ml* platelet-rioh plasma and 2*0 jil* 0,9 per cent sodium chloride* 
Into the first tube were also added 0*1 ml* caloittm chloride 1i/4 and 
0*1 ml, saline, and in the second 0*1 ml* ADP (final concentration 
0*125 t^ g/ml) was added instead of the saline* As soon as these 
reagents wera added one stop watch was started for tube 1 and two for 
tube 2* Tho two loops were then rotated on the turntable of a blood 
cell suspension mixer (&tburn Ltd., London), rotating at 28*5 r*p*m, 
in a glass fronted incubator at 37^ 0*
The results were assessed as follows;- for the first tube 
the end point was the first visible appearance of platelet aggregates 
(snow storm). For the second tube the first appoarame of platelet 
aggregates mediated by ABP was recorded and after disaggregation the 
time from recaloification to aggregation preceding fibrin formation 
was also noted*
35
2* The Tugbidimetgic l\^ thoA*.
Tho turhiclimetrio method ao deooribed l>y O’Brien (1962b} and 
Born and Q m m  (1963b) was used to moasnro the platelet aggregation 
by recording the changes in optical density ooourring as a result 
of reoalcifioation of diluted platelet-rich plasma with and without added
Platelet-rich plasma is diluted 1*4 with barbitone buffered 
saline pH 7/2, then 1,9 ml, of the diluted platelet-rich plasma were 
transferred into a perspex cuvette containing a magnetic stirring rod 
and fitted onto an EEL titrât or, The platelet-rich plasma was 
allowed to stir for 30. seconds, the optiool density was then adjusted 
to 0,600, 0,05 ml, M/4 calcium chloride and 0,05 ml, barbitonc 
buffered saline added and a stop watch v/as started. Optical donoity 
readings wore then taken every 5 seconds until clotting occurred, A 
similar experiment v/ae carried out in which ADP (final concentration 
0,125 M^ ?/ml, ) was substituted for the borbitone buffered saline and & 
third in which ABP v/as used without calcium chloride, and the optical 
density readings were talmn every 5 seconds for 10 minutes, These 
experiments were also carried out on tho diluted platelet-rloh plusim 
further diluted 1*2, 1*4, with platelet-poor plasm, X^ latelet counts 
wore done in duplicate on the diluted platelet-rich plasma.
All experiJTiejnts were performd on the same EEL titrator and 
galvanometer but the order in which the three experiments were carried 
out was varied at random from plasma sample to plasma ©ample,
The optical density readings were plotted on graph paper. Several 
phases of optical density changes were regularly found to ooour, and 
the oua?ve of £alcium A^DF a^:roaution was divided into five 
phases (figure 9)#
2- SiageJ: ^8 moasured from the time of addition of the
ag'gregatxng agents to the point of maximum ag'gregation and 
represents the initial platelet aggregation, probably mainly
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dUG to ADP.
2. Phase .2 is maasurod from the point of maxiiMi aggregation
to the point of mxirmisi disaggregation of platelets 
following initial aggregation#
3* Phase 3 where the optical density remains stationery.
4* Phase 4 represents a slight increase in optical density
which occurs before tho second phase of platelet 
aggregation#
5. Phase 5 represents tho second phase of platelet aggregation
immediately occurring before clot forroation.
In tho oalcium-nlOftelet a^%^e^mtion only phases 3» 4 and 5 are 
present (figure ?).
The results of the turbidimetrio method were expressed ao 
followci-
1. A^ ggremitiqn time is the time at which tho first lowering of optical 
density in phase 5 ie recorded.
2. Onticai density fall in phase o ia masured by subtracting tho 
optical density recorded just before the beginning of phase 5 
from the optical density recorded just before dot formation.
3# The duration of phase 5 is measured as the tlm taken by 
platelets to aggregate in phase 5*
4# The dotting time is the tim at which the first increase in 
optical density is recorded after maxisra aggregation in 
phase 5»
5* ^30?60..platd#^a^^ is the fall in optical density
between 30 and 60 seconds and was used to determine the offeot 
of calcium on ADP-induced platelet aggregation. This was done 
by comparing tho results of 30-60 platelet aggregation in both 
A3)P and ABP plus calcium platelet aggregation expérimenta.
Galcium and oalciura plaa ADP platelet aggregation in a normal 
control (tables 6 and 7» fig^ ires 7 and9) and a uraemic patient (tables 
8 and 9? figures 8 and 10)$ both having nearly the came platelet count »
3?
were selected to represent the optical density changes oocurriiig 
in these experimente.
TurMiMQtyio fethod
The apparatus used in this study eoueieted of an EEL titrator
oonneoted to a galvanometer (BBIL» type 20» Evans Electroselenium,
Ltd# 3 TûiQlmà) figure 5# A perspex cuvette was fitted onto the
titrator above a magnetic stirrer and in the path from the
photo-electric cell# Two ml# distilled water were delivered into
the cuvette together with a small stirring rod# Both the stira?ing
motor and the light source were svdtohed on and by means of tho zero
control knob, the hala? lino m m  brought to infinity on the upper
galvanometer scale and then brought to zero by the sensitivity knob#
Au idoutioal Olivette containing 1#9 ml# platelet-rloh plasma and a
stirring rod was substituted for the blank and a stop watch wae
started at the time th# cuvette was placed in position on the
mohine* Tho optical density reading was then adjusted to 0#600
by the sensitivity knob# The plasma was left to stir for 30 seconds
and at%r change in the optical density during this period was
corrected by returning It to 0#600* At tho end of the 30 seconds#
tho aggregating agent was then added in 0#I ml# quantity a M  a stop
watch was started# Tîio aggregatiîîg agent was always delivered on
the wall of the cuvotto near the surface of the plasma and away from
the light path, caution was taken not to allow formation of air bubbles
in the sample# As platelets aggregated tho light transmission through
the sample was increased and was recorded aa a fall in optical density
on tho galvanometer scale, and as platelets diceggregafcecl an increase
in optical density resulted# Changes in light tran^ Biission using a
green filter (bo# 604 Beale length 5200 Angstrom units) were recorded
by talcing optical density readings every 30 seconds over a period of
ten minutes (or longer), from the time of addition of tho aggregatiîig 
agent#
All experiments unless specified v/ere carried out at room
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temperature# In an experiment done at 37 0^, tho titrator was placed 
in an Ineubator at 37^0 and left for half an hour before starting the 
experiment# The platelot-rlch plesïm wan separated In a 
ellioonised tube and inoubated together with an empty perspex cuvette 
at 37^0 for ten minutes# The cuvette was then filled with the platelet- 
rich plasma, placed in tho titrator and the experiment was started#
All experiments were carried out at a fixed appropriate epoad* Tho 
stirring speed selected caused only a miMrnum vortex In tho plasma, 
and in no way interfered with the light path#
Paramotem Plat.elQ.t Agrégation
and .Msa^^^ogation#^
Platelet aiOi^ rofrntign was measured by tho following parameteroe- 
1# 30-60 platqlet aggremtiout Tho fall in optical density
between 30 and 60 oeconds, this being tho steepest part
of the curve#
2. 30-90 platelet, q/%gregatiop* The fall in optical density
between 30 and 90 seconds to include the main part of
the optical density fall duo to aggregation*
3# Maxiifluua a^ im?a>Q:atio.n$ This is measured by subtracting 
the lowest optical demity recorded from the optical 
density before addition of the aggregating agent#
4* ti This is tho time taken by
platelets to reach the first lowest optical density 
recorded#
PlatelejL^disM^
1# FerqentQ^ q^ disa^ Q^ f^ re^ ation was considered m  -
increase in optical density in five minutes from the
  ....
fall in optical density duo to maximum aggregation 
3* Di.Bai^ Aregatlon time* is the time at which tho optical 
density shows its first increase from the lowest optical 
density recorded#
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Galculations when the nuixiraum aggregation or die aggregation 
times ?/ea?Q in excess of 10 minutes utilized the u5?bitrary figure 
of 600 seconds#
Factors affecting tho results in the Turbidimetrio I&thod#.
The method used in the v/oaAc of this thesis to measure platelet 
aggregation can ho affected hy a^'mmhor of variables which may modify 
the results obtained* Of those, the effect of valuation in 
haematoorit, plasma white cell count, stirring speed and Incubation 
temperature were studied experimentally and the results are discussed 
below# The ABP concentration added was fixed at 0#25 pg* per ml* of 
plasma* An appropriate fixed speed was used and experiments were done 
at room temperature# The effect of platelet count on the results was 
studied by vaa^ing the platelet number through addition of platelet- 
poor plasma to platelet-rich plasma (Chapter 5)»
The Effect of lowering? the Haematocrlt on ABP-induced 
Hatelet.. ,AfiCTemtion..
Seven experiments were carried out in which the haematoorit was 
lowered in vitro by adding platelet-poor plasma to whole citrated blood# 
3*5 ml# platelet-poor plasma was added to 6,5 ml* citrated blood in & 
siliconized graduated centrifuge tube# The contents of the tube wore 
mixed by inversion 20 times and contriguged together vdth another tube 
containing undiluted citrated blood (control), at 600 g* for 5 minutes 
at room temperatux’e# Platolet-rioh plasma was separated from each 
tube and ABP-induoed platelet aggj?egation was carried out as described 
previously#
The results (table 38) showed that platelet aggregation was 
diminished as the haematoorit v/as lov/ered# There was also a 
diminution in the platelet count# The 30-60 platelet aggregation 
although diminished was within the normal range t g standard deviations 
in 6 out of 7 experiments# Hoc/evor the results of 30-90 platelet 
aggregation and aggregation wore below tho lower limit of normal
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:ln four out of eeveu oxporimonts* There was no eignifioant change 
in the maximum aggregïation time, dicaggi'egution time and percentage 
disQgaregation, all were vMthin tho normal limits in tho 7 oxporiments 
performed#
From the results it can be concluded that the diminution in 
platelet count that accompanied the lowering In haematoorit partly 
explains tho diMnution in platelet aggregation# Another factor l8 
that tho larger platelets tend to sediment with the red cells and 
white colls (Mitchell, I96B). Stormorken et el#, (1965) have 
shown that there io also selective sedimentation of the more 
adhesive platelets#
However, the 38-60 platelet aggregation was not significantly 
affected by lowering, the haematoorit, and as it was the paroraeter which 
gave eignifioant differences between normal controls and uraemic patients, 
it can be concluded that the abnormlities in platelet aggregation and 
disaggregation were not to bo wholly attributed to lowering of the 
haematoorit.
ghe lfge«s». ..of m i t e gellB. .ot^ M)g»inattqoA_ffat.e,Xe;fc-. 4^^
White coll counts wore performed on 9 normal controls and 7 
uraemic patients, using a OouXtor counter (Coulter Electronics, Ltd.)
In one patient, with clironlo renal failure tho count was done before and 
after haemodlalyeis (table 37)* Ho significant difference was 
obtained between the mean white cell count in normal controls and the 
mean value of uraemic patients (t « 0*334, F> O.l)#
The effect of white cells on ADP-itidueed platelet aggregation has 
been studied by Harrison et al#, (1966)# Flatelot-^ rich plasma from 
citrated blood is separated into two fractions, the first is the top 2 
ml# and tho second contains tho romalndor of tho plasma, talcing the 
pipette as oloae to tho huffy coat as possible# Tho top fraction 
contained loss white cells than the bottom fraction# Although the 
bottom fractions of plasma showed slightly more active reversal of
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ABP-induoed aggregates than the top fraction, the difference in 
reversal between the two is not significantly correlated with the 
difference in their white cell count.
In the work for this thesis, the platelet-rich plasma was 
separated leaving the bottom 1 ml; the plasma separated was then 
mixed by inversion and tested.
The Effect of the Stirrin# Speed on ADP-induoed,ii Iw i«-i w nhTiBiwTiPu^ iiaiiiil#>#xii»iMi ■ i iwu i
Platelet Aav?:3?eA~ation,
The effect of the stirring speed was studied by increasing 
decreasing the speed by one quarter turn of the speed knob in the KEL 
titrator.
iVo experiments were conducted in which ADP-induced platelet 
aggregation was done using a high, low and the ordinary speed used in 
all experiments. The results in table 25 showed that increasing the 
stirring speed caused lees platelet aggregation and earlier and more 
complete disaggregation. Using a low speed, although the effect on 
aggregation was not constant compared to tho controls yet less and 
rather do leered dioaggp?ogation resulted*
O’Brien (1962b) has shown that the degree of agitation of plasma 
influences tho extent to which platelet aggregation occurs* He found 
that at a low stirring speed no aggregation resulted. Increasing the 
speed caused platelets to aggregate but has not increased significantly 
the maximal rate of fall inoptioal density.
The Effect of Intubation TeBiperature on ABP-induoed 
.glalolQji AgflJOgation.
An experiment was carried out in which platelet-rich plasma was 
incubated at 37^8 for 10 minutes. ADP-induced platelet aggregation 
v/as then performed at 37*^ 0. The results from this experiment showed 
that platelet aggregation 'was diminished and early and more complete 
disaggregation occurred v/hen compared to another experiment done at
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room température (table 35)# These results were similar to the 
flndiii^ p of O’Brien (1962b) that platelet dis aggregation is greatest 
at 37^C and does not ooour at 0*G,
The turbidimetrio method measures changes in optical density, 
but whether a large number of small platelet aggregates can cause a 
greater fall in optical density than a small number of large 
aggregates is not clear. Moreover it is not knovm whether the number 
and size of platelet aggregates bear ar^ relationship to the rate of 
aggregation and disaggregation. Born and Humo (196?) investigated 
the relationship between the optical density and the numbers and sizes 
of aggregates. The results showed that the increase in light 
transmittance ia associated with two effects, namely the formation of 
aggregates and their increasing density. Formtion of platelet 
aggregates begins before there is any change inMght transmittance. 
During this time, tho concentration of single platelets decreased 
steeply as they associated to form small aggregates. The number of 
these aggrogates reached maximum about the time when the light 
transmittance began to increase# The subsequent increase in 
transmittance is associated with a progressive diminution in the 
number of both single platelets and small aggregates and the formation 
of fewer larger aggregates in which the platelets are no longer 
countable. During early aggregation, the density of the aggregates 
diminished, indicating that the platelets were packed loosely with 
considerable space between individual platelets.'Born and Emae(l967) 
also demonstrated that the initial velofCity of increase in light 
transmittance is a measure not of the rate of formation of small 
aggregates from single platelets, but of large aggregates from small 
aggregates. Furthermore, a high initial velocity is caused much more 
by aggregate contraction than by agg}?egate formation.
Their findings suggest that any mathematical expression of the 
relation between the light transmittance and the aggx*agation process is 
bound to be complex.
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Methods toy the %tlîaatlon of Platelet AdheslveMom^
in Vitro.
BacîS? anâ BsekoXy (l929) oatlmtod the deo^oaeo of platelet mmabeie 
in plasma after otoragge of the plasma In glase containers* Baas (X94I) 
eiaiïaed this to be the first test devised for platelet funotion. In 
1930 îuorawita and Jurgens constructed an ap|?aratus they called 
**Eapillar-thrombomoter** consisting of two pumps which draw blood 
without antiooaaulant through a calibrated glass capillary tube and 
the direction of the blood stream is alternated at intervals* The 
time taken by the blood stream to stop due to plugging of the 
capillary tube by platelets is taken as an indirect measure of the 
adhesiveness of platelets*
Methods described for the study of e^traoorporeal thrombosis 
(Hountrco and ahinoya» 1927; Best ct &!** 1938) were used to estimate 
platelet adhogivonesc in a somiquantitative way* The prinoiplo is to 
shunt the blood atroam from arteries to veins through tubes or chambero, 
in which thrombi are formed after a certain period* The time required 
for the formation of white thrombi or for plugging of the iiubm is taken 
as a rough estimate of platelet adhesiveaosa*
The first real attempt to measure platelet adhesiveness 
quantitatively was made by Wright (1941)# The principle of the method 
is to transfer blood mixed with anticoagulant to a special glass flaal: 
whose sides have boon ^ ound away to form two windows each about 
1.5 cm. in diameter* The windows are covered with uncoated glass, 
while the internal surface of the bulb is coated with melted vaseline* 
The tubes are rotated at 3& revolutions per minute and every twQBity 
minutes platelet counts are made in samples withdrawn from the tube, 
and the results are expressed as percentages of the initial count*
tn 1949» Mbolten and Vroiaan devised the glass wool method, in 
which the time of contact between the platelets and glass am?faoe is
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Qhortoned* After a "delay time" of 10 juimtoe from the vonopunoture 
1 ml* of citratod blood ia passed through a triple-plait of glass 
wool braid previously moistened with 1*5 ml* physiological saline 
solution* The red cells and platelets are counted in the blood 
sample before and after filtration* The platelet adhesiveness is 
calculated from the ratio rod oells/platel.ts in both samples* The 
platelet adhesiveness can also be measured by the method described by 
Rovatti (1951) using the capillary pm?t of a red cell counting pipette 
as foreign surface* In the method of Bevol (1954) platelet-rich 
plasma is deposited between a slide and a cover-glass and examined 
microscopically for spreading and adhesion to glass*
Itex and Borlath (l957) described a method in which oitratod blood 
is run into a capillary tube of a fixed length and bore* The tube is
then tilted for a fixed time and the difference in the platelet number
before and after the procedure is the mmber of adhesive platelets.
The first of the glass bead column methods was described hy HeHorn 
(i960)* Kstimation of pistolet adhesiveness is carried out in 
oitrated blood. By an olootrically-driven mechanical device the blood 
is pushed from a graduated syringe through a standardized glass bead 
column at a constant rate* Tho reduction in platelet count after 
passage through the glass bead column is taken as a measure of platelet 
adhesiveness*
A siiüilar method was devised by O’Brien (196I) in which native 
or heparinisGcl blood is allowed to corne in contact with a
standardized glass bead colmm* The contact time is short (15
seconds) compared to Hellom’a technique* An initial platelet count is 
imdo on the blood before passage tîirough the filter, a second count is 
made on the first drops of blood coming from the filter, and a third 
taken I5 seconds later when about 1 ml* of blood hasn passed through the 
filter* The difference between the initial and the second count 
expressed as a percentage of the initial count is considered as a 
measure of the number of the platelets that stick in the leading front
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of the blood passing over a large dry glass surface of known area*
The difference between the initial and the third counts, expressed as 
a percentage of the initial count, is a measure of the number of 
platelets that stick to glass which had been in contact with blood 
for 15 seconda*
Xn S^ iXzman’s method (1963) a control vonouo blood sample is 
collected in etl^lone-diamine tetra acetic aold (disodium salt), a 
second venepuncture was then performed in the opposite arm with a 
siliconized needle and blood is made to pass directly through a 
standardized glass bead filter into a  ^ml# "i/aoutoiner" tube 3204% 
(Beoton, Dickinson and Company, Rutherford# ) containing ethylene 
diamine tetra acetic aoid (dlsodlim salt) as an anticoagulant* The 
negative pressure in "Vaoutainer" tube io uniform within i 2 mm, of 
mercury* The rate of filling of the collection tube and the time of 
contact of blood do not vary appreciably from one determination to the 
next*
The diffcreme between the platelet counts in the control and 
test blood samples is expressed as percentage of the control count and 
talr.en as a value for platelet adhesiveness*
Oalzman’s method differs from Helleiîî’s technique in that native 
blood is passed through the glass bead column directly from the vein* 
The rate of blood flow during passage in the column is rapid (I8O-36O 
cm* per minute versus 28 cm. per minute in Hellem^s method). The time 
of contact of blood with the glass beads is also shorter than in 
Hellom’s method (l.? - 4*5 seconds versus 30 seconds).
Hume {1966) described a ,simple method in which one ml. of 
native blood is drained by gravity through a vertical column containing 
1 gm, of glass beads* fho effluent is collected in a plastic 
container with dried ethylene diamine totra acetic acid* The 
percentage adhesivenosB is determined by noting the difference in 
platelet count between the OBlglnel eample ana the aamplo which has 
paeoea through the ooluim. Shis method la Influenced by the
46
hæmatoorit as it will detormina tha aaount of ADP liborateâ from 
tho red colla m â  also the rate of flov/ through the oolmm#
All these methods have advantages and disadvantages# It wao 
decided on an arbitrary baeio to select the modification of Eel lorn’a 
technique as described by Hirsh et al#s ( 1966$ #^
BSethod for Platelet Adhesiveneas»
The technique used in this thesis was a modification of HeXlem’s 
original method (Hirsh et al#* 1966a)# The glass bead oolumm were 
made by filling a length of transparent vinyl plastic tubing 
("Portez" code number HT/13, Portland Plasties limited, Kent) with 
2#5 grammes of Ballotini glass beads (0#57 ssu diameter) to give a 
column 6 cm* in length# The glass beads were held in the column by a 
filter of fine stolon gauze fitted at each end of the column by end 
pieces made of "Bsco" translucent silicone tubing (^ mth bore, 2 mm# 
wall)# Blood was collected by a clean venepuncture into disposable 
plastic syringe as described on page 30 and mixed with 3# 8 par cent 
sodium citrate solution (one part citrate to nine par?ts of blood) by 
gentle inversion 3 times in siliconized graduated centrifuge tuba; 
using parafilm over the end of the txibe.Htio blood was allowed to stand 
at room temperature for 30 to 45 mimâtes# Just before storting the 
test, the blood was mixed by gentle inversion for 20 times using 
parafilm over the end of the tube and then delivered into a 5 ml# 
polystyrene tube* 2 ml# of this blood was drawn into a 2ml# graduated 
plastic syringe ("Plastipi^ k", Becton, Dickinson and Co#, Ireland) which 
was fitted to one end of the glass bead column# The syringe was then 
fitted to an eleotrioally»*drivon mechanical pump which gives a constant 
speed and the blood was forced to one end of the glass bead column# at 
a constant rate (figure 6)# The time talcen for the leading edge of 
the blood to traverse the whole length of the column was measured#
ÎFslîii^’ the same purap, syringes and glass bead columns* the blood-glsso 
bead contact time was 30 Ï 1 second# Any observations lying outside
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this range ware discarded# The blood Issuing from the oolumn was 
oollGQtecl in another 5 ml# polystyrene tube# The two blood samples, 
before and after passage through the column were mixed 10 times by 
inversion and duplicate platelet counts were performed on each smmle# 
0?he difference between the two counts was expressed as a percentage of 
the initial platelet count, and this value was taken as an index of 
platelet adhesiveness in the smiple# The haoiuatocrit was estimated 
in the oitratod blood sample using a microhaematoorit centrifuge 
(Hawksley, London)*
As with all glass bead methods, this technique is dependent on
variables which can influence the accuracy of the results# 
Variations in the size,, shape and surface area of the glass beads and 
their surface properties as regards adsorption of trace moisture* oils, 
et# , m y  be of importance# In Hellem’s original method (i960) It vms 
found that platelet adhesiveness increased as the glass surface area 
was increased, and some investigators noted difficulty in obtaining 
consistent results from one batch of glass beads to the nezct 
(iSucker, 1963; O'Brien and Hey wood, X967)# The bore and surface 
characteristics of the plastic tubing is another element that must bo 
standardized# The presence of the personal factor in platelet counting 
has not been completely solved by the use of electronic counting*
Hellem (1960) showed that adhesiveness depended directly upon the 
haematoorit# This observation was confirmed by other investigators 
(Hireh et al#, I966, a^ bj MoDlure et al#, I966)# Appropriate 
corrections were made either by adjusting the packed cell volume by 
adding red cell conoentratos or mathematically from the percentage 
adhosivenoss - packed cell volume curve* Harrison and mtohell (1966) 
found that reduction of erythrocyte ABP by enzymatic phosphorylation 
also reduced the platelet adhesiveness in Wright's roller flask method, 
but such studies have not yet been carried out with the glass bead 
colurm method* The question whether the rod cells influence platelet 
adhesiveness as inert particles by affecting the flow through the
4à
oolmim is still to be answered*
Leuooeytes in norml blood were found to otiok loss than 
platelets to glass* O'Brien (1961) xmltig hie own method found no 
retention of Xeucooytes to the glass bead eolmm# and it seem that 
leucocyte stiokiness is not greatly influenced by the factors that 
QDMB0 platelet adhesiveness (Garvin, 1961* Allison and Lancaster*
1967)#
The driving force which controls the rate of flow of blood tlirough 
the glass bead coIoti oan bo precisely controlled In the Hellem'e 
technique* However* this precision is obtained at the expense of 
using an anticoagulant (citrate)* any minor changes in the 
coiioentration of which can markedly affect the adhesiveness of 
platelets (Eellem, lg60$ ÎÜrah et al», 1966b)#
In conclusion It seems that in the method used for platelet 
adheaiveness some variables auoh aa the platolet#^ glase bead contact 
time* the glass beads, the plastic tubing om  be etaii4ardiwod# Tho 
persoml factor in platelet counting can be reasonably controlled* 
by coding and the use of electronic counting# "Blind" counting was 
adopted in the present study ms electronic counting was not available# 
Other factors such m  the effect of orythrocytes and leucocytes, the 
use of anticoagulant are variables ?/hloh present problems inherent 
in the method*
Platelet Adhesiveness* %rrqotion Ourv<^  for Pa^ dced Oe.ll. .yplume#.
Eighty ml# oitrated blood were collected as described above end 
40 ml* were then centrifuged at 1200 g# for 10 niinutes at 4*^ 0, the 
supernatant plasma was oentrifugod again at lOjOOOgfor 3 îïdnutoa and 
the upper two thirds of plasma was pipetted off* Eight experiments 
were carried out in which oitrated blood was diluted with platelet- 
poor plasma* to obtain decreasing packed cell volume values'# The 
blood waa diluted with the appropriate amount of platelet^poor plasma 
(table 45)* the tubes inverted 20 times and inaodiate’iy passed through
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the glass bead column*
Platelet adhesiveness was estimated as described above, and was 
found to be significantly correlated with corresponding packed cell 
volume Values (figure 33)* The curve obtained was used to correct 
the platelet adhesiveness results in both normal subjects and uraemic 
patients#
î&asurement of Platelet Factor 3 Availability*
Platelet factor 3 is probably a lipoprotein (Shinowêira, 1957) 
which the platelet contributes to the interaction of plasma coagulation 
proteins in the formation of intrinsic prothrombin activation 
(Horowitz and Tfercus, I964)*
Platelet factor 3 was first found by van Creveld and Paulssen 
(1953) in combination with platelet factor 4, the antiheparin factor, 
in a water insoluble lipid moiety of platelets# The distinction between 
the two factors was made possible by ultracentrifugation (Deutsoh,
1954$ Jurgens, 1954; Deutsoh and Kain, 196l)* The lipoprotein was 
extracted from platelets by freezing and thawing and/or sonication* 
Impm?ities wore removed by adsorption \7ith kaolin and charcoal and 
platelet factor 3 was then sedimented by high speed ultracentrifugation 
(Alkjaersig et al#, 1955), or was separated by barium sulphate 
adsorption and elution (Stefanini and Campbell,1994)#
Platelet phospholipid has been localised in platelet granules 
(Johnson et al#, 1959î feupin, 1959, Panic, I960), and more recently 
in both platelet granules and membranes (Marcus et al#, 1966)#
The Observation that the Russel Viper venom or "Stypven time" 
of intact platelct*rieh plasma is barely shorter than that of platelet- 
poor plasma, and that disx*uption of platelets greatly accelerates 
clotting (Pantl and Ward, 1958) has led to the belief that in normal 
circulating platelets the phospholipid is not available for the 
coagulation reaction# When platelets are fragmented (Pantl and Ward, 
1958# O'Brien, 1958) or washed (îtecus, I969) they become more active
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in accelerating the Stypven time*
Platelet factor 3 was determined qunntitatively hy Alkjaersig 
et al*, (1955) using a platelet extract prepared hy ultrasonic 
treatment of packed platelets# Addition of this extract to a 
reaction mixture of purified prothromhin, antihistamine and calcium 
results in the generation of thrombin* the concentration of which is 
dependent on the amount of platelet factor 3 added.
The "Stypven time" was used by fantl and Ward, (1958) to
determine the availability of platelet lipids in platelet-rich plasma 
which has been frozen and thawed* O'Brien (1958) applied a similar 
method but used Eicchanioally fragmented platelets*
Product I substrate time vms used by Des Pros et al., (I96I) to
determine the availability of platelet factor 3 following the 
incubation of platelet^rich plasma with endotoxin. Preformed product 
I (diluted serum, adsorbed plasma and calcium) and further caloltun 
were added to tost plasma and the clotting time of this mixture became 
shorter in the presence of more available phospholipids*
One of the most commonly used methods for measuring platelet 
factor 3 activity is the thromboplastin generation test (Biggs and 
Douglas, 1953)* Abnormalities in the test have been reported in 
uraemia (Gahalane et al*, 1958)* However, this was not the experience 
of !fercus and 2îuoker (1965) who found no abnormalities in patients 
with suspected thrombooytopathy#
There are disadvantages of using this test for detecting platelet 
disfunction; e*g* a large volume of blood is needed to obtain 
sufficient platelets especially in thrombooytopaenic patients and 
children, groat accuracy is required and the normal range is wide*
Bonnin and Cheney (196I) described the "platelet thromboplastio 
function test" which is a modification of the thromboplastin generation 
test of Biggs and Douglas (1953)# Platelets used in the test were
I  . 5 1
f
Qbtairicd by eontriftüging platelet-rioh plasma m à  removing the 
supernatrmt# Hormal B B l i m  In them added without disturbing the 
platelet button and the tube reoentrifuged# The supernatant is 
removed and the platelet button emulelfled in oerim# It la then 
inoubated with aoetom, dried ehlorofom extracted brain suapenBiom 
and reoalolfied. Aliquots of this jaixturo are added periodically 
with oalcium to high spun oubstrate plaom, and the clotting times 
determined* According to Boimim and Cheney (196I) the résulta of 
this technique are better related to the clinical occurrence of 
haemorrhage in thrombooytopaemio statos than those of the thrombo- 
plaatin generation teat* The tost is also found to show 
conaiatently reduced platelet thromboplastin function in 18 uraemic 
subjects* Cheney and Bonnin (1962) later reported the same abnormality 
in 28 out of 3I uraemic patients*
% li (1961) and Hucom (196I) desorlbed a simple one-stage method 
for the assay of platelet factor 3* Husom's teat is based on the 
determination of the reGaloifieation time of coatact activated platelet 
free plasma enriched with factor V and ?IX through the addition of 
adsorbed platelet free plasma* The platelets after washing, freezing 
and thawing, are tested in their own plasma in high dilution*
The prothrombin conaumptlon has been used by many workders to 
measure platelet factor 3 activity in various platelet dy of m ot ions,
The test was shovm by many authors to be abnomal in uraemia 
(Larraln and Adelson, 19563 Lewis et al*, 1957# Rath et al#, 1957; 
Oahalane et al,, 3.958$ Geiger et al*, 1959# O'Grady, 1959;
Alachuler et al*, I960; Donner and Heuwirtova, I96O; Wurzel, I96O; 
Kendall at al,, 3.961; Willoughby and Orouoh, 1961; Salzman and 
Heri, 1966; Oastaldi et al,, 3966; Stewart and Gastaldi, 1967)*
In the method desoriljed, platelet phospholipids are made 
available by disrupting platelets, either by freezing and thawing or 
by mechanical fragmentation* Iteeover, platelets used are subjected
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to washing or sedimentation and the tramaa to which the platelets 
are subjected mBy thus render the results of little pliysiologioeJ. 
significance,
ïlardisty and Hutton (1965) described a method for studying 
platelet factor 3 availability based on the kaolin clotting time of 
platelet-rich plasma* Inoubation of oitruted platelat-rloh plasma 
with kaolin mokes about l/20th of the platelet phospholipid 
available for coagulation but had no such effect on red cell phospho­
lipid, Spaet and Gintron (I965) cleTised a similar method for 
studying platelet factor 3 availability, Huoeall viper vonoEi v/aa 
used to activa vO factor X affactively and rapidly, 'Stypven' time 
were determined on "intact** platelet-rich plasma after incubation 
with either kaoldn or connective tissue fragments, Platelet factor 
3 availability developed In response to kaolin in citrate# but not 
in plasma antiooegulated with EBTA* Hovmvor commetIve tissue 
fragments were effective in both types of plasma*
The most recent test fbr platelet thromboplastlo function was 
described by Horowitz at al,, (X967) where ÀDP was used to activate 
platelet factor 3 in oltrated platelet-rich plasma* The 'Stypven' 
time was then determined#
The use of 'Btypven* in the method of Spaot and Olntron causes 
full activation of factor X, with subsequent conversion of 
prothrombin to thrombin in the presence of phospholipid and factor ¥, 
This method was therefore selected for use in the present study,
.3,,
She method «aed ia this study vjaa simiXesj to that desori.bod by 
Spaet and Ointson (1965). 'So 0.9 ml. of plataleWlch plasma 
obtained as deaorlbed earlier# was added 0.1 ml. g pea? cent kaolin in 
a sllioonlsed centrifuge tube. ®ho two reagents were mixed by gentle 
shaking 10 times and then left undiatusbad in a water bath at 37°0
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for 30 minutes. After :kicubation the plateXet^ rleh plasma and 
kaolin were mixed by resusponding the kaolin uoJiig a silieonlsed 
pipette 9 m u\ 0*1 ml of the mixture vjas added to 0,1 ml M/40 
calcium chloride and 0*1 m l Russel, viper venom (10 pg per ml)*
A stop watch was started and the clotting time determined,
Duplicate readings were carried out on each sample, Borne of the 
experiments were carried out using platelet-rich plaama diluted with 
platelet-poor plasma to determine the "stypvon time" at different 
platelet rich plasma counts,
The principle of this test (Biggs miâ Mmeféirlaneg 1956) is tîmt 
plasma is recalcified in the presence of a platelet substitute after 
the plasma has bemi exposed for a standard preliminary period of two 
minutes to a suspension of kaolin* Heduoad levels of plasma factors 
Ig Ilf ¥§ Vlilg XKf Xg XI and XII will result in a prolonged clotting 
time* Although this test has overcome the disadvantages of the 
r ec aid float ion time and the partial throniboplastxja time g it still 
has its own ehortcomlngs* Elevated levels of one or more individual 
factors or the presence of active intermediates which would tend to 
reduce the clotting time may mask a prolongation of the clotting 
time due to a deficiency of another factor# Minor deficiencies 
in several, factors may on the other hand result in prolongation 
of the clotting time.
Method
0*1 ml of plasma and 0*1 ml of Bell and Alton platelet 
substitute are pipetted into a clotting tube and left for 1 miiiute 
in a water bath at 37^ 0* 0*1 ml of kaolin suspension (3 mg per rnl
in saline) is then added and after 2 minutes 0*1 ml of M/40 calcium 
chloride is added and a stop watch started* The tube is gently 
tilted at 3 to 10 second intervals and the clotting time recorded* 
Being fully aware of the limitations of this testg it was used
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together with platelet factor 3 availability te^t to detect prolonged 
clotting times duo to reduced plasma clotting factors*
Platelet Count*
Platelet counts were performed using formol-oitrato as the 
diluting fluid (l)acie 1956#) 10 ml* freshly filtered diluting fluid 
were pipetted into a clean test tube together with 0*1 ml* blood or 
platelet-rioh plasma* The contents of the tube were mixed by 
inversion 20 times and a sample was izun onto an improved Meubauer 
couting chamber, The chamber was allowed to stand in a damp atmosphere 
for 20 minutes and platelets were counted with a microscope using a 
white light source.
OHAFTER 4.
PLATELET AGGREGATION XTOOED BY OALCIÜM 
Aim Q A h G W m VJITH ADP*
The preeonoQ of oaXoium ioue seenie to be eosential for platelets 
to aggregate in response to added ADP* ADP does not oluiQp platelets 
in platelet-rioh plasma from blood collected with erythylenediaaine- 
totracetate (EBTA)^ but the addition of calciuia chloride restores 
the responsiveness to AD? (Born and Gross, 1963 a and b ; Mitchell and 
Sharp, 19645 and Hovig, 1964)* When unv/ashed platelets are 
suspended in Tyrode's solution containing heparin, aggregation occurs 
when ADP is added; aggregation is not affected when glucose, 
phosphate, bicarbonate or maghosium chloride are omitted. However, 
aggregation is reduced when calcium chloride is excluded (Born and 
Cross, 1964)* The same authors also found that when ADP is added to 
suspension of unwashed platelets in solutions containing sodium 
ohl03:ide, potassium chloride, calcium chloride, heparin and 
imidiasole buffer, the initial rate of aggregation is proportional to 
the logarithm of the caloimi concentration up to 1,7 % 10 At 
higher concentrations, calcium chloride inhibits platelet (Aggregation, 
Magnesium is relatively ineffootive when substituted for calcium at 
concentrations up to 1*7 x 10"^%, while afc higher concentrations it 
Inhibits agiT-egation more effectively than calcium (Born and Cross, 
1964), This last observation was also confirjjied by Hovig (I964) v/ho- 
found that calcium is essential for the clumping of rabbit platelets 
by AT)Pj îaagne.siuïn being only effective in the presence of otherwise 
ineffective concentrations of cèlcium*
To study the ionic requirements of platelets ideally a plasma free 
system should be employed, but the use of washed platelets creates 
additional difficulties, 3?or examplo, although human platelets 
subjected to centrifugation and subseguont suspension in plasma can 
clump with ABP (Kacor-Glanzaiann and Lüschei?, I9625 Mitchell and
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Sharp, 1964), their ability to do bo is diminished (Born and Gross,
1 6^4)»
Haslam (I964) was able to prepare a bufferod suspension of washed 
human platelets which did not olump with oalcium alone, but did react 
with added ABP# Aggregation of washed h^man platelets by ADP showed 
an absolute requirement for either oalcium or mgnesium ions and the 
effect of both is enhanced by potassium ions*
Galoium was found to b© necessary for the release of AD? by 
collagen (Hovig, I964)*
Divalent ions are also essential for the aggregation of platelet 
by thrombin, the effect of tdiroiabin being blocked by the addition of 
citrate or BDTA (Bounameavtx, 1957b; tucker and Borrelli, 1958; 
Bounamegiux, 1959» 8hermar et al*, I96I; Or et te, 1962; Hovig, I964)#
It can be concluded that calcium is a necessary factor both for 
the reaction leading to release of ABP from platelets and for the 
aggregation of platelets produced by ABP*
Born (1962a) using a turbidimetrio method, found that the addition 
of oalcium to heparinized pig plasma caused an immediate increase in 
optical density, followed by a. sharp drop over the suoeeodiîig 10 
minutes ; the addition of further calcium at this time causes a rise in 
optical density# On the other hand, when calcium ia added to 
platelet free plasma, there is an immediate rise in optical density, 
smaller than the rise seen with platelet-rioh plasma, but with 
platelet-poor plasma the small rise is sustained* The observation 
suggests that the rise in optical density after addition of calcium 
to platelet-rich plasma represents both a direct effect of calcium 
on the plasma and an effect of calcium on the platelets themselves; 
this point is treated in more detail in the discussion section of 
this chapter*
In this chapter are described exporimonts in which the response 
of platelets from normal and uraemic sub;] sots to oBlolum and a
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combination of calcium and AD? were studiecl*
Mornial Controls#
1* Results in  the Olmt^dler tube evntem.
Seven normal controls were studied us:Uig calcium alone and calcium 
plus ADB# The results show that the mean aggi'egation time (snowstorm) 
occurring before clot formation when adding oaloiurA alone was 
456*14 ^ 54 seconds and when adding oalcium and AD? was 393 - 25*2 
seconds (table l)* The difference between the two means was 
significant (t « 2*702, 0.02,> 0*01)* There was no correlation
betv/een the .aggregation time and the platelet count of diluted 
platelet-rich plasma*
2* ,Reau.l;ta ..sys.temt.
The changea in optical density following the addition of calcium 
and calcium plus ABP to platelet#rich plasma have already been described 
in terms of a representative experiment (Chapter 3, tables 6, 7» 8, 9, 
figures 7 and 9),
aggî^ egstion time, duration of phase 5 and the clotting timeg 
given beloR ware the mean values from seven norm! controls* To study 
the effect of the platelet count on these times and on the optical 
density fall In phase 5, another 9 expérimenta were pëgformcd in which 
the platelot-rioh plasma was diluted 1:2 and 1*4 with platelet-poor 
plasma*
All correlations with the platelet count given below include the 
results of the diluted and undiluted experiments (a total of 16)*
(a) Oalcium induoed platelet gg^ rBigation*
It was observed that when oalcium chloride was added to stirred 
diluted platelet-rich plasma an initial fall in optical density 
occurred due to dilution of the eyetern* This was followed by lag phase
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la which mo appreciable change in optical density vjae observed* A small 
iacreaBe in optical density then occurred which usually lasted a feu 
seconds (phase 4) and preceded the fall In optical density duo to 
platelet aggregation (phase 3), eventually folloued by clot formation# 
The increase :5ji optical density seen in phase 4 uas a constant finding 
in all nornml controls exami^ ied (figure ?)*
The onset of platelet aggregation occurred 490*71 « 63#B seconds 
from the addition of calcium and was correlated with the platelet count 
of diluted platelet-rich plasma (r ts 0*343, 0*03 > P > 0,02) (figure Ig), 
The time taîœn by platelets to aggregate in phase 5 was found to be 
60*71 1 13*36 seconds § and was also correlated with the platelet count 
(r ss 0*648* 0*01 > P > 0*001) (figure 15)* The fall :lji optical density 
resulting from platelet aggregation In phase 3 was also correlated with 
the platelet count (r - 0*966, P < 0*001) (f:igure 11)* The clotting 
t'hm of diluted platolet-rich plasma %7as 551*4 1 62 seconds; there was 
a aignifleant positive correlation with the platelet count (r - 0*545$ 
0*05 > ? > 0*02, figure 17)*
When both ADP and oalcium were added to, diluted platelet-rich plasma 
an Initial fall in optical density due to dilution was followed by a  
continuous fall due to platelet aggregation (phase l)o After a time the 
optical density began to increase as a result of platelet disaggregation 
(phase 2), Disaggregation became almost complete mtd the optical density 
reached a constant level (phase 3)* This m m  followed by a small increase 
in optical density (phase 4), then a fall resulted, eontljiuing until clot 
formation evontuëLlly occurred (phase 5), when a sudden rise in optical 
density was recorded (figure 9)*
The onset of platelet aggregation in phase 5 occurred at 515 «71 
87 seconda from the addition of the calcium plus ADP, The duration 
of phase 5 was 100 Z 15*27 eeoonda mid the olott^ .^ ig time vfae 623#57 ^
91 aeconds* The aisot of phase 5§ the duration of phase 5 end the clotting 
time were In correlation signiflcant3.y with the platelet count of the 
plasma (r e? 0*687; 0.01 > P >#001 (figure l4) r ^  0*904, F < 0*001 
(figure 16) and, r ;a 0*7685 P < 0*001 (figure I8)
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respectively).
The fall In optical density as a result of platelet aggregation 
in phase 5 was also in correlation with platelet count (r - 0,9^ f8,
P < 0,001; figure 12),
The results of both calcimi and calcium plus A DP experiments 
indicate that the higher the platelet count the more delayed the onset 
of platelet aggregation in phase 5» the longer its duration and the 
more prolonged the clotting time.
Compc^ ison between the results of calcium and oalcium
Although the mean onset times of both the platelet aggregation 
in phase 5 and the clotting times in the calcium ADP system were 
longer than those with calcium (alone, the differences ai’e 
insignificant (t s 0,615? ? > 0,1 and t == 1,734* P > 0,1 
respectively).
However* there weis a significant difference between the mean 
time taïien by platelets to aggregate in phase 5 in the two sets of 
experiments* being longer in the calcium ABP system (t - 5.120*
P < 0,001).
The correlation between these times and the platelet count 
though significant in the calcium experiments* became more so when 
ADP was also added (tables 2 and 5)#
The effect of calcium on ADlwineluoed platelet aggregation was 
studied in ? pairs of experiments and the fall in optical density 
between 30 and 60 seconds in phase 1 was compared* In one set of 
experiments* ADP was added to diluted platelet-rich plasma and in 
the other calciuiE was also added. Analysis of the results showed 
no significant difference between the two groups,
Hraemic Patients
The results of calcium and calcium plus ADP induced platelet
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aggregation :ln 10 uraemic patients are presented below. Two of 
these patients were examined before and after haemodiaXysis,
The onset of platelet aggregation in phase 5 occurred 519 ^ 8l#4 
seconds after the addition of oalcium* There was no correlation 
between the onset of phase 5 and the platelet coimt (r %= 0,24* P > 0,1),
The duration of phase 5 was 60 i 31*4 seconds and the mean 
clotting time was 579 ” 77*63 seconds (table 4),
Oalcium plus ADP induced platelet aggregation
The onset of platelet aggregation (i,e, the onset of phase 5) 
occurred 515*7 ^ 109*7 seconds from the addition of calcium and ADP,
The duration of phase 5 was 96*^ 5 - 14,50 seconds and the mean 
clotting time was 575 ^  137*5 seconds.
The results of the onset of platelet aggregation and the 
duration of phase 5 given above were the mean values of 8 uraemic 
patienta because two failed to disaggregate in phase 2, The mean 
value of the clotting time was that of 10 uraemic patients.
In three experiments (table 5? experiments 9$ 11 and 12), the 
addition of calcium and ADP caused platelets to aggregate but 
disaggregation occurring in phase 2 was either absent or very slight. 
This made the determination of the onset of the second platelet 
aggregation (phase 5) very difficult or almost impossible. In one 
patient (table 5, patient No, 15) who was examined before and after 
dialysis, the pre-dialysis sample showed inability to disaggregate 
but this finding v/as later corrected in the post-dialysis sample,
Qomparison between the results of Calcium and Calcium 
plus ADP Experiments
There was no significant difference between the mean onset of 
platelet aggregation in calcium and calcium plus ADP experiments 
(t K 0,075, P > O.l), The same was also true with clotting times
6X
(t B 0.00, P>0.1). Ilowevoj;, them v/ao a significant difference 
between the dwsation of phase 3 in calcium and oalciiira plue ABP 
(t = 2.987, 0.0l> P> 0,001).
QommriBQ^ b e tv/oQii no3?m3. co n tro ls . aM
Although the onset end dm?€ition of phase 5 end clotting t i m o  
v;g3?g Gignifloantly correlated with the platelet count being 
131*920 - 2403/o*m, in nomil controls, and 71*300 i 2364/o*mi* In 
uraemic patients (t « 5*140, ?<0*00l)t there was no significant 
difference in the results between the normal and uraemic patients,
When the results of renal failure patients were compared with 
normal results the following observations emerged (table lO),
Onset of platelet aggregation in phase 5 iR both calcium and 
calcium plus ABP vms found to be normal in all patients except two 
(iToe, 21 and 38, figures 13 and 14)* As regards the fall in optical 
density in the oalcium experiments, all were normal except one 
patient (Ho# 22, figure ll) while in the calcium plug ADP exporlment. 
(figure 12) all were normal except two (Hos, IB and 22) in whom the 
abnormality was possibly a result of failure to disoggregate at 
the end of phase 2# The duration of platelet aggregation in phase 5 
wag normal in all patients in the oalcium experiments (figure 15),
However, in the calcium plus ADP geries all except three (Eos, 18, 20 
and 21, figure 16) fell outside the 95 per cent confidence limit of normal, 
Tho clotting tiiae was normal in both sots of experiments in all patients 
except two (Nos, 21 and 38, figures 17 and 18),
When the results obtained before and aftor haemodialysls were 
compared in two patiente, there was shortening of the clotting time in 
both patients after dialyeia (calcim plus ADP exporimants) • Hov/ever, 
only one patient (Ho* 21, table 4) shov/ed such shortening in the 
calcium experiment, the other showed an increase.
In summry, all uraemic patients (except patient Ho. 20), showed 
an abnormality in one or more of the parameters either in the calcium
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or calcium plus ABP experiments or both. It is of interest to note 
that the ebnormalities were more evident in the calcium plus ABP 
experiments and were most marked in the duration of phase 5 (calcium 
plus ADP experiments).
BISOÏÏSSIQN
In the Chandler tube technique* when comparing the time of onset 
of platelet aggregation (snow storm) it is found that addition of both 
ABP and calcium significantly shortened the time for the snow storm 
effect to occur as compared with experiments in which calcium alone 
WO.S added. A similar finding v/as also reported by t-ilson et al.*
(1967). However, when this method was used to study uraemic patients 
it was sometimes impossible to record the snow storm time visually, 
perhaps because of the low platelet count. It was therefore thought 
v/orthwhile to examine the phenomenon in the turbidimetrie system*
Prom the results of the normal controls there oq/pears to be a 
significant correlation between the platelet count and both the time 
of the onset and duration of platelet aggregation in phase 5» the 
fall in optical density due to platelet aggregation in phase 5» ond 
the clotting time* These correlations are present in both calcium 
txnd calcium plus ADP experiments. The results indicate that the higher 
the platelet count, the more delayed is the onset, the bigger the 
magnitude and the longer the duration of platelet aggregation in phase 
5, and the longer the clotting time. The coiTelation betv/een the 
platelet count mid the clotting time is at variance with the finding 
of Brinldious (1947) that the clotting time of recalcified plasma is 
long if platelets have been virtually removed by high speed centrifugation. 
In the platelet factor 3 availability test (Hardisty and Hutton, 1965) 
the clotting times fall as the platelet count increases*
The difference between the results obtained in this chapter and
the/
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the evidence stated above is not fully understood, A difference 
in the techniques employed can partly explain the discrepancy 
between the results. Dilution of the platelet rich plasma in 
barbitone buffered saline with stirring probably causes delayed 
clotting, thus "telescoping" the changes that occur before fibrin 
formation.
A possible explanation for these observations may be teat when plasma 
is recalcified the rate and amount of thrombin released should be 
similar whether tiio platelet count is high or low. Thrombin when 
released acts on platelets causing aggregation and eventually clot 
formation. With a low platelet count, the proportion of thrombin 
per platelet would be higher and aggregation and subsequently clot 
formation will result sooner than where the platelet count is high*
There was slight, but constant increase in optical density/....
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density (phase 4) which occurred just before the beginning of 
platelet aggregation in phase 5* Born and Cross (1965b) have also 
reported that when oaloiuEi chloride is added to plasma, a small 
increase in optical density ooours just before platelet aggregation, 
This increase is found to be dependent on the presence of platelets, 
because when calcium ohlorido is added to platelet-poor plasma, 
only a very small increase in optical density is noted. It was 
suggested hy Born and Cross that the increase in optical density 
may be due to a change in platelets themselves or that the platelets 
acted as nuclei for the preoipitation or adsorption of calcium ions. 
Changes in platelet morphology do occur as one of the earliest 
changes after reoaloification of plasma, A change in shape, 
formation of spilgr pseudopods, and increase in volume resulting in the 
so called spiny spheres have been described by tucker and Borrelli 
(3-954) snd Vliite and Krivit (1967)* An increase in platelet volume 
may therefore be the oause for the increase in optical density after 
recaloifioation,
There ws.s no significant differences in the turbidimetrio system 
with normal plasma in the mean times for platelet aggregation (onset 
of phetso 5)f whore calcium alone was added (490 i 63 seconds) as 
compared with the addition of calcium plus ABP (5?6 - 87 seconds). In 
the Chandler tube system on the other hand ABP plus oalcium produced 
significantly faster aggregation than oaloium alone.
This discrepancy can possibly be explained by the difference in 
speed and axis of rotation and incubation temperature in the two 
systems# An experiment was conducted (see chapter 5) to s*fcudy the 
effect of rotation and temperature on platelet aggregation and 
disaggregation in the turbidimetrio system. It was found that if the 
speed of the rotator v/as increased in the turbidimetrio system, 
earlier and more complete disaggregation was obtained, while if the 
speed was reduced less dissaggrega-tion ooouzxed.
It is possible that the low speed in the Ohandler tube causes
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pXatGlets to aggregate and stay partially aggregated with the result 
that the seeond o.ggi'egation occurs earlier#
However in another oxporiment in the turbidimetrio systom 
(described in chapter 3) there was less aggregation awl more 
dlsaggregati^ m at 37^0 than at room temperatui'e, The full 
explanation of the difference in results obtained v/ith the two 
systems is not apparent*
Oalcium (6*25 % 10*%i) produced no significant changea in the 
optical density in phase 1* Born ( 1962a) sbov;ed that when platelets 
are made to aggregate by calcium in the presence of heparin? the 
initial rate of ivDP-platolet aggregation is proportional to the 
logarithm of the calcium concentration up to 1*7 % 10 but at a 
higher concentration calcium chloride inhibited platelet aggregation* 
The calciim chloride concentration used in the present experiment v/ao 
6*25 X 10 M, that is? a concentration of calcium abovo the range at 
which it might be expected to enhance ADP induced aggregation.
When comparing the results of the oaloium and calcium plus ADP 
experiments in noraial controls? it was found that although there v/as 
no significant difference between the mean aggregation time (phase 5) 
and clotting time between the tv/o sets of experiments? there was a 
significant difference between the duration of platelet aggregation in 
phase 5 i^  ^the two experimental groups? being longer in the oalcium 
plus ABP experiments* A possible explanation is that when platelets 
oggrog te and disaggregate in the calcium plus ABP system some of the 
added ABP may have been converted to AMP (Spaet and Lejnioks? I966) 
which inhibits ABP (Born?1962b; O'Brien? 1962a; Born and Gross# 
1963a; O'Brien# I963 and O'Brien# 1964)*
The difference between the duration of platelet aggregation in 
calcium and oaloium plus ABP experiments v/as also found in uraomic 
patients (t Ç3 2*987? 0,01 ;> P ^ O.OOl)* When the duration of phase 5 
in the caloiuift plus ABP experiments in normal and m'aemie patients
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were compared in a normal dilution curve? taking into account the 
platelet count; it v/as found that out of 8 patients# 5 fell outsidë 
the 95 per cent confidence limit around the regression line 
(figtu^ o 16), in these patients the platelets took a longer time to 
aggregate than controls having the came platelet count. No auoh 
difference was oh hained when caloimi was used alone*
A possible explanation of this finding is that when ADP is added 
uraemic platelets aggregate releasing their own ABP in the process 
(McMillan# 1966)* Thrombin brings about platelet aggregation by 
promoting the release of endogenous ADP from the platelets? the time 
taken for platelet aggregation is a function of both the extent of 
ADP release? and the inhibition of ADP by ADP inhibitors* Salzman 
and Hori (1966) found that the mean ATP content of uraemic plAtelets 
ia significantly less than normal and hence presumably a low ADP 
availability, Uraemic platelets cannot release a normal amount of 
ADP in response to thrombin* ,
GB.mm 5*
à m m B l i m  BIPIIOSPHATE IîCTGED PMTëMI AGOREGATIOa#.
One of the major phyoiologicaX fixnotiono of blood platelets 
is thoir ability to aggregate* Masses of aggregated platelets are 
a oharaotoristio component of the thrombus or haemostatic plug 
formed either in vivo (Kjaerheim and Hovig# 196a; I^enoh et al.#
1964) or in vitro (Poole# 19593 Mntenfass and Rozenberg# 19&5)'
The most important discovery in the understanding of the role of 
platelets in haemostasis was that of Hellem (1960) v/ho found a factor 
in erythrocytes which markedly increased the adhesiveness of 
platelets* This factor was later identified as adenosine diphosphate 
by Gaarder et al## (1961)#
Earlier, Born (1956a) found that platelets contained a high 
concentration of ATF which disappeared during clotting (Born 1956b), 
or when the platelets underwent the changes known as viscous metamor­
phosis (^ luoker and Borrelli# 196I)* Since ADP is the first breakdown 
product of ATP it was suggested by Born (1962b) that the increase in 
adhesiveness brought about by ADP might underlie the physiological 
aeohanism responsible for the formation of haemostatic plugs and be 
the pathological mechanism responsible for thrombosis*
When platelets are exposed to a variety of stimuli ranging from 
contact with foreign surface to proteolytic enzymes? there is a 
release of serotonin and histamine# a fall in platelet ATP and 
escape of nucleotides including ADg into the ambient fluid (Movat 
et al.p 1965)* Since all these stimuli will in appropriate 
circumstances clumx* platelets it seems likely that aggregation is 
produced by some substances liberated from the platelet itself*
Of the various possible stimuli the moot Impressive claims can 
be put forward for ADP (tucker and Borrelli, igg&p Hovig, 1963;
Spaot and Eucker, 1964$ and Glynn et al., 1965). ADP was found 
to be able, to produce platelet clumping in vivo (Born and Gross,
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196303 Eegoli and 19§3$ 3)avoy and Itandler» I9641 Eordoy
and Chandler, 1964) and in vitro (Ollgaard, 196X3 Born, 196Sbj 
O'Brien, 1962a; %ndker and Borrelli, 1962$ Hellem et al#, 1963$
Mitohell and Sharp, 1964)*
In addition to ADP, four other oloaely related nuoleotides
desoa^adenoslne dlphoephate, the W#o%ide of adenoeine diphosphate, 
adenosine tetraphosphate and oordyoepin diphosphate also bring about 
aggregation, but the potency of thooe is much less than that of ADP 
(Gaarclor et al#, 196I; Gaarder and baland, 1964)# Uridine 
diphosphate, oytidine diphosphate, inosine diphosphate can also cause 
platelet aggregation (Spaet and lâuoker, 1964$ Salsman, 1967) •
The effect of ABP on platelets was found to be Inhibited by 
adenosine monophosphate, by adenosine and by high concentrations of 
ATP (Born and Cross, 1963a; Clayton et al#, 1963; Skalhegg et al#, 
1964$ Born, 1964$ Born et al#, 1965)# ïhoae substances also inhibit 
platelet aggregation in vivo (Eegoli and Clark, 1963)$ the inhibitors 
may act by competing with ABP for sites on the platelet surface# 
Adrenaline, nor adrenalin© and serotonin which ar4 also carried by the 
platelet (Ol^ton et al#, I963) have boon shown to produce clumping in 
certain circumstances (O'Brien, 1963; O'Brien, I964; Wchell and 
Sharp, 1964)# It seems probable that the clumping action of these 
compounds is mediated th#oug^ i the release of ABP from the platelets 
themselves, since clumping by adrenalin© and serotonin can be blocked 
by A W  (O'Brien, I964)*
Several authors (Kaser-Olanzmana and Busoher, 1962; Grette, 1962; 
Haslam, 1964) observed that thrombin can release ABP from platelets 
and suggested that this activity may be reponsible for the 
aggregating property of thrombin# However, Biewiarowski and Thomas 
(1966) have demonstrated that ABP and thrombin act synergistically 
and not additively in producing platelet aggregation#
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Moreover, adherence of platelets to both collagen end latex 
particles produces aggregation tln?ough release of platelet AJDP 
(Zucker and horelli, 19625 ilovig, 196$; G-lyn et al*, I969)# In 
most of these reactions there is a fall in platelet ATP (Mustard 
et al.p 1966) probably mediated through stimulation of adenosine 
triphosphatase activity leading to conversion of ATP to APP. Since 
APP is known to stimulate glycolysis and respiration within the cell 
(Chance and Williams, 1956) metabolic changes would be expected within 
the platelets under these circumstances* It has been shown that 
thrombin stimulates oxygen consumption by platelets (Hussain and 
Newcomb, I964) and this may also be true for most of the other agents 
which induce platelet aggregation. The amount of AhP present in the 
platelet will be increased by conversion of ATP to ADP. The extent 
of platelet aggregation will presumably correlate with the amount of 
ADP escaping into the ambient fluid.
Haslam (I964) has shown that in the presence of an enayioe system 
which catalyses the phosphorylation of ADP to ATP, neither thrombin nor 
fatty acids were able to induce platelet aggregation.
Platelet aggregation by ADP is dependent on viable platelets, 
calcium (Born and Cross, 1963b| Hellem and Owren, I964; Mitchell and 
Sharp, 1964) and on the presence of a plasma factor (Born and Cross, 
1964)# It is also temperature dependent (O'Brien, 1962a).
The identity of the plasma factor has been the subject of recent 
conflicting reports* Hellem and Owren (I964) suggested that the 
plasma factor is that entity missing in von Willebrand's disease but 
others (Salsman and Chambers, 1964; Cross, I964) have found that ADP 
induced platelet agrregation nrocieds normally in plasma from 
patients with established von Willebrand*s disease* McLean et al., 
(1964) and Cross (I964) have indicated that fibrinogen may be the 
plasma co-factor and Caen (I969) has recently suggested that both
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fibî?inogen ami the von v/illebrmid factors participate in ADP» 
induced platelet aggregation. deykin et al* (I965) demonstrated 
that at least two plasma factors, fibrinogen and a heat stable 
plasma protein distinct frofu the anti-von V/illebrand factor, 
participate in ADP»induced platelet aggregation in the presence 
of human plasma.
This platelet aggregation induced by AD? can therefore be 
inhibited by deficiency or inactivation of a component of the 
platelet, deficiency or inactivation of a plasma protein, lack or 
excess of ionic calcium, elimination of ABP by the action of 
enzymes, and by certain substances related to ADP, specifically its 
breakdown products as adenosine.
The action of A lW and adenosine is competitive, powerful and 
highly specific for these substances and few of their analogues ,
The high specificity of ADP in promoting aggregation, and the 
specificity of its closely related inhibitors, suggest that there 
are equally specific receptors for these substances probably on the 
platelet surface.
I'hujy hypotheses have been put forward to explain the mechanism 
of action of ABP in inducing platelet aggregation. Born and Cross 
(1963b) suggested that ADP causes a,,greg:ation by becoming associated 
with aggregating sites on the surface of platelets. Owren (I963) 
proposed that ADP participates in a binding reaction together with 
oalcium ions and also a plasma protein, probably von Willebrand's 
factor, resulting in a complex bridge between the platelets. This 
hypothesis has also been adopted by Skalhegg et al, (1964).
Mitchell and Sharp (I964) stated that the clumping agents act at 
the platelet surface enabling; intercellular bonds to be formed, 
perhaps using the divalent ions, calcium or magnesiim, as linking 
groups.
Gaarclar and LaXand (1964) suggested that the adenosine part of 
the A W  molecule forme hydrogen bond with suitably located *00» and 
Œ* groups present in proteins located on the surface of platelets#
The importance of hydrogen bonding in the ABF*platolot aggregation 
was suggested by the finding of Hellem et al* C1964) that urea, which 
splits hydrogen bonds, inhibits platelet a,ggrogîation* Of the known
inhibitors, 2*oxy-6*amino purine riboside diphoepbopyridino 
nnolootide, AW, ATP, 6»methyl amino purine riboside, adenosine and 
flavin adenine dinucleatide (Olayten et aX*, 1963) all can form 
hydrogen bonds In an identical manner to that of ADP on the platelet 
surface and thereby compete with ADP for active sites# The 
nucleotides known to bring about aggregation have at physiological pH 
an uneven number of negative chargee# Inhibitors on the other
hand have either no charge e#g# adenosine, or an even nmiber of
charges# OaXoiim which is required for the aggregation of 
platelets, Is attracted by ionic forces to the negatively charged 
groups of ADP* Duo to the double charge of calcium ions, nucleotides 
with an uneven number of negative charges would, when attached to the 
platelets, provide more opportunities for oaloium ion bridges between 
platelets than nucleotides with an even iiumbor of charges, thereby 
promoting aggregation# Another hypothesis (Born, 1967a* Born,
1967b) is that bombardment of ADP molecules produces a 
configurational change in another component (a protein on platelet 
surface) and that this change Is re%uired for the formation of 
disulphide bonds between the platelets and molecules of the protein
oo*factor in the plasma# Bvidenco in favour of this liypothesis ie .
that in the presence of ADP, platelets swell before they aggregate, 
that there is or no binding of ADP to platelets, and that
aggregation but not swelling is Inhibited m t  only by substance© 
which block sulpliydyl groups but also by others aucli as dimeroaproX 
dlthiothreitol which bind to prevent oulphydyX group £ m m  reacting#
Salaman et al. (1966) ps?oposea that platelet aggregation might
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result .from the inhibition by ADP of an enzyme in the platelet 
membrane whose normal function is the dephosphorylation of ATP 
to ADP* This enzyme utilizes the energy of hydrolysis of the 
teiminal phosphate bond for maintenanoe of the unsticky state of 
the platelet through and active process analogous to the contraction 
of striated muscle* According to this hypothesis, inhibition of 
membrane adenosine triphos phatase would allow the platelet to 
become adliesive peiliaps by relaxation of a contractile protein 
involved in the preservation of platelet size and shape. Exposure 
of adhesive sites on the platelet surface would permit bridging to 
adjacent platelets through a metal-mediated intermediate most likely 
composed of fibrinogen or other plasma proteins and calcium. In 
support of this hypothesis, Salzmari et al* (I966) demonstrated a 
potent adenosine triphosphatase in the platelet surface membrane 
capable of splitting ATP on the outer surface of the intact 
platelet with resultant formation of A3)P f.ind inorganic phosphate.
This enzyme is found to be distinct from the sodivni^ pump adenosine 
triphosphatase which is thought to split ATP on the inner surface 
of the cell membrane* The activity of the ecto-adenosine tri» 
phosphato.se is inhibited by specific antisera to thrombosthenin 
suggesting a. possible identity with the eoto-adenosine triphosphatase. 
Spaet and Lejnioks (I966) proposed an energy yielding reaction 
involving breakdown of A .DP as the cause of platelet aggregation.
It has been found that under appropriate circumstgLnces ADP- 
induced platelet aggregation in vitro is reversible (Born, 1962b; 
O'Brien, 1962b; Born and Cross, 1963b). Reversibility is gx'eatest 
at 37^ C and does not occur at 0^ 0 (O'Brien, 1962b). In vivo, 
intravenous infusion of A.Ü? to animals and man produces a fall in 
platelet count which rapidly reverses when the infusion is stopped 
(born and Cross, 1963a; liordoy and Chandler, 196/41 Davey and 
Lander, I964)* Such spontaneous disaggregation is p.robably due to 
destruction of ADP by enzymes in plasma. In vitro destruction of
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ADP by plasma is not observed in plasma which has been heated to 
98^ 0 for 15 minutes (Hellem and Owren, 1964)*
Salzman et al. (I966) supports the view that disaggregation 
following a^ g^regation produced by ADP results from degradation of 
AJ)P which allows membrane adenosine triphosphatase activity to resume# 
Increasing temperature favours disaggregation (O’Brien, 1962b) by 
favouring dephosphorylation of ADP of plasma enzymes and by 
increasing the membrane adenosine triphosphatase activity#
In this chapter are described the results of ADP-induoed 
platelet aggregation in normal controls and uraemic patients.
Normal Controls
ADP*induced platelet a{>;gregation was examined by the turbidimetric 
method (Born, 1962b; O'Brien, 1962b)* The details of the method 
and parameters used for measuring platelet agf;regation and 
disaggregation were described in Chapter 3* Platelet-rich plasma 
from nineteen normal healthy controls (eighteen males and one female) 
were examined; the age range was from 18 to 90 years* An early 
objective w^ae to study the effect of differing platelet counts in 
platelet-*rich plasma on ADP-platelet aggregation; uraemic patients 
may have reduced platelet counts# To allow for comparison between 
normal controls and uraemic patients, some experiments we.re performed 
by diluting nori7jal platelet-rich ple^ nma wdth platelet-poor plasma.
In all experiments the same quantity of ADP was added regardless of 
the platelet count. A total of thirty-five experiments were 
performed#
The results of normal controls were grouped in four ranges of 
platelet counts in platelet-rich plasma#
Group 1 between 3909000 end 490,000/c#mm.
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Gæoup 2 between 290,000 and 390,000/c. .##
Group 3 between 150 #000 and 290*000/0,ma.
Group 4 between 90 #000 and I90#000/o»ma,
Results of the undiluted normal controls.
The mean platelot*rlch plasma platelet count in the 19 normal 
controls exmiined was 359*447  ^5Q*300/o#iiim»
The results of ADP*indueed platelet sggreglon are shoim in 
table 11 and the optical density readings in table 24*
There was no correlation between the platelet aggregation as 
measured by the 30-60, 30»90 and maximum aggregation and the 
platelet count (r % 0,357# B > 0,1$ r ^  0,272# F >0,1$ 
r « 0*252, P > @, 1) respectively, However# there was a significant 
correlation between the platelet count and percentage disaggregation 
(r 0,456, 0,05,> P > 0,02),
Results in ,the diluted and undiluted normal control.
The results were grouped in four ranges of platelet-rich plasma 
platelet count, as shown in tables 12# 13# 14 and 15# There was a 
aignifleant correlation of the platelet counts in the platelet-rich 
plasma with all the parsmBtars used to measure platelet aggregation 
and dieaggregation, The 30-60 platelet aggregation* r 0*853;
P < 0*001* (figure 23*) 30-90 platelet aggregation r &= 0*605, P< 0,001# 
maximum aggregation# r « 0*813* P< 0*001# percentage disaggregation 
r 0*590# P <0*001 (figure 24)*
There was also a significant correlation between 3G-60 platelet 
aggregation and pero-mtage disaggregation (r « 0,503# 0,01 > P> 0*001) 
i,e* the more aggregation the greater the disaggregation (figure 25),
Thirty nine uraemic patients were included in this study. 
Patients Hos* 3# 6# 7# 14# 15 and 28 were examined for ADP»platelet
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aggregation more than onoe durii^ the course of their 1linees*
Patient Ho, 29 was also examined after diluting her platelet-rich 
plasma with platelet-poor plasma* A total of 46 .experiments were 
carried out*
Of these patiente# 30 were suffering from chronic renal failure* 
Thirteen of these patients were examined at a time when the uraemic 
process wasfMriy stable, and ten when there was an acute exacerbation 
resulting either from infection or post renal obstruction* Seven 
chronic uraemic patients were tmder treatment of haemodialysis*
Mine patients had acute renal failure# seven of whom were given 
baemodialysis treatment*
Mlevon patients were bleeding at the time of study and these 
included 5 patients with chronic renal fail^ uro# and 6 with acute 
uraemia*
The results of thirty nine patients with uraemia were grouped in 
four ranges of platelt-rich plasma platelet count regardless of the 
aetiology# the rate of development of the uraemic process or the 
blood urea levels (tables, 16, 17# IB and 19)* The mean results of 
platelet aggregation and disaggregation were compared with those of 
normal controls# having the same range of platelet-rich plasma 
platelet count*
Results showed that platelet aggregation and disaggregation were 
significantly different from normal controls la all four ranges of 
platelet count (table 22), The most significant and constant 
difforonces were found in the 30-60 platelet aggregation, percentage 
disaggregation, and the disaggregation time as this occurred in all 
four ranges of platelet-rich plasma counts* However the rest of 
the parameters (30-90 platelet aggreg^ i^tion, maximum aggregation and 
maximum aggregation time) were significantly different in some but not 
all the ran^s*
Î5
Uraemio patients wore divided into four groupe*
1. chronic renal failure
2* acute renal failure
3, chronic renal failure on haemodialyeiB
4* uraemic patients with clinical haemostatic
failure*
The results of platelet aggregation and disaggregation from 
individual experiments (first experiment'if more than one was 
performed on the same patient) were compared with the normal mean 
values of the same platelet count - 2 standard deviations# 
result falling outside the no mal ran^ io was considered abnormal#
The porcontage abnormality in the four groups of uraemic patients are 
shown in table 40* Analysis of the results have shown that the 
highest percentage diminution in platelet aggregation occurred in 
patients with bleeding# and was lowest in chronic uraemia patients 
on haemodiadysis and patients with acute renal failure* The 
disaggregation time was prolonged in 91 per cent of patients with 
clinical haemostatic fai3.m:?o* The diminution in percentage 
dlsaggrogvation was similar in all four groups but was slightly lower 
in chronic renal failure patients on haemodialysis#
Chronic Renal Failure patients on Haomodialvsis*
Seven patients sufferirig from terminal chronic renal failure 
were examined for ADX^ -platelet aggregation before and after 
haemodialysis#
There was no significant difference between the platelet count 
before and after dialysis (t » 0.136, F> O.l), the mean count after 
dialysis being slightly higher# There vms an increase in platelet 
count in four, and a drop in three patients following the dialysis.
To compare the mean pro-and post-dialysis results with the 
mean values of normal controls, it was found that both their platelet
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coiuito fell ill the platolet-rioh plasma mn-e of 250,000 - 
350,000/0#mm# The two moan values were not leantXy different
from the normal moan of this range (before dialysis, t » 1*557»
F >0*1, after dialysis, t » 1#986 0*10 > F> 0#05)# This allowed 
comparison to he made hetweeu the two m m  values (i.e.» before and 
after dialysis)» also comparison was possible between them and the 
noacmal means of that range# Mion the mean values of pre-and post- 
dialysis results wore compared, it was found that there was no 
significant change in aggregation, although an increase in 
aggregation did occur in six out of seven oases, the only case 
which showed a drop in platelet aggregation also showed an appreciable 
drop in platelet-rich plasma platelet count after dialysis. However 
there was a significant increase in percentage disaggregation after 
dialysis (t =, 4#489, P < 0.00l), and this increase was a constant 
finding in all seven oases.
The 30-60 platelet aggregation before dialysis was significantly 
different from the normal mean (t => 3*145, 0.01, > F > 0.001), but 
became very near the normal moan after dialysis (t 0.715, F;»0.l). 
This vms also true for the percentage disaggregation (before dialysis, 
t K 3*319, 0 .0 1 > P> 0.001, after dialysis, t %» 0.318, 0.1).
When the results of the pre- and post-dialysis were correlated 
with the corresponding blood urea levels in mg. per 100 ml, a 
significant correlation existed between blood urea and 3O-6O platelet 
aggregation (t « O.564, O.O5 0.02) (figure 30) while it was 
insignificant with other parameters of platelet aggregation and 
disaggregation.
Acute Renal Failure patients on Haemodialvsla^
Seven patients with acute renal failure were examined for ADP- 
induced platelet aggregation* Platelet aggregation Increased in 4 
patients and diminished in three following dialysis, while paroentoge 
disaggregation increased in 5 and diminished in two (figures 26, 2?)
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The mean pXatolet aount did not change significantly after 
dlalysie (t * 0*404# F>0*l)* Being a markedly haterogonoxia group 
as regards the platelet count# it was not possible to compare the 
mean pre- and poet-dlalysls results with the meau nowal values. 
Therefore the results of each experiment were compared with the 
means of normal controls of the same platelet count Î 2 standard 
deviations# From the results shown in figure 28 no consistent 
improvement was obtained in aggregation sud disaggregation.
Ho correlation existed between the blood urea levels and the 
results of platelet aggTogation and disf^gre^ation# nor between these 
and the platelet count.
maouasioH.
The degree and reversibility of M)F**lnduced platelet aggregation 
in vitro depends on the concentration of ADP praaent (Born# 1962 a and 
bj Born and Oross# 1963b; O'Brien# 1964)# the number of platelets 
present in the platelet-rich plasma (O'Brien ,1962b# Born and Oroes# 
1963b)# the stirring spaed (O'Brien# 1962b; Born and ^oas# 1963b) 
and on the temperature of incubation (O'Brien# 1962b).
fhe effects of the stirring speed# the temperature of incubation 
and the ABP-oonoentrations on the rssUlts wore eliminated by using a 
fixed speed# a constant incubation temperature and the same dose of 
ABF in all experiments performed. The only variable was the 
platelot-riçh plasma platelet count*
the results presented above in undiluted normal control 
plasmas there appears to be no correlation between the ABP-induoed 
platelet aggregation, and the platelet count of platelet-rich plasm# 
but such a correlation existed between percentage disaggregation and the 
platelet count. In these undiluted normal controls# the mean 
platelet count was 369#477A*mm. When samples from normal controls
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vjom diluted with platelet-poor plasma to determine the ADF- 
platelet aggregation in a wide range of platelet count, platelet 
aggregation, percentage disaggregation and the disaggregation time 
were signlfI- :antly correlated with the platelet-rich plasma 
platelet count*
It seems when using a fixed dose of ADP to aggregate platelets 
then the more platelets present in the plasma, the larger clumps 
will form and the greater the optical density will fall. In the 
presence of a smaller number of platelets and a relatively higher 
concentration of ADP, the platelet aggrogutes will be smaller and 
the optical density fall will be less. As platelets aggregate under 
the influence of ADP there is also simultaneous déphosphorylation of 
ADP by plasma and platelet onsymes (Jorgensen, 1956$ OllgaardJ 
I96I; O'Brien, IgGSa; Spaet and Lejnieoks# I966) resulting in the 
formation of A W  and adenosine which are known inliibitors to ADP 
aggregating effect. The point of maximum aggregation (maximum 
aggregation time), can be considered as the time at which there is 
a balance between .ADP and inhibitors in th^ system# When this 
balance is offset towards more inhibitor formation or the presence 
of loss ADP, platelets begin to disaggregate (disaggregation time).
By using a fixed concentration of ADP, then the less platelets 
present in the system, the longer the time taken by them to reach 
maximm aggregation, the longer time they take to begin disaggregation, 
and their disaggregation will be less complete compared to that of a 
larger number of platelets. The presence of a correlation between 
platelet aggregation and disaggregation, and their correlation with 
the platelet count in the diluted group can be explained by this 
mechanism*
In the comparison of ADP-platelet aggregation in uraemic 
patients with normal controls, all were subjected to the same ADP- 
Gonoentration regardless of their platelet count. The results were 
thon grouped in four ranges of platelet count and the moan values
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of normals and uraendoB wore compared* Other authors 
(Hozenborg and Firkin, 1966$ Gastaldi et al*, 1966$ 8tev/a3?t 
and GastaMi# I967) adjusted the platelet count of platelet-rich 
plasma of normal contrôla and uraemic patients to 200,000 - 
250s000/o*um* and thus were unable to establish the results in these 
patients with lower counts* In the series studied in this thesis, 
patients with a platelet count below 200#000/c,mm* constituted 
of the total number of observations and included the majority of 
patients with thrombocytopenia and bleeding*
S2âÈgàetJte2SâM2as.
When comparing the mean results of uraemic patients with those 
of normal controls, it was found that there was a significant 
difference between the two moans in the 30*60 platelet aggregation, 
percentage disaggregation and the clisaggs?ogation time, in all four 
ranges of platelet count, This shows that when mean results are 
considered uraemic platelets aggregate less* take a longer tinio to 
d;lsaggre.;ttte and fail to disaggregate in a normal way* Mhen oaoh 
observation was compared to a norjiîal range with confidence limits 
of 95 per cent (-2 standard deviations of the mean) * 22 out of 46 
experiments (i.e. 4^0 shov/ed diminished 30*60 platelet aggregation. 
These results are similar to the findijigs of Rosenberg and I'irkin 
(1966) who found impaired platelet aggregation in 5 out of 12 patients 
without bleeding tendency* and grossly depressed or absent platelet 
aggregation in 7 patients with established bleeding* of I9 patients* 
12 had diminished platelet aggregation (i.e. 53 per cent). Balzman 
and Mori (1966) on the other hand found platelet aggregation with 
ADP to be normal in all five patients examined by them. This was 
also the finding of O'Brien (1967) that ABP»inducod platelet 
aggregation proceeded at a normal rate in lu-aeDda*
Traeger et al. (196?) used the method of Revel (1954) to 
measure platelet Bgg3:egation and adhesiveness by the phase contract
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microscope. They found improvement in platelet aggregation in 11 
out of 15 chronic uraemic patients following haemodialysis*
Gan and Firkin (I968) found a correlation between platelet 
aggregation and the plasma enzyme*(s) ability to degrade ADP* This 
plasma activity was sliown to be 37educed in six patients with uraemia 
in whum platelet aggregation was impaired; but not in two cases whose 
platelet aggregation was normal. The incorporation of 14C labelled 
ADP»0«^ '^g vms also reduced in tlio uraemic patients with abnormal 
platelet aggregation*
Platelet ])isaggx;egationiu J A* Hill #mi H*i w i li
Percentage disaggregation was found to be diminished in 28 out 
of 46 observations (60*9 cent) and disagigregation time to be 
prolonged in 28 out of 46 (60*9 per cent)* This is in accordance with 
the observation of O'Brien (I967) that the time till disaggregation 
was probably prolonged*
Comparison between acute and chronic renal failure patient
To make a, comparison between the results of acute and chronic renal 
failure, the first experiments carried out in each patient wore grouped 
according to rate of development of the uraemic process* Of the 59 
patients 5 50 were suffering from chronic renal failure and 9 from 
acute uraemia* liiree cases had post-renal uraemia* 50*60 platelet 
uggregaticju was diminished in 55 psr cent of patients in tho chronic 
group cind in 55 per cent in acute* However, disaggregation was 
diminished or absent in 67 per cent of acute uraemic patients in 65 per 
cent of these with chronic renal failure* These results show that 
although there was no difference between the acute and chronic uraemias 
as regards platelet disaggregation, there were less cases with diminished 
platelet aggregation in the acute group of patients* (Table 40)•
Effect of Haemodialysis
The effect of treatment by haemodialysis on patients with acute 
and chronic renal failure was assessed. The two groups of patients
Ûl
v/ore Btudlocl ©oparatoXy beoause of the dlfforonoo in aetiology# the 
diu’ation of tho uraoniio prooeae# tho typo of artificial Icidnoy and the 
duration of haomodiaXyeie* There was â fixed tlmo at which tho post- 
dlaXyoio sample was collected in oaoh group# Btowart and Qaataldi 
(1967) grouped all patients with acute and chronic renal failure 
together regardXeos of whether they received poritoneaX or 
haoraodiaXysis treatment# and there was no fixed time at which tho post- 
diaXyoia sample was talœn# this varied from one to six days#
In the ohronio renal failure group# although an increase in 
platelet aggregation was obtained in six out of seven patients after 
dialysis# this increase was not statistically significant. However# a 
significant improvement did occur in percentage disaggregation following 
dialysis (t « 4*489» F<0#00X). #ien compared with normal controls of
tho same range of platelet count# there was a definite improvement in 
both agg:ægatlon and disaggregation after dialysis#
Mo eignifioant change occurred in tho platelet count or in the 
whole blood platelet count after dialysis (t 0.136# P> 0.1; 
t ~ 0.199» 0.1 respectively)# This was not the finding of Stewart
and Castaldi (I967) who reported a significant increase in platelet 
count fallowing dialysis in the patients studied by them whether 
treated by peritoneal or haemodialysis# and for tho patient treated by 
haemodialysis only# These findingjs may be explained by the fact that 
in this group of patients# the post-dialysis sample was not taken at 
a fixed time after tho end of dialysis but varied from one to six d%rs 
and it is probable that the more time allowed between tho end of 
dialysis and tho collection of tho post-dialysis sample tho greater the 
possibility of quantitative as well as qualitative i#rovemont in 
platelets.
In the acute uraemic group of patients# there was a great 
variability in platelet count in different patients and also between 
the pro- and post-dialysis samples in individual patients. Therefore
it became impossible to consider thee© cases ae a uniform group os 
la the ohroaio m?aemi© patients* Thus the résulta of each 
experiment were compared separately with the moan results of normal 
controls* From the results, there appears to be no consistent 
change in ADP-plateXet aggregation in oases of aoute renal failure as 
a consequence of treatment by haemodialysis* This is probably due 
to the presence of different added actiological factors other than the 
uraemic prooeBS# tho rate of development and duration of the uraemio 
process# and the type of artifical kidney used* Tho platelet count 
did not change significantly after dialysis (t S3 0.393» Fy O.l); tho 
mean was slightly lower after the dialysis* Mo significant change 
occurred also in the citraied blood count (t =< 0*455# 0*1).
Eleven patients with bleeding due to haemostatic failure were 
included in this otu% (the bleeding group)* Six patients were 
sufferi% from acute renal fallu:!?© and five had chronic uraemias two 
of whom were having an acute exacerbation of their usraemio process. 
Thrombocytopenia (below lOOfOOO/c.smu) was present in 4 patients*
Boven patients showed diminished or absent 3G«^ 6G platelet aggregation 
and seven diminished or absent disaggregation* The bleeding group 
showed the higheat abnormality in platelet aggregation and disaggregation 
time (table #)* Oaetaldl et al* (1966) found that ©very patient 
with an established bleeding tendency and a long bleeding time bad grossly 
depressed or absent platelet aggregation with ADP whatever their eermi 
urea concentration#
Although a significant correlation existed between the blood urea 
level and the . 30-60 platelet aggregation in tho chronic haemodialysis 
patients (t % 0*574# 0*05 >P> 0*02)# such a correlation did not exist
with percentage disaggregation or with a%r parameter of aggregation and 
disaggregation in the acute renal failure groupe before and after 
dialysis*
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In suianiaxy# there seems to he a tendency for platelets to 
ag£P?0gate and disaggregate# less than normal in cases of uraemia 
regardless of the progress ind duration of the uraemio process.
This qualitative defeat was corrected by haemodialysis in the 
chronic uraemic group but not in the acute uraemic patients.
Platelet aggregation v/as lowest in the bleeding group# and also 
the disaggregation times were longest (table 40)•
lie chan ism of disordered platelet aggregation end tiisaggregation
The defective aggregation and disaggregation in cases of renal 
failure may be explained on the basis of the mechanism mid hypotheses 
of AJlP-platelet aggregation mentioned above and disorders of these 
from the biochemical changes that occur :ln uraemia. The high blood
urea level may have a role in causing this defect, According to
Qaarder and Laland (1964) the adenosine part of ADP-molecule forms 
hydrogen bonds with similarly looated-CO-and HH-groups present in 
proteins located on the surface of platelets. Urea is known to 
break hydrogen bonds (Hellem et al,# I964) and this might interfere 
with platelet aggregation in this way.
The osmotic effect of urea on platelets in combination with the 
electrolyte changes and the excessive endogenous protein catabolism 
known to occur in uraemia# may result in shrinkage in platelet size 
thùs probably causing less aggregating sites to be avpliable for ADP, 
Urea in vitro was shov/n to cause diminished .DP-aggregation and 
disaggregation (Chapter 8) and tills has also been reported by Borner 
et al, (1968), Those in vitro experiments may suprort the view that 
urea, could be responsible; at least in part, for the changes that 
occur in uraemic patients, back or excess of calcium ions is one of 
the factors responsible for inhibition of ADP»platelet aggregation.
In uraemia# althoudi hypocaloaemia may be present (Panconi and Hose, 
1958) the uraemia patient is protected from tetany by the presence of 
acidosis, since higher proportion of total oalcium is ionized at low 
plasma pH, Plasma levels of citra.te have been reported to be
elevated In renal failure (Blaokg I96T)# leading to an inoreas© in 
th© ooïïiplexed fraction of plasma calotoii and lowering of the amount 
ionized* Hordmann# et al* (1959) has questioned this# since they 
found that the methods used were not speoiflo to citrate but subject 
to interference by ketoaolds# and the plasma citrate concentration 
in their patients was normal#
The ATP content of platelets from patients with m?aamla has 
been reported by Salsman and lari (1966) to b© lower than normal* 
However; Pitney et al* (1968) found that the adenine nucleotide content 
of platelets from uraemic subjects did not differ fa;om normal* The 
filtered uraemio sample© did not ©how the inoreaee In nuolootld© 
content recorded for the normal ©ample# indicating either look of 
hetoroganeaity of adenine nucleotide content of platelet from oases 
of ivmemic or inability of such platelet© to adsorb nucleotidG© 
liberated during the passage of blood Idirough glass filters* Fazoia 
this evidence it is probable that uraomie platelets are unable to 
adsorb or react with the ADP added in a noxmial way, The intra­
cellular ©nsymes concerned with the formation or inactivation of ADP 
m y  be inhibited a© a result of intracellular electrolyte changes.
As regards inability to disaggregate tMs may be due to membrane 
changes or intracellular enzyme change causing less production of 
inhibitors* According to Balxman et al* (1967) disaggregation 
following ADP aggregation results from degradation of ABP which 
allows membrane adenosine triphosphatase to resume its action in 
maintaining platelets discrete*
P i m m #  MMBsimmm. m  m m s
In addition to their aontrlbutlon to tho coagulation moohanlom# 
platelet© alco participate in haemostaclo by adhering to Injured 
Vascular ondothellmii and to one another, forming a haemostatic plug 
(Eockam et al,, 1959$ Sharp, 1961$ Kaeer-Glansmann and huscher»
1962)* The fommtlon of a haemostatic plug seem# to occur in stages, 
an early phase of aggregation not requiring thro#in which can be 
reversed by décalcification, (sharp, 1961), and a subsequent fusion of 
the aggregated platelets to form an irreversible amorphous maes 
(viscous metamorphosis). The latter stage may be mediated by the 
coagulation mechanism perhaps by the action of thrombin (î^ ucker and 
Borrelli, 1959$ Schraid at #1», 1962$ Spaet and dicker, I9G4),
Attempts have been made to measure tho in vivo property of 
platelet adhesion by the use of in vitro teats of platelet adhesiveness 
to foreign surfaces ospeoially to glass, although there is lack of 
agreement that in vitro testa of adheeiveness accurately measure 
in vivo platelet behaviour#
Platelet adhesiveness measured ae the adhesion of platelets to 
glace, is expressed as either the absolute mmber, or more oommonly the 
percentage of platelets, which stick to glass surfaces by comparing the 
platelet coimts before and after exposure of the specimen to glass 
surfaces. Although many methods have been described in the past 
(Chapter 3), the moat importent and more accurate methods were those 
which determined the par cent of platelet sticking to the wall of a 
rotating flask (Wright, I94I) to a glass wool column (loolten and 
Vromn, 1949), and to a column of glass beads (Hellem, 1960$ O'Brien, 
1961$ Balzman, 1963)# These tests depend not only on platelet-glass 
adhesion, but also on plsitolet-platelet aggregation, since it appears 
that the bulk of platelets retained in the filter are in contact vvlth 
other platelets rather than with glass (Wright, I94&; Balzmaa, 1963)#
eg
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111 i960, Borch{?revink described an in vivo method for platelet 
adhesiveness, based on comparison of venous blood platelet counts 
with, those in a capillary blood sample from a modified bleeding time 
incision. The difference between the two c'nurbs represents the 
platelets adherent to the wound surface*
The mechanism of platelet adhesiveness was first explained by 
Hellem (I96O, I964) and Gaarder et al. (I96l), Hellem observed that 
although about one half of the platelets in citrated blood adhered 
to a column of glass beads, no platelet adhesion occurred when 
platelet-rich plasma was used Instead of whole blood* This observation 
wa,s also reported by ilonorato et al. (196I)* Adhesiveness was found to 
vary according to liaesatocrit (He.Hem I96O; Hirsh et al*, 1966a,
McClure et al., I966). Hellem isolated a "factor .U" from boiled red 
cells which v/as found to cause platelet aggregation. This factor 
was identified by Gaarder et al. as ADP &md vjus thought to be released 
from the erythx’ocytes during passage of blood through the column..
Of the three glass-bead column methods, the Hellem's technique 
as modified by Hirsh et al. (1966a) was used to study the platelet 
adhesiveness in nonml controls and uraemic patients. The details of 
the method used were described in Chapter 5*
REHÏÏLT3 
Results in Normal Controls
Results without correction for packed red cell volume
Tweiity-seven noxaaal healthy controls, 4 of who;;i were females, 
were examined, for platelet 'ilhesiveness to (glass by He Hem's technique 
as modified by Hirsh et al, (1966a). The mean normal percentage 
platelet adhesivoness was 98.2 1 7*81 (» 2 standard deviations:
54*9 ^ 69*9)5 (:^nd the mean, percentage packed cell volume was 40*6 
1 5*1 (table 41)* The mean platelet count in citrated blood was 
1945379 ^ 495800/0,mm. (» 2 standard deviations 102,579 - 286,579/G*mm,)
A significant oorrelatlon oxlstod betTfcen the paokecl cell 
volume and platelet adhesiveness (3? 0*651» P< 0*001)» (flgusre 32)#
Mo oorrelation was found between the peroentago adhesiveness and the 
platelet count in oltieatcd blood (r « 0*231» F>0*l)*
Relationship between platelet adhesivenose and ABP platelet a/m^egation 
and disaa^Axamtion*
Platelet adheeiveneôc Was assessed In 1? normal controls 
together with ABP platelet aggregation in m  attempt to find a relation* 
ship beivjoen the two teats* Mo correlation existed between platelet 
aggregation as measured by 30-60» 30-90» maximum aggregation and the 
percentage adhesiveness (r 0*0317» F> 0*1, r « -0*014» F >0*1» 
r Î3 0,056» F> 0*1 respectively)* However » there was a aignifioant 
correlation between-percentage disaggregation and percentage 
adheslvenesB (r 0*549» 0*05 >F> 0*02) (table 42, figure 35)* % o  
mean platelet count was 365#970 Ï 62#690/0* am*
Results in tJracmic Patignta*
Thirty-nine patients suffering from renal failure wore oxaisined 
for platelet adhesiveness# 30 of these were suffering from chronic 
renal failure» 9 had aoiat© renal failure (table 43)* Tho mean value 
for platelet adhesiveness was 30*1 t 12*2 per cent the mean packed cell 
volume was 26*64 - 7*75 per cent* and the mean platelet count in 
citrated blood was 159,936 t 72»2ll/o.aB. Mo correlation existed 
between the percentage adhesiveness and tho percentage packed cell 
volmie (r 0*310» 0*1 > F> 0*05)» nor between the adhesiveness and 
the platelet count in citrated blood (r « 0*161» F 0*1).
The mean values of platelet adhesiveness in acute and chronic 
renal failure were 31*5 Î 15*6 per cent and 291? * 11*3 per oont 
respectively# showing no significant difference (t » 0*362, F>0*l)* 
Eleven uraemic patients had a clinical haemostatic failure at the tim 
of the study* Their mean percentage platelet adhesiveness was
29*9 Î 16*4 and was not sigÈiifioantly different from tho man value
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of the rest of the uraemio patients (t # I#33, F > 0,l)*
Severn patiente suffering from terminal obronio uraemia were 
examined before and after dialysis treatment (table 46)* The mean 
platelet adhesiveness before cllaXyela was 30*2 per oant and after 
dialysis 42,1 per cent# showing a elgnifleant inoreaee (t « 2,#31*
0,02 > 0*01), Thin inereaae in platelet adhesiveness after
dialysis was a consistent finding in all ? patients examined (figure 
37)* The packed cell volume did not signifioantly change after the 
end of dialysis (t » 1*104§ P > 0,l)• Tho resuite of platelet 
adhesiveness before and after dialysis were elgnifleantly correlated 
with their corresponding blood urea levels (r =» -0,636# 0*02
> P>0*01) (table 46» figure 38)*
Acute Rene,! Failure mtients op Haemodialyaia*
Seven patients with acute renal failure were examined for 
platelet adhesiveness (table 47)*
The mean percentage platelet adhesiveness before dialysis was
32,9 - 16*3 per cent and after dialysis 22*9 * 19*9 per cent* There 
was an increased adhesiveness in 3 und a fall in 4 patients following 
dialysie (figure 37)* Mo significant change oociirred in adhesiveness 
after dialysis (t ^ 0*994» F^D*l) and in this respect these patients 
differed from those with ohronio renal failure. The mean packed cell 
volume did not change significantly, being 29,5 per cent before and 
30 per cent after dialysis (t 0*102, 0*1)* lo correlation
existed between the blood urea levels and pe3?centage adhesiveness
(r =, 0.055, P; 0*1)*
jAO^ Rnal controls and ^ iraemio natients.
Of the 39 patients examined# 26 showed diminished platelet 
adhesiveness (6? per cent) when compared to the normal range *- 2 
standard deviations. When the moan percentage platelet adhesiveness
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of normal oontrols and uraemio patient© were compared# the mean 
value of uraemic patients was significantly lower than the mean of 
normal contrôle (t 7*483» P <,0*001# figure 3l).
Tho mean va3.ues for platelet adhesiveneee In acute and chronic 
israsmlo patients ware also significant3y lower than the normal value 
(t S3 4.766» P< 0.001; t tîï 7*739, Pc 0.001 respectively).
Of tho 11 uraemic patients with bleeding# 8 showed diminished 
platelet adhesiveness (73 per cent) when compared to the normal mean 
value i 2 standard deviatiom* When the mean percentage platelet 
adhesiveness of the uraemio patients with bleeding and normal controls» 
were compared the mean value of the patients with bleeding was 
signifioantly lower than that of normal controls (t » 6.214» F< 0*001)*
The mean values for platelet adhesiveness of pro- and post- 
dialyaic In chronic renal failure .atients were significantly lower 
than the mean normal value (t «3 5,725* Pc. 0*00];; t « 2*552» 0*02 
) P ; 0,01 respectively), The same waa true for acute renal failure 
patienta ta’eated by haemodialysis (pre-dialyaia t «a 4.154» F <0*001, 
post-dialysis, t « 5*767, P 40*001).
.Relationehlp between Platelet Adhesiveness and Percentage Digg.%relation 
in ÏÏraemio Patiente*
Percentage platelet disaggregation was found to be dependent 
on the platelet count (Chapter 5). The mean platelet count of normal 
controls used to demonstrate the relationship between percentage 
platelet disaggregation and percentage platelet adhesiveness was 
365,970 - 62,690/0,mm. To show such a relationship in uraemio patients,
the results having a platelet count within the nomal range - 2 standard 
deviations were ohosen. Fourteen out of 18 patients (?8 per cent) 
showed m  abnormal platelet adhesiveneBS-disaggragatlon relationship 
i.e. a decrease in either adhesiveness or disaggregation or both 
(table 44» figure 3g). Tho four patients who showed normal relationship 
included two suffering from chronic renal falliree but with a 
relatively low blood urea level (in fact tho two patients in the group
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of chronic uraemics with the lowest urea levels# 106 mg per 100 ml*# 
and 85 mg per 100 ml)* The other two patients were suffering from 
renal failure resulting from post-renal obstruction*
Results after correction for Packed Red Cell Volume 
%  changing the packed cell volume using v^ irious concentrations 
of whole citrated blood and platelet-poor plasma, a curve was 
constructed in which a significant correlation existed between the 
percentage packed cell volume and the percentage platelet adhesive­
ness (figui^ e 33)* A correction factor of 1:1*8 was found between 
the two variables, i,e* for every 1 per cent reduction in packed 
cell, the platelet adhesiveness was increased by 1*8 per cent*
Normal results in the citrated blood showed a mean value of 40*6 
per cent for the packed cell volume# Results of platelet adhesive­
ness obtained from normal controls and uraemic patients were 
corrected to this level either by increasing or decreasing the 
percentage adhesiveness*
The mean normal value for platelet adhesiveness after correcting 
for the packed cell volume was 30 ,2 Z 6*93 per cent (- 2 standard 
deviations 38*2 - 52*1), while that of the whole group of uraemic 
patients was 35*3 - 15*9 per cent, the difference between the 2 groups 
was insignificant (t » 1*630, P > 0*1, figure 3^)* The smne was also 
true for acute and chronic uraemic patients (t = 1*309, P > 0*1$ 
t « 1*328, P > 0 ,1 respectively). The negative correlation that 
existed between percentage platelet adhesiveness and percentage 
platelet disaggregation became more significant after correcting the 
results of platelet adhesiveness for PGV (r = «0,611, 0,01 > P > 0,001), 
This relationship is mhoim in table 42, figure 35*
When the results of individual uraemio patients were compared 
to tho normal rang© of platelet adliesiveness (moan « 2 standard 
deviations), 19 patients showed normal results, 14 were increased and 
only in 6 the platelet adîiesivoness was diminished* Uraemic patients
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with bleeding had a mean platelet adhesiveness of 52*9 psr cent, and 
showed no significant difference from the mean normal platelet 
adhesiveness (t = 0,711, ?>0,l), or from the rest of the nraemic 
patients (t - 0*451» P> 0*1), Of tho 11 patients with bleeding 7 
showed normal results, 2 wore diminished mid 2 had increased 
platelet adhesiveness* Chronic renal faillira patients under haemo­
dialysis treatment had a mean corrected platelet adhesiveness of
65.6 i 9*2 per cent before dialysis, and 70*7 ^ 7*6 per cent after 
dialysis (t « I.I5I» P > 0,1); both were significantly higher than 
the mean of noriïial controls (before dialysis; t «= 5*599» P< 0*001; 
after dialysis; t « 7*660, P <0*001),
The mean values of pro-and post-dialysis in chronic uraemio 
patients were compared to the rest of the uraemio group excluding the 
chronic dialysis patients mean (53*54 ^ 16*15 per cent)* The mean 
pre-dialysis results showed no difference from t|ie rest of the 
uraemio group (t a 1*900; 0*1> P )0,05), while the post-dialysis
mean showed a significant increase (t =< 2*749» 0*01 > P > 0,001)*
The significant negative correlation that existed between percentage 
platelet adhesiveness and the blood urea levels before and after 
haemodialysis became insignificant after correction for PGV 
(t = 0,0419» P } 0*1)* Tlie mean values of pre- and post-dialysis 
on the acute uraemio patients undergoing haemodialysis treatment was
51.9 per cent - 14*61 before dialysis and 47*5 per cent i 15*8 after 
dialysis thus showing no significant change (t = 0*951» P > 0.1); 
furthermore no difference was found between the mean normal and the 
acute uraemic patient either before or after dialysis (pre-dialysis 
value t a 0*505, P> 0,1 and post-dialysis value t 0*687, 0,1),
DISCUSSION
Platelet adhesiveness to glass appears to ho mediated by the 
release of ADP from red cells during their passage through the glass 
bead column (Hellem I96O, 1964» Gaarder et al*, I96I), a process which
followed by aggregation beWeoB the piatelote thameelvea (Wright 
X94i| SaXman 1963) •
An important factor Influenolng platelet adhesiveness in the 
glass bead oolmm method is the padked red oell volume (FGf). A 
positive correlation between platelet adhesiveness and the POV was 
foand both la normal controls (t ^  0*651* ? <0*00l) (figure 3^ ) 
and also where the POV was modified in vitro using various concmtratlom 
of oitrated blood and platelet-poor plasma (t K, 0#989, P<0*00l)
(figure 33)* (This correlation has previously been reported by Hellem* 
1960$ Birah et al*# 1966; tfeOlur© et al## 1966* Platelet 
adhesiveness was also found to be negatively correlated with the 
ability of platelets to disaggregate following the addition of A W  
in thé turbidimetric system (r » 0*549# 0*03 >^>0^02) i*e* the 
more disaggregation# the leas the adhesiveness# As ADP released from 
the red cells is the factor responsible for platelet adheslvenees# and 
as platGiet*to~pl8telet aggregation is part of the process of 
adhesion# it is possible that some platelets aggregate primarily then 
disaggregate as ABP released from the red cells io converted to AMP; 
platelets after disaggregation may then pass through the column without 
aggregating again*
The results of étudiés of platelet adheeivenesa in uraemic patients# 
when no correction was made for variation in the packed cell volume# 
have shown that the mean platelet adhesiveness in the whole group was 
30*2 4 12*3 per cent. (Phis was significantly lower than the mean of 
either normal controls (t « 7»4031$ P<@*00l)# chronio uraemic patients
undergoing dialysis (pre-dialysis; t 5*723# 0*001; post-
dialysis Î t « 2*552* 0*02# > B >0*01)# and acute uraemic patients 
(pre-dialyaie» t ^  4.154» P< 0.001; pogt-aialysis« t « 5.767,
P <0.001). îîithowt ooï'ïôCîtion for haaniatocffii-fc, platelet adhesiveness 
v/as diminished in 26 out of 39 cases of uraemic patients oKomlned (1S6 
per oont), there was no significant difference between the acute 
and chronic uraemic patienta under dialysis and the whole group of 
uraemic patients. It was of interest to note that the mean platelet 
adhesiveness in the 11 patients with a haemorrhagic tendency wae
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25*9 oent whiob was not aignifiqantly lower than the mean of 
the other uraemic patiente (t K: 0*433. F>0*10)*
the effect of haemodlXayais on platelet adheslvenees in the 
chronic group was to oauae an increase in platelet adhesiveness*
This was statistically significant (t ^ 2*831* 0*02 0*01) n^d
occurred in all T patients* On the other hand^ such an Increase 
did not OGOur in the acute uraemic patient© following dialysis 
(t ^ 0*994# P>0*l)* There was a diminution of platelet
adhesiveness in 4 patients and an increase in 3*
Hgure 35 shows the relationship between platelet adhesiveness 
and disaggregation for the normal controls and the uraemic patients.
It will he seen that 14 (?8 per cent) of the 18 uraemic patients show 
a relationship outside the 95 per cent confidence limit of the normal 
controls* Furthermore it is ohvi'.uo fs?om the figure that in the 
uraemic group there is no correlation between adhesiveness and 
disaggregation*
In four uraemic patients, the re3,ationship between adhesiveness 
and disaggregation was within the 95 por cent confidence limits of 
I'Xormal* Of these four, two were patients with post renal uraemia 
one of whom was bleeding at the time of study# and the other two were 
patients with chronic renal failure due to presumed renal tuberculosis 
and chronic pyelonephritis respectively. Mmn the results of 
platelet adhesiveness in both normal controls and uraemic patients 
were corrected for O T  only six out of 18 patients showed an abnormal 
platelet adheaiveness-dleaggregation relationship (figm^e 36).
In summary, the present studies show that platelet adhesiveness 
is diminished in the majority of patients with uraemia when no 
correction is made for variations in haematoorit* The results 
obtained in the uraemic patient© with a bleeding tendency wore not 
significantly different from those of the rest of the uraemic group.
An increase in platelet adhesiveness occurred after haemodialysis in
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in the chronic hut not in the acute uraemic patients. The majority of 
patients showed an ahnorinal relationship between platelet adhesiveness 
and disaggregation.
The low platelet adhesiveness found has been reported hy others 
using different assay system. Dormer and Neuwirtova (196O) found 
a reduced platelet adhesiveness to yeast hy the method of 
Bourxaaieaux (l95?u)* In cases of uraemia where a functional deficiency 
of platelets resulted in disturhmice of the thromboplastin formation, 
reduced adhesiveness was found after rotation in a glass rotator 
according to Jurgen’s procedure (1959)*
Hellem at al. (1964) found low ADP-induced platelet adhesiveness 
in citrated platelet-x’ioh plasma, in oases of uraemia with a prolonged 
bleeding time. Salaman and Heri (I966) reported in vitro platelet 
adhesiveness to be diminished in 21 out of 24 patients with chronic 
renal failure, the abnormality being correlated with prolongation 
of Ivy bleeding time, abnormal prothrombin consumption and with 
clinical bleeding. The in vivo platelet adhesiveness method 
(Borchgrevinîc i960) showed low calues in 5 patients with prolonged 
Ive bleeding time but v/as normal in patients without bleeding 
(Oastaldi et al. I966). Tlie effect of dialysis on platelet 
adhesiveness has boon investigated by Oastaldi et al. (1966),
Anderson et al, (1966) and Stewart and Oastaldi (I967). A return 
of platelet adhesiveness to normal was observed in two patiente 
following dialysis (Oastaldi ot al. I966). Anderson ot al. (1966) 
compared the arterial and venous platelet adhesiveness and found an 
increase in adhesiveness as blood flowed through the dialyser.
Stewart and Oastaldi (19&7) showed by Borohgrevinlc’s method a beneficial 
effect of dialysis in 7 uraemic patients out of 6. O’Brien (1967) 
reported low platelet adhesiveness in few patients with renal failure 
using his own glass bead column method, but normal results were found 
with Wright’s technique.
In all the glass bead column methods described in the preceding
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paragraph# no oorrootlon fos? paotced cell volume was performed either 
because platelet-rich plasma and ADP were used (Hellem et al.# 1964) 
or because the method was not dependent on haematoorlt (8al^ man and 
l©ri# 1966) or not reported to be so (O’Brien’s method)*
,Oqrreqtio^  for B07*
The relationship between the BO? and platelet adhesiveness 
îBight appear to justify applying a correction factor to the results 
obtained from controls a#from uraemic patients where the PC? differs 
from the mean results obtained in normal controls (40*6 per cent).
A standard curve (figure 33) which the POV was varied in vitro by 
usiïîg various concentrations of whole citrated blood and platelet- 
poor plasma# was employed to determine the correction factor, rather 
than a standard curve prepared from noszmal oont3?ola (figure 32)9 in 
which there were no low FO? values*
The mean corrected platelet adhesiveness in uraemic patients 
was 53*3 * 15#9 per cent, and was not found to he significantly different 
from the value from the normal subjects (t 1*63, F >0,1), Only 
6 out of 39 uraemic patients showed low platelet adhesiveness# I4 were 
increased but the majority (19 oases) showed normal results, The 
group of patients with bleeding showed no difference in platelet 
adhesiveness from the nosmml mean value (t » 0*711 g F >0,1) and 
was not aignificantly lower than the remainder of the uraeoic patients 
(t ^ 0*431, F> 0,1),
Before dialysis, patients with chronio renal failure showed a 
significantly higher mean platelet adhesiveness of 65*5 Î 9I3 per cent 
than in normal controls (t ^ 3*339, P< 0*001), This became even 
higher after dialysis 70*7 t 7 ,6 per cent (t «a 7,660, 0*001),
However in patients with acute uraemia, the mean platelet adhesiveness 
before and after dialysis was not different from that of m m m l  
controls (before dialysis? t « O.gOg, Pq 0*1; after dialysis# 
t ^ 0*687, P^O.l), The mean of pre-dialysis was not significantly
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different from the rest of the uraemic group (t 1.908$ F;r O.l) 
hut was significantly high after dialysis (t 2*749* 0*01 0*001)*
Ho significant changes occurred in platelet adhesiveness in either 
chronic uraemic patients following dialysis (t - 1*51# F>0*1) or in 
the acute group (t » 0.591, B> O.l)*
When platelet adhesiveness vms corrected for POV 
adhesiveneas and die aggregation became more significant (t 0*611 
0.01> F> O.OOl) than before correction* Only 8 patients out of 
18 (aa compared to 14 before correction) fell outside the 95 cent 
confidence limit of normal (figure 36)*
In cmmaiy, after correcting for the PCT# the mean platelet 
adhesiveness in uraemic patients was within normal limits, as v/ae the 
mean value of acute uraemic patients before and after dialysis*
However, in the chronic uraemic group# the mean platelet 
adhesiveness was significantly higher than normal m à  became even 
more so after dialysis* After correction for POV lass than half 
of the uraemic patients showed an abnormal platelet adhesiveness* 
platelet dlaaggrogation relationship»*
The results obtained before correction for FOF probably reflect 
an overall picture In uraemia where platelet adhesiveness is 
diminished as a result of the low packed cell voltuBo frequently 
encountered In these cases* However# after mathematical correction 
for packed cell volume# normal results were obtained In 49 per cent 
of cases# increased results In 36 per cent and diminished 
adhesiveness In only I5 .4 per cent* The high values obtained in 
chronic uraemic patients before and the even higher results seen after 
dialysis may be explained by the fact that these patients’ platelets 
were exposed twice weekly for 10 hours to the dialysis membrane In the 
kidney machine, such exposure to a foreign surface perhaps being 
responsible for this increased adhesiveness* However, in acuta 
uraemic patients under dialysis the results were nofiaal before dialysis 
and did not significantly change after the end of dl&lysis, perhaps
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because these patients have not been dlalyaed as frequently as the 
ohronio patients# and that the dialysis time was also shorter.
PIAm.1® FâCTOgJ? AVAILABILITY
Platelets are the main source of phospholipid for the intrinsic 
coagulation pathway, Shis is evident from the fact that the clotting 
time of recaleified plasma is long if platelets have boon virtually 
removed by high speed centrifugation (Brinkhous# 3.94?)# It ccm be 
restored to normal by addition of platelets or appropriate phoBplio- 
lipid* Conley et al* (1949) found that prothrombin coneiimption 
showed a significant decrease when platelets were reduced* Morskey 
(1950) confirmed the effect of platelets on protlirombia consumption 
and foimd it to be almost absent in thrombocytopenia and in normal 
plasma when pl^ itolets were removed by centrifugation*
The observation tliat the ’^Btypven’’ times of intact platelet-rich 
plasma differs little from that of platelet-poor plasma (Marcus and 
Sucker, I965) Ms led to the conclusion that platelet phospholipid is 
not available in normal circulating platelets* Disruption of the 
platelets by fraesing emd thawing (Fantl and Ward# 1958)# by mechanical 
fragmentation (O’BriOîi# 1958)# sonication (Axelrod, 1956), or oven by 
centrifugation and washing (Marcus and tucker, 1965) readers their 
phospholipids available thus shortening the ’^Stypven** time,
Phoaphollpid is thought to be necessary for tlie ^mteractloa 
between factors VIII and IX (lundblad and Davie# 1964) and also between 
factors X and V (Davie and Eatnoff® 1964), In vivo# this phospholipid 
may well be provided by platelet factor 5# which is probably a 
lipoprotein complex* In vitro# agents such as total platelet lipid 
extracts or isolated platelet ethmiolamine end serine phosphoglycoride 
provide an effective substitute (Troup et al*# 1960% Barkhan ot al*® 
1961% Marcus et ai,® 1962% Ferguson et al*# 3.963? Woodside et al,# 3.964)
The subcellular localisation of platelet factor 3 activity was
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made dlffioult by the fact that complete separation of platelet 
oomponentB could not be obtained# So called granule préparations 
m^Q always found to be mixed tdth sœtoane fragmenta when 
examined by the electron mloroscopo (Earcua and guck0r-Fra#:llB,
1964). Recently Marcus et al$ (I966) using an improved method oi 
platelet homo^nisation, and tiltraoentrifugation in a oontimious 
euorose density gradient, were able to achieve complete separation 
of platelet granules and membranes# #en tested in vitro, platelet 
membraneB ware more efficient as olot*^ promoting agents than were the 
granules# Howaver, when the lipids were extracted from each fraction, 
the clot-promoting activity of both granules and miArane lipid was 
the same# This led to the conclusion that the lipoprotein of platelet 
membranes is more available for interaotion with coagulation proteins 
than is the lipoprotein from the 0 ?aml0s#
Electron microscopy studies showing intact platelet membranes 
throughout the major part of the olottl*3g process is In favour of the 
proposition that the platelet contribution to prothrombin activation 
may be a function of their external or plasma membrane (Oastaldi et 
al#, 19621 Rodmm et al#, 102$ Hodman et al#, I963)# The mechaniom 
by which platelet factor 3 is activated from intact platelets is not 
clear# There is now evidence to support the proposition that A W  micy 
be responsible for both platelet factor 3 activation m  well as 
platelet aggregation (llardiaty and Hutton, 1966b $ Horowitz and 
Fapayaunou, I968)# In the process of haemostasis, the ABP released by 
platelets which have adhered to collagen may be the responsible factor 
for inducing platelet aggregation and factor 3 activation# Eventually 
a platelet plug will develop which is the first step in the formtion 
of a haemostatic plug#
Platelet factor 3 availability h m  been studied by a technique 
using m%ssel Viper Venom (stypven) as described by Spaet and Pintron
(1965) in both nomml controls and uraemic patients and the results are 
presented in this chapter#
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Results lu Hormal OontrolB
Twenty-three normal healthy subjeota were examined for platelet 
factor 3 availability by the method of Spaet and Gintroii (105)*
The meaan ^ rStypven* time of normal controls was 19*09 Ï 2*8 seconds, 
and the mean platelet coimt was 374,21? - 74,420/c#nmu (table 49, 
figure 39)* The normal Kaolin oephalln clotting tiîne was $0*9 1 5*3 
seconds (table 36)*
There was no significant correlation between the platelet count 
and the ’Btypven’ time in 23 normal control subjects tested (r =3 0*131, 
P > 0.1), There was a tendency for the ’Stypven’ time to be prolonged 
when the platelet count was lowered by dilution of the platelet M;ch 
plasma with platelet poor plasma (experiments 24-31, table 49)#
However, when these latter results were included with the results for 
control subjects a eigaificant correlation between the platelet Count 
and the ’Btypven’ time was not obtained (r ^ O.298, Oil > P > 0#05; 
figure 40)* It should be noted that in all 5 results with a platelet 
count less than 177®000/c#rmiu, the ’Btypven’' time exceeded 23 seconds, 
whereas in only 2 of the 26 :ln which the count was I'iigher than this 
figiiro did the time exceed 23 seconds*
Relationship betv;een platelet factor 3 availability and ADF-induced 
Lateiet asp’rc
Ten experiments were carried out in which platelet factor 3 
availability test was done together with ADP-induoed platelet aggregation 
from the same blood sample* Ho correlation existed hetvjeen platelet 
aggregation (as measured by 30*60, 30-9O, maximum aggregation) and 
the ’Stypven’ time* However, a significant correlation was obtained 
between percentage disaggregation and the ’Stypven’ time (r =a 0.645,
0.03 > P > 0*02% table 32, figure 42).
Results in Uraemic Patients 
Thirty-one patients with uraemia were examined; of these 25 were 
suffering from chronic renal failure and & from acute uraemia* The 
moan ’Btypven’ time of the whole ç^roiip was 30*2 - 10.4 seconds, mid
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the mean platelet ooimt was 227,750 ^  107®000/c«mmo (table 50, 
figure 39), all expérimenté the kaolin cephaXin clotting time 
was also performed* In studying the results® 3 patients had 
prolonged kaolin cephalâJi clotting time*
To determine the relationship between the platelet count and the 
hStypven’ time® the results from uraemic patients with prolonged kaoHn 
cephalin clottjjug time wore excluded* This is because any prolongation 
in the kaol:?ii cephalin clotting time would result in prolonged 
’Stypven^time (r es 0*462, 0*02 > F > 0*01; figure 4l)*
In stuclying the results, platelet counts below and kaolin cephalin 
clotting time© above Z 2 standard deviations from the normal were 
excluded, the meim ’Stypvon’ time from 13 uraemic patients vjas 
24*8 1 3,9 seconds*
Effect of HaemodiaXyeie
Five chronic renal failure patients were examined before and after 
haemodialysls (table 53)* The mean platelet count was 251%900/ctmm. 
before dialysis, and 286,300/0.*mm* after dialysis, allowing no significant 
change (t sa 0*6761 P > 0*1)* The mean ’Btypven’ time before dialysis 
VÎSB 29 i 8*8 seconde and after dia3.yeis 26*5 - 5*8 seconds. The 
difference between the two was inaigilfleant (t ^ 0*531$ F > 0*1)#
Four patients with acute uraemia were tested before and after dialysis 
(table 54); one patient (Ho. 23) who had a markedly prolonged ’Stypven’ 
time and kaolin clotting was excluded from the calculation of the 
moan* The mean pre-dlalysls ’Stypven’ time of 3 patients was 30 seconds 
mid post-dialysis 25*13 seconds. All 3 patients had a platelet count 
below the normal rimge# There was no significant difference between 
the two me&ma it ^ 0*587$ F > 0,1)*
Helationshln between platelet factor 3 availability and percentage
Of the 13 uraemic patients who showed normal kaolin cephalin 
clotting time and had a platelet count within the normal range, 12 had
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also been examined for ABP-induoed platelet aggregation (table 5l).
The eigniflcant correlation found in normal contrôle between the 
’Btypven’ time and percentage disaggregation was absent In uraemic 
patients (r =* 0,389$ B >0.l), The results of 8 uraemi.c patients fell 
outside the 95 per cent confidence limit of normal (6? per cent) l,e* 
prolonged ’Btypven* time or diminished disaggregation, and only 4 showed 
normal results (figure 42)# These were two patients with chronic 
renal failure under haemodialyaie and one case of post-renal uraemia, 
the fourth patient was suffering from chronic renal failure under 
treatment in the ward. Her blood urea fell from 310 rag. per 100 ml,
5 days before platelet studies were done to 131 sig* per 100 ml,
femLJfeHteoAa.*.
The mean ’Stypven* time of the whole group of uraemic patients was 
significantly different from the normal moan (t 4.613# F < 0,001).
The mean of 13 patients with a platelet count above the low mem 
normal controls and having a normal kaolin cephalin clotting time was 
compared with the mean normal, The mean of uraemic patients vms 
significantly lor*ger than the normal (t 4.256# F<0,OOX).
CoDîparison was made between the mean ’Stypven’ time in 10 normal 
controls and 12 uraemic patients having a platelet count in the range 
of 200#000 - 300f000/o.mm, (tabic 5&)* In some oxperlmente the 
platelet count was adjusted to this range by appropriate dilution of 
platelet-rloh plasma with platelet-poor plasma, The mean ’Btypven* time 
In normal oontrole was 20,5 - 2 ,7 seconds# and in uraeioio patients
S6,6 Î 4*5 seconds, The mean ’StypverM time in uraemic patients was 
slgnlfioantly longer than in normal controls (t =3 3,764# 0 .01 >P> 
0.001),
Both pre- and post-dialysis mean ’Stypven’ times of chronic uraemic 
patients were signifioantly longer than the normal moan (pre-dialysiss 
t = 4,227, B <0.001$ post-dialysis* t ^ 3,878# F< O.OOl). The same 
%me true for the acute tiraemio patients (pre-dialysis* t - 3,581# 0,01
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 ^ O.OOli Fost-dialyalBS t - 2,544* 0.02 / F >0*0%),
MBQWiUlQB*
It has been shown by Hardlaty and Hutton (1965$ 1966a) that 
kaolin riiakes platelet factor 3 available in platolet-rioh plasma by 
a reaction which involves platelet agg^ regatlon# and which can be 
inhibited by antagonists ^,|f ABB such as adenosine and related compounds. 
Hardlsty and Hutton (1966b) confirmed the observations of Mustard et 
al# (1964b)# and Oastaldi et al, (l96g) on the role of ADB in the 
clotting activity of platelets. They measured the changes in optical 
density and ’Btypven’ time of platelet-rich plasma aggregated by ADF. 
Their results showed that aggregation by ABF# adrenaline# nonadrenaline# 
5-lurdroxytryptamine or collagen is closely followed by a reduction in 
the ’Stypven’ time which reaches a nmxiimm after about 20 minutes#
The effect of the ’Stypven’ depends on the rate, degree and duration 
of platelet aggregation* They suggested that the membrane change© 
which lead to platelet aggregation may qlso provide an active catalytic 
surface for the interaction of coagulation factors#
The work of Horowits and Pap#roanou (I968) also confirms that ABB 
activates platelet factor 3 oF intact plat©let-rich plasma. Activation 
is dependent on the concentration of #P and it occurs with sufficient 
speed to have a potential pluyeiologioaX role in blood coagulation#
Inhibition of aggregation by adenosine Is associated with a 
proportionate inhibition of the fall of ’Stypven’ time; and 
phonothiagfine derivatives # which also Inhibit ADP# halt the effect of 
ADP on the ’Stypven* time but do not reverse it (Hardisty and Hutton#
1966), The relationship presented in this chapter between platelet 
disaggregation and the ’Btypven’ time in normal controls 
(r 0.645? 0,05/ F >0.02) may be explained from the above findings.
Disaggregation following platelet aggregation induced by ADP results 
from degradation of ABB by plasma enzymes (Hellem md Owren# I964) and 
by platelet enzymes (Balsman ot el.# 1966)1 hence in platelets with a
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high capacity for destruction of à W  it may be that the more 
disÉaggregation occurs, the earlier and greater Is the degradation 
of ADP so the greater the amount of ADP inhibitors formed* As these 
inhibitora can halt the fall of the ’Btypven’ time CHardiaty and 
Hutton® 19665 Horovjits and Papayoauioit® X968) then it should bo 
anticipated that the more jmhibltor formation, the more disaggrogation 
and the more prolonged the ’Stypveii’ time will be. P3.atolet factor 3 
availability as tested by the method of Spaet and Cintron (I965) 
was foimd to have a mean of 19*98 - 2#8 seconda in normal controls#
There was no cora:*03.atioB between the ’Stypvon’ times fmd 
corresponding platelet counts# The correlation was still insignificant 
when eKpex*iments were included where the %)latelet^ rlch plasma was 
diluted with platelet-poor plasma. The results with normal controls 
show that ’Stypven* times within the nœ^ mal A 2 standard deviations 
were always obtained with platelet counts down to 17?5000/c*mm#| 
below this level either normal or prolonged *8typvon* times may be 
found#
Tests of platelet factor 3 availability in uraemic patients showed 
prolonged clotting times when compared with norma], controls* This 
difference was obtained with the whole group (t 4#6l3g B < 0*001), 
and also when samples showing a prolonged kaolin cephalin clotting time 
and/or a platelet count two standard deviations below the normal mean 
were excluded (t 4.236, P < 0*0001). The mean ’^ typven’ t±ne In 
uramiic patienta was also eigniflcimtly longer than normal controls 
when the platelet count in both groups was adjusted to 200,000 » 
300,COO/c#mm* (t ^ 3*764, 0#01 > P > O.OOl),
Results with normal subjects have ahoim that with a platelet count 
above 177$00Q/o#™*$ the ’Stypven® time will be within  ^2 standard 
deviations of normal (figure 40), When these criteria were applied 
to uraemic patients the following 4 groups were observed* Patients with 
prolonged kaolin cephalin clotting times were excluded and 28 were 
ana3ysed (figure 4l)*
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Results from normal subjects have shovffî. that with a platelet count 
above 177,000/o*mni# the ’Btypven’ time will bo normal (figure 40)« The 
results from 3 patients with prolonged kaolin cephalin clotting time 
were excluded and the remaining 28 patients were divided into four 
groups based on their platelet coimts and S^typven’ tnjue * For the 
purpose of this analysis a normal platelet count is defined as being 
greater than iy7pOOO/o#mm*
(1) Lois platelet count and prolon,c>:ed ’rStypven’ time
Six patients had a platelet count less than 177®000/c#mm* and 
prolonged ’Btypven® time# Of these® three showed a bleeding disorder? 
two had acute renal failure (Moa# 2?® 28® table 50,35)I mid one had 
chronic renal failure (No* 13)# Of the remaining three, two had 
clironic renal failure (Hos. 21$ 26) and one had acute or chronic renal 
failure (No. Ig).
(2) Lop platelet,opunt^ mid normal ’Btypven’ time
Three patients with acute renal failure (Hoa. 23, 37 ajid 39)$ two 
of whom were bleeding (Nos. 23» 3?)? showed normal ’Stypven® time 
despite low platelet count# All three patients were jaundiced.
(3) Normal -platelet ooimt and prolonged ’SbYPVeh® time
Six patients idth a platelet count above 177sOOO/c#mm. showed 
prolonged ’Btypvon’ time. All were suffering from olironio uraemia 
(Nos. 14,13,16® 22, 30,33)* Three patient© were bleeding at the time 
of study (nos. 14, 13, 30).
(4) Normal platelet count and normal ’Stymren’ time
Thirteen patients (46^ 0 showed normal LStypven® times and platelet 
counts above 177,000/c*mm. One patient had acute renal faili?re and 
bleeding*
Platelet factor 3 availability was tested in 9 of the 11 patients 
with clinical haemos-tatic defect (table 33)* I^'our of these 9 patient© 
had a platelet count above 177,000/o#mrji. 5 In 3 the ’Btypven^  time was 
prolonged and in one the result was normal# Five of the 9 patients had 
a platelet count below 177,0OO/c.mm*§ in two the hS-typven’ time was 
normal, and in three it was prolonged*
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A sig^ iifioant negative correlation between the ’Btypven’ time 
and the platelet count was obtazlned in uraemic patients® but was 
insignifioant in normal controls* This may suggest that in normal 
Controls, platelet factor 3 cm. be made available for the intrinsic 
coagulation mechanism from relatively low platelet count and is not 
highly dependent 0.0 the number of platelets ♦
However, in uraemic patients® lowering of the platelet count 
can significantly affect the ’Btypven’ time*
A significant cozTelation existed between the ’Stypven’ time and 
percentage disaggregation in normal controls, i.e. the leas 
disaggregation, the shorter the *Btypven* time* In uraemic patients 
such a congelation was absent and most patients showed dijiiinished 
disaggregation or prolonged LStypven® time or both#
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ADP is found to activate platelet factor 3 (Hardisty mid Hutton® 
1966b? Horowitsi and Papayosmou, 1968)» Kaolin malcee platelet 
factor 3 available in platelet-rich plasma by a reaction which 
involves platelet aggregation and which is inhibited by ADP 
antagoniste® such as adenosine and A W P (Hardisty and Hutton® 1963$ 
1966a). It is possible that kaolin acta by releasing ADP from 
platelets resulting in platelet aggregation and availability of 
platelet factor 3#
Analyses of the results in uraemio patients (table 329 figure 42) 
have shoim that the ’Btypven® time was normal in 80 per cent of 
patients with low disaggregation® as compared to 6? per cent when the 
disaggregation was norma].* This shows that diminished platelet 
disaggregation In uraemic patients may be responsible for correcting 
the ’Stypven’ tiine but did not cause the expected increa.se in platelet 
factor 3 availability*
The effect of haemodialysis on platelet factor 3 availability 
in clisT'onic uraemia was studied (Table 33)* Three patients who showed 
normal bStypvm® times before dialysis remained imchanged after 
dialjrsis* In two others the ’Btypven’ time was prolonged before 
dialysis, becoming normal in one® and improving in the others® after 
dialysis* In patients with acute uraemia, one patient showed normal 
results before and after dialysis® one showed improvement after 
dialysis and one showed a prolongation the clotting time after 
dialysis (table 34)#
These results are similar to those sreported by Oastaldi et al
(1966) who tested platelet coagulant activity by the method of Hardisty 
and Hutton (1963) and the method of Bpaet and Gijitron (1963) in two 
cases of chronic renal fad.lure before and after dialysis* They reported 
a return to normal in both oases followiîig dialysis* Btewart and 
Oastaldi (196?) also reported similar findings using the protiirombia 
consumption index and platelet factor 3 availability test#
The prothrombin oonanmptlon index, abnormal before dialysis on 10 
ocoasion©, wos restored to normal T times and improved 3 times* The 
test of platelet faotor 3 availability was abnormal on 6 ooeasiona* 
became normal in 3 but showed no improvement after the other 3 
haemodialyses•
FXatelet thromboplastio function in uraemia has been iiweetigatcd 
by several authors using different teohniquee, A poor prgthroiiMn 
conoumption is a common finding (terain and Adelson# 1956§ Leuds 
et el. 9 1997; Alschuler et al. * I96O1 Donner and Keuv/irtova# I96O; 
Wur^el# I96O; Willoughby and Orouoh# 196X5 Kendall et al*® 196X; 
Salesman and Herl# 19665 Oastaldi at aX,# 19661 Stewart and 
Oaetaldi, 1967)* Serum prothrombin times were found to be longer in 
chronic than in acute uraemia (Donner and Neuwirtova, i960)*
Defective oonsumption has been attributed by gome to an abnormality in 
platelet thromboplastin function (Cahalane et al,, 1958), while other© 
found poor prothrombin oonsumption in patients who had no mea&m»able 
platelet abnormality (Altschuler et al*, 196a)* Oahalane et al*
(1958) showed a poor platelet function in the tbrombeplastin generation 
test using a diluted system but could not bring the résulta back to 
normal by sonicating the platelets, contrary to the findings in 
thro3iibocytopathy* Ohanoy and Bonnin (1962) studied 33 oases of 
uraemia using the platelet thromboplaetio function test* Twenty- 
eight patients showed reduced levels of platelet thromboplaatio 
function and there was a positive relationship between the levels of 
blood urea nitrogen and the results of the test*
Im^ e^stigation of platelet factor 3 availability in uraemia has 
been recently carried out using intact platelet-rich plasma*
Activation of platelet factor 3 was achieved either by addition of 
kaolin (Hardisty and Hutton® 19651 Spaet and Gintron® 1965) or by 
ADP (Horowitz et al*, I967)* Oastaldi et al* (1966) reported that 
56 per cent of uraemic patients with blooding had abnormal platelet
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factor 3 availability while the majority of the patients with no 
bleeding had normal teats»
Vihen ADP was used to activate the platelet factor 3; 16 of 17 
wraemio patients showed prolonged ‘Stypven* times (Horowita et el.,
1967).
Ill the result© shov? a reduoed platelet factor 3
availability in 15 out of 31 uraemic patients exaW.ned (50 per cent)# 
However® when the résulta from uraemio patients with low platelet 
counts and prolonged kaolin cephalin clotting times are excluded, only 
3 out of 13 patients showed a prolonged ’Stypvcn’ time (23 per cent). 
The majority of the patients with bleeding were thr .mbocytopenio and/or 
had prolonged ’Btypven’ time. Dialysis had no effect where 
platelet factor 3 availability was normal» but tended to restore 
normality in patients with reduced platelet factor 3 availability.
ffil&PÎBH 8.
ïiœ  m ? IÏI1 0  EB’.PEOT Qg tïHBA. eB S A fltriK E . ÏÏR.ÎG AOIP
For many years® Investigators have been trying to identify the 
GuhataiiGô or substances responsible for the toxic changes that occm?
In uraemia® and in particular for the liaeBioetatic abnormlitiee 
encountered in some uraemic patients*
Although abnoraialitiee of blood eùagulation have been reported 
in some patients with uraemia (Bonner and Neuwirtova# I960)# and the 
prolonged bleeding time frequently found has been attributed to a 
vascular defect (Gualdi# 1935)# seecent evidence points to a 
functional platelet disorder#
Attempts to determine the agent responsible for thedefect and 
the nature of the platelet dysfunction took many lines of approach*
One Was to determine the deleterious effect of uraemic plasma on 
normal platelets and the correcting effect of normal plasma on 
uraemic platelets* Oahalane et al* (1958) demonstrated an inhibitory 
effect of uraemic plasim on platelet factor 3 extracted from normal 
human platelets* Although Salgman and Neri (I966) detected abnormal 
findings in thrombin-induced platelet aggregation in uraemic patients# 
they were unable to reproduce these results In vitro® either by 
adding normal plasma to uraemic #itelets or vice versa# Stewart and 
Oastaldi {1967) found that neither in vitro dialysis# nor mixing 
nomal plasma with abnormal platelet and vice versa# for 2 hoiM# had 
m w  effect on aggregation# coagulation activity and clot retraction 
in either uraemic or nomtal platelet-rich plasma* However# Horcwlts 
et al*(l967) u©l% ABP to activate platelet factor 3 found that the 
presence of uraemic platelet-poor plasma prevented ADF-induoed 
platelet factor 3 activation in normal plasm with rough dose-response 
relationship* Fully activated factor 3# obtained from frozen and 
thawed platelets was not inactivated during 60 minutes of
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incubation in uraemic plasma#
The high blood urea found 3Ai uraemic patients had led many 
Investigatora to believe that urea may have a role in causing 
platelet dysfimctlon*
Hellem et al (1964) infused IgO g« urea intravenously to a 
subject with normal haemostasis* This resulted in lowering of 
platelet adhosiveneee and prolongation of the bleeding time, They 
also obtained a prolonged bleeding time when the skin wound is 
flushed with a solution of urea in buffered sal.lne* However® this 
is not the finding of Oastaldi et al (1966) who failed to detect 
any absiormality in platelet function when the blood urea ia raised 
to about 200 mg per 100 ml In normal controls by means of jjitravonous 
infusion of urea# Hrea Itself is found to cause platelet aggrogatioii 
at a concentration of 20Ck.400 mg per 100 ml but failed to inhibit 
âDP^ :Uiduoed platelet aggregation (Balman aazd Neri, 1966)*
Addition of urea iîi a coneentration of f5Q to 1000 mg par 100 ml 
of normal, platelet-^ rich plasma did not inhibit factor 3 activation 
with ADP (Horowitg) et al# 196?),
Fantl (1966) found that urea at si concentration of 820 mg per 
cent C400 m^oemole) did not inhibit ADP^lnduoed platelet %ggrQgatlon#
Recently Borner et al* (1968) studied the effect of urea on 
platelet aggregation and found that urea in concentrations frequently 
encomitered in the uz'aemlc state initially inklbits and later 
enhances aggregation induced by ADP#
Bubstasicea other than urea® loiovjn to be raised in uraemia^ have 
also been introduced in in-vitro eystems to determine their effect 
on platelet functions# Hellem et al (1964) found that high
ill
oonoeEtratian© of oreatimna and inorganie phoephato had no effect 
on ABP-induoed p3.atolet adhesivenose of piatelot-rioh plasma In 
vitro* However® Praga and Gortellaxo (1967) reported a direct 
inhibitory effect of oreatiiilnQ on platelet adhesiveness in vitro*
The in vitro addition of creatinine,ureate, phosphate® potassium and 
mgnesiiM In concentrations that might occur in uraenda# or changes 
in pH to 5*2 and 8*1 had no deleterious effect on platelet 
aggregation® coagulant activity of platelets or clot rétraction 
(Stewart and Oastaldi, 1967)# These authors also found that dextrose 
and mannitol impaired platelet coagulant function at concentrations of 
167 K* Eol* per litre# clot retraction at 250 m Mol* per litre and 
aggregation at 333 ^  Mol* per litre*
Phase contrast microscopy showed that impairment of platelet 
function resulting from addition of urea# dextrose and mannitol is 
aasooiated with shrinkage and distortion of platelets*
The finding that 1-4 âiguanidino diphoi^l sulphone causes 
inhibition of ilBF-induced platelet aggregation (Jerushalt\^  ot al*» 
1966) has led Horowitz et al# (1967) to Investigate the effect of 
analogous compounds which might bo present in uraemia*
Of these® guanidine succinic acid was found to be a powerful 
inhibitor of ADP-induoed platelet factor 3 activation» while arginine 
and guanidino acetic acid had no auoh effect,
Xn this chapter are presented an account of the in vitro study 
of the effects of urea» creatinine» m:'ic acid and guanidine succinic 
acid on ABP-induoed platelet aggregation#
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lœASÜHSiïBîTO OP TOi! Ill VIKRO EPPECT OP tIKEA., CREATINIHE,
TilîIC ACID AMD GTTAWIDIMO SÜQCKJIG ACID OH 
ADP-IHWCED PLATELET AQGBEGAglOAr
1* Urea
Urea was added to citrated platelet rich plasma to give a 
final concentration of 800, 750» 500* 400* 250* and 200 mg. per 100 
ml* This was done in the following matmer:
1# 800 mg. per 100 mil- 0 .1 ml. of 20 gm per 100 ml* stock
urea solution was added to 2*4 ml, platelet-rich pla-sma,
2. 750 mg* per 100 mil- 0,1 ml, of 50 por 100 ml, stock
urea solution diluted in 1»2 was added to 1*9 ml* platelet-rich 
plasma,
5* 500 mg. per 100 ml*- 0 ,1 ml, of 20 gm per 100 ml, stock
urea solution diluted in 1 :2 was added to 1 .9 ml, platelet- 
rich plasma,
4* 400 mg, per 100 ml,a- 0,05 ml, of 20 gm por 100 ml, stock
urea solution was added to 2*45 ml, platelet-rich plasma*
5* 575 mg* per 100 ml, s- 0 ,1 ml, of 50 gni per 100 ml, stock
urea solution diluted 1 :4 was added to 1 ,9 ml, platelet-rich 
plasma #
6, 250 mg, per 100 mis- 0 ,1 ml, of 20 gm per 100 ml, stock 
urea solution diluted 1*4 was added to 1*9 ml, platelet-rich 
plasma.
7, 200 rag, per 100 mil- 0,05 ml, of 20 gra per 100 ml. stock 
urea solution diluted is2 was added to 2*45 ml, platelet-rich 
plasma.
All dilutions were prepared in harhitone buffered saline pH 7*2» 
For the controls the appropriate amounts of harhitone buffered saline 
was added to platelot-rich plasma.
After the platelet-rich plasma ha.d been incubated with the urea
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for 5 minutes at room tesiperature the plasma was mixed by inversion 
for 5 times? a 1*9 ml* aliquot was transferred to a cuvette and the 
ÂDP-induced platelet aggregation assessed by the turbidimetrio method 
described above*
Tkree experiments were carried out for each urea concentration*
A teat followed by a normal then another test were caa’ried out in 
that order*
The mean results obtained from the 2 test experiments were 
subtracted from the valuo obtained with the normal control* The result 
obtained vfas considered a measure of the degree of inhibition by urea 
of platelet aggregation said disaggregation* A negative value would mean 
that the test is greater than the control*
2* Creatinine
0*1 ml# of 0*2 gjïi per 100 ml* creatinine in barbitone buffered 
saline was added to 1*9 ml* platelet-rich plasma and incubated 
for 5 minutes at room temperature* Final concentration of 
creatinine was 10 mg, per 100 ml* ABP-platelet aggregation ?/as 
assessed as described above*
5# brio Acid
0*2 ml# of 50 mg per 100 ml* uric acid in barbitone buffered 
saline was added to 1*6 ml* platelet-rich plasma and incuTjated 
for 5 minutes at room temperature. Final concentration of uric 
acid was 5 mg* per 100 ml* Al)P-induood platelet aggregation 
was assessed as described above*
4* Ouanidino succioinic Acid
0*2 ml of an 0*586 gm per 100 ml* solution of guanidino succinic 
acid in imidazole buffered saline were added to 1 .8 ml* platelet- 
rich plasma in a siliconized centrifuge tube and incubated at 
room temperature for 10 minutes* The final concentration of the 
guanidino succinic acid was 2 x 10 M*
1*9 ml. of the plasma was transferred to a cuvette and placed in 
position in an EEL titrator* 0*1 ml. ADP were added and ADP platelet 
agrgrofration was assessed as described* A control experiment was
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performed in which 0*2 ml# imidlazole hiiffereâ saline were added® 
then another test experiment was performed* The degree of 
inlilbitlon was oaloulated as desoribsd before#
mg_Mi:Qat.ofJteaa.m.isaM«^^
Bight experiments were carried out to determine the effect of 
urea In vitro on ADF-induced platelet aggregation and its reversal 
using a wide range of concentrations (from 20D-80D mg# per 100 ml# 
of plasma) # The details of the method used on the caXoulatlon of 
the results were given previously in this chapter#
ÏÏrea caused an inhibition of platelet aggregation in all S 
experiments x^ erformed# However* the degree of inhibition was not 
signlfioantly correlated with the corresponding ireea eonoentrationa#
30-60 platelet aggpzegation: r - 0*666® 0*1 pP;> 0*05 
30-90 platelet aggregation? r =? 0*261» P ^ 0* 1
Maximum platelet oggregaticner 0*403» F>0#1
Urea also resulted in a dliïdnution of percentage diaeggxegation 
in all experiments® and was in correlation with the respective urea 
concentration (r 0*882, 0*01 > 0*001)* This relationship is
aho?m in figure 43*
A representative experiment (Ho# 4, table 56 end 59} is shown in 
figure 44*
, glaWIet àg^imHoa.
Or eat Ini ne added in a concentration of 10 mg. par 100 ml* of 
plasma caused a negligible increase in platelet aggregation and 
disaggregation when compared to a saline o ntrol (table 57)*
ÏÏric acid added in a concentration of 5 mg, por 100 ml* of plasma
Î15
ôàused a negligible diminution in platelet aggregation and a slight 
Increase in percentage dieagg-xegation aa compared to a saline 
control (table 57)#
The Effect of Guanidino Isacoinic Acid on ABF-induced Platelet 
m,motion»
Ho effect vma obtained when gaanidino euceinio acid waa added
x^A
in a final concentration of 2 x 10 ^ molar wliiqh 1© the concentration 
used by Horowitz et al# (1967) to demonstrate Its effect on ADP- 
Induced factor 3 availabl 11 ty* However when the oouoentratlju was
"^3
increased to 2 x 10 molar a constant diminution of plabelot 
aggregation and an increase in percentage disaggregation wae obtained 
in all 7 experiments performed* This effect was not significantly 
different from the saline controls (table 58® figure 45)*
30-60 platelet aggregation: t =j 1*813® 0*1 > P> 0*05
30-90 platelet aggregation: t 2*146® 0*1 > 0*05
Maximum platelet aggregation:'!; 1*309® F >0*1
Percentage disaggregation :t ^  1.172* F> 0*1
The platelet dysfunction in uraemia has bean described by several 
authors to be reversed by correction of the uraemic state (Oastaldi 
ot al*g 1966; Traagar ©t el.® 1967; Stewart and Oastaldi» 196?).
The corrective effect of haomodialysis and peritoneal dialysis on the 
abnommlitles in platelet function suggest that the cause may be due 
to dlalysable metabolites*
An attempt was made to reproduce a platelet abnormality by 
incubating urea, oraatinxna® urio acid and guanidino succinic acid with 
plat ©let-rich plasma* After a short Incubation, ABP-induced platelet 
aggregation was assessed#
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Hzea caueeâ e oonata'at cliaîimvbion in platelet aggi^ agatlon anü 
disaggSÉ’egatlon when added In conoentx’ations varying i m m  200 ta 800 
m g per 100 ml* of plaama# $he degree of inhibition of platelet 
aggregation ime not elgnifiosntly oorrelated with the oorreeponding 
nraa levele* However the Inhibitory effa# on platelet 
dioaggregstion wae eignifioant3.y correlated with the reapeotive urea 
oonoentrationa (figure 43)#
*fhora are conflicting reporta in the literature as regarde the 
in vitro effect of umii on pXateleta* Fantl (1956) showed that urea 
can inhibit ABP-platelet aggregation only in a concentration of 
1000 m^ogmole or .more# Stewart and Oastaldl (1967) observed that 
urea alone has no effect on ADP^iaduced platelet aggregation within 
the range that iaay be encountered in uramiia. Studiea performed 
by 8omer et al, (1968) have ehovm that over a wide range of 
concentrations, urea initially inhibits and later enhanoos platelet 
aggre .ation induced by ABB# This blphaoio off act is explained by the 
authors im resulting from the formation of stable platelet 
aggregates probably due to damage by uï?ea# Balaman and Heri (1966) 
and Somor et al. (I968) have shown that urea can cause platelet 
aggregation# This effect la Independent of eatiom and differs from 
aggregati ,n by ABF in that the inhibitory effect of adenosine and 
AMP la markedly delayed#
The mechanism by which urea acta on plataleto ia not clear.
Hell era et al# (1964) postulated that imea breaks hydrogen bonds thus 
interfering with the binding of ABP to proteins looated on the 
platelet surface* Somer et al# (1968) explained the urea effect on 
platelets as being due to alterations in the cohesive property of 
platelets? leading to stable platelet aggregation,
The different reauXts obtained by various authors regarding the 
effect of urea on ABP^ induoed platelet aggregation rimy be due to
individual variations and different methods of study,
The findings an this thesis of the in vitro effect of urea on 
ADF^platelat aggregation were almilar to the results obtained front 
patienta with uraemia? i,e* diminished aggregation and disaggregation 
(Ohcipter 5),
Other metabolites like creatinine and uric acid added in 
concentrations which might be found in uraemia had negligible effect 
on ADP-*induced platelet aggregation * This is in agreement with the 
results of Stewart and Oastaldi (1967) who reported that uroato and 
creatinine had no effect on platelet aggregation induced by ABP,
GuanidinoBHoclnio acid? an intermediate or urea metabolism? has 
been reported by Uolien et al (1966) to be increased in the urine of 
uraemic patienta and is thought by Horowitz et al# (1967) to be the 
uraemic inhibitor# When guanidliiosuccinic acid m d  MjB are incubated 
with platelet^rlch plasma for 1 hour at 37^8 ADP induced platelet 
factor 3 availability is markedly diminished (liorowits et al? 1967)*
The effect of guanidinosucoinie acid on iU)P«*induced platelet 
aggregation was tested in the turbidimetric system. No effect was 
obtained when the substance was added in a concentration of 2 x 10^ ^ Molar# 
However* when a concentration of 2 x 10 Molar was used a diminution 
in platelet aggregation and an increase in platelet disaggregation 
waa found in all 7 experiments performed (table 58), This effect was 
found to be insignificant when compared to controls# Farllur© to 
obta:h'i signlficeiace may be due to the shorter Incubation time (10 
minutes aa opposed to 60 minutes) and the aiiGubation temperature 
(room temperature as compared with 37 0^) as used in tlio present 
experiments as compelled v/ith Bor owl ts et al (1967)#
The evidence presented In this chapter and the results of in 
vitro cmd in vivo experiments by various authors cm the effect of 
urea and its intermediate? gumiidinosuccinic acid? on platelet f miction
1X8
support the view that these may have a role In causing the platelet 
£\bnormality in ur&mila#
rnimim 9* 
m m m t  m n  mimumiotm*
fho haemom^hagic tendency in nmemla has been rooogni^ed for 
many,years* but its specifio mtmze has not been established. It 
has been attributed to vascular fragility# throinhooytoponia and 
ahnoraiallties in the coagulation raechaniom# The clinical pattern 
of the bleeding In uraemia suggests that the haemostatic failure is 
likely to he in the platelet#vascular group# i*e* bleeding from 
IÎ1UOOU0 meiahraneo rather than deep tissue haematomai the latter 
elitîioal feature ie charaoterietio of clef acts of the blood 
coagulation mechanism* Eeaent evidence suggests a Qualitative 
platelet defect parrain and Aclelson# 1956î &e#is et al,, 1956î 
Hath et al», 19571 Oahalan© et al,* 1958| 0«Grady# 1959» Donner 
and Heuwlrtova# X960| Wuraal, 19601 Willoughby and Qrouoh# Igëlÿ 
Ohenoy and Bonnin# 196g| Hoîlem et al,# 1964; Oaataldi et al,#
1966; Bayer et al.# I966; Salesman and lori# 1966$ Rosenberg and 
Firkin# I966; Stewart and Oastaldi. 196?i O^Brien, 1967? Praga 
and Oortellaro# I9671 Iforowits et al,# 196?; Gau and Firkin# 
i960). Im this thesis an attempt has been made to investigate some 
aspects of platelet function In uraemia# to evaluate the effect of 
haemodialysis on platelet ftmotion in acute and chronic renal failure 
and to study the effect on AB)?*^ indiioed platelet aggregation in vitro 
of some blochomioal abnorimlities known to he praeont in uraemia#
1. ELatelet morphQlo^ ry and fiction,
Ohaptor 1 contains à short account of platelet morphology and 
the role of platelets in haemostasis and thrombosis.
2, General introduction on platelets in uraemia*
In Ohapter 2 an historical account is given of the progress of 
knowledge on the bleeding tendency in uraemia and tho evolution of
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ideas ou etiology# together with some accoimt of the methods used in 
these studies.
3j Materials and methods
Chapter 3 contains a description of the materials e;ad methods 
used in this thesis* The methods outlined are those used to study 
some of the properties of platelets* These include platelet 
aggragationi platelet adhesiveness to glass and the availability of 
platelet factor 3*
The ability of platelets to aggregate with oalciwa and with 
calcium plus ABF was tested by a Chandler tube method and by the 
turbidimetrio method* In the Chandler tube system the time 
interval between recaloification# or the addition of calcium plus ADP 
and the appearanco of the "snow storm" effect* was used as a measure 
of platelet aggregation* In the turbidimetrio modification# optical 
density readings were talcen to measure platelet aggregation and the 
clotting time*
ABP^induood platelet aggregation and its reversal was determined 
by a turbidimetrio method (0*Brien, 1962b; Born and Cross* 1963b). 
Optical density readings were taken every 30 soconds for 10 minutes 
or longer*
Platelet adhesiveness to glass was measured by a modified 
Hellem*s glass bead column method as described by Hirsh et al, (1966a), 
In tlrJa method oitrated blood is forced through a glass bead column 
by an electrically driven mechanical pump y/hich gives a constant 
speed*
Platelet factor 3 availability was estimated by determining the 
"Styîpven" time of kaolin»0,ctivated platelet rich plasma (Spaet and 
Cintron# I965)*
Hxpeximents on the effect of factors influencing the results 
of some of the tests were described e*g* the effect of haematocrit 
on platelet aggregation and platelet adhesiveness, and the effect of
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the stirring speed# ineubaticn temperature and plasma white cell 
count on platelet aggregation*
In Chapter 3# the kaolin cephalin clotting time is also described, 
this v/as sused as a simple screening test to detect any plasma coagulation 
abnormalities in uraemio patients*
4# Platelet eggregat3.on induced by calcium and calcium ulus ADP
As shown in Chapter 4» the addition of ADI^  to reoalcified 
platelet^rioh plasma in the Chandler tube system resulted in 
significant shortening of the platelet aggregation time# However, 
a comparable effect on platelet ag^ çregation was not obtained in the 
turbidimetrio system* The cause for this discrepancy is unimown*
Â significant positive correlation was obtained in normal controls 
between the platelet count and platelet aggregation time, duration 
of platelet aggregation and the fall in optical density occurring 
just before clot formation, A similar correlation v/as found with 
the clotting time and the platelet count i.e. the higher the platelet 
count, the more delayed the onset of platelet aggregation oocurr*ing 
before clot formation, the longer its duration and the more prolonged 
the clotting time* It is possible that thrombin released as a 
result of recalGilMcation will act on platelets causing aggregation 
and eventually clot formation# With a low platelet count, the 
proportion of thrombin per platelet would be higher and consequently 
aggregation and clot formation will occur sooner*
Comparison between the results of calcium and calcium plus AfP 
experiments have shown that the addition of ABP as well as calcium 
significantly prolonged the duration of phase 5 (i.o* the time taken 
by platelets to aggregate prior to clot forHiation) * This effect of 
A3)P was also obtained in uraeraic patients. In normal controls no 
difference was obtained in the mean platelet aggregation time and the clotting
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times im the e^ cperimeats with ADP and ealciura as compared with calcium 
alone. There was no difference between uraemic patients mid normal 
controls a.s regards the aggregation time and the clotting time? although 
the uraemic patients had a significant3y lower platelet ooimt than 
normal controls# However, the duration of phase 3 in the calcium 
plus ADP experiraent was found to be prolonged in. 3 out of 8 uraemio 
patients examined# This may be a reflection of a qualitative platelet 
defect in uraemia resulting in Inability of the platelets to release 
a normal aîiîoimt of ADP in response to thrombin#
Chapter 5 deals with the platelet response to ADP in both norraal 
control subjects and uraemic patients as measured by the turbidimetrio 
method# Uraemic patients have a wide range of platelet coimts, and? 
to stuay the patients with low counts as compared to normal controls, 
the ADP induced platelet aggregation was studied after diluting the 
platelet«rich plasma with platelet^poor plasma.
In normal plasma a positive correlation was found between 
platelet disaggregation mid the platelet count but not between the 
count and platelet aggregation# However? when the results of experiments 
in which the platelet count was diluted with platelet-poor pl&isma 
were included, both aggregation and diaaggregation wore significantly 
correlated with the platelet count* A positive correlation also 
existed between aggregation and disaggregation. Because of the 
correlation with the platelet count? the results obtained from 
norma]* subjects and uz'aemio patienta wore grouped into four ranges 
of platelet count emd the mean values compax^ ed# In all fom' ranges 
the 30-60 platelet aggregation and the percentage disaggregation 
were sigsxificaiitly lower in uraemic patients than in control subjects 
and the disaggregation time was more prolonged in uraemic patienta#
The effect of haemodialysis on ADP-induced platelet aggregation 
was assessed. In olxronlc renal failure? although platelet aggregation
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ijaoreaseé in the majority of pationto examined^ *tho differonoo 
before and after dia3ysia did mot reach levels of techmiosl 
Bigmificamoo. Blatclet aggregation résulté were aigmifioamtXy 
correlated with their oorrespoiidimg blood m^ea level, Platelet 
dio£^gregatiom showed a oonetamt and eigaifioamt increase after 
dialysis* usually reaching normal levels*
It was mot possible to consider the effect of haomodialyois in 
acute uraemic patients as a group beoauBe of the marked variations 
in the platelet count; this variation was much greater than in the 
chronic uraemic patients, For this reaoom the res>,:tlt© of each 
experiment wore compared with the result of neriml controls diluted 
when required with platelet free plasma to produce the same range of 
platelet coimt# The effect of huemodialyela on the platelet 
behaviour In acute uraemic patients v/as not constant, This could be 
due to the varying aetiologioal factors producing acute uraemia, the 
rate of development and duration of the uraemic proooss and the type 
of dialysis.
In uraemic patients tvith a haemostatic defect, the time taken 
by their platelets to disaggregate was prolonged in the majority of 
cases, their ability to aggregate was more diminished than the rest 
of the uraemic group,
6, Flatelqt adhesiveness to /Jglasa.
In Ohapter 6 the results are described of platelet adhesiveness 
to glass in control subjeote and umemic patients by a modified 
H@llem$g glass bead column method# In the controls, the percentage 
platelet adhesiveness was found to be correlated with the haeimtccrlt 
Value, but not with the platelet count of the oitrated blood* When 
the haematocrit was varied in vitro by addition of plateXet^poor 
plasm to oitrated #od, a significant correlation was obtained 
betwem the percentage adhesiveness end their corresponding haematocrit 
values# à slgnlfloant negative correlation existed between the 
percentage disaggregation and percentage platelet adhesiveness, but
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mot between the latter m à  platelet aggregation.
When no oorreotioa wae made for the haematocrit value, the 
majority of uraemic patients showed low platelet adhoeivemeos, a%id 
the mean value was eignifiosntly lower then the mean of contrôle*
The man value of platelet adhoeiveaeae of mmemlc patients with 
clinical bleeding v/as not eigQifioantly different from the man of 
the rest of the uraemic group*
ïlaoEîodlalyais Increased platelet adheslvonese oonoistently in 
otoonio uraemic patienta * and the résulta before mil after 
haemodialyoie vmm correlated with the corresponding blood lU’ee 
leyela* lowovor platelet adheoiveneoe did not change eignifieantly 
in the acute uraemic group following ImomodialyaiH*
Most uraemic patienta {?8 per cent) had an abnoritial relation* 
ship between the ability of platelets to adhere to glace and their 
ability to dieaggeegate after aggregation with ADP#
When the results of platelet adhesivonoee were corrected for 
haematocrit, the mean value of uraemio patients was within normal 
limits* IJraeraio patients with bloadlïig also had a normuil mean 
value* Eovmver patients with chronic renal failure under haemodlalysie 
showed significantly high results before dialysis (i*a* the platelets 
were more adhesive), becoming more so after haeiaodialysia*
The relationship between percentage platelet adhoalvenCBS^ ^^  ' • 
and percentage platelet disaggregation in uraemic patients was otlll 
InsignlflcEmt when the results of platelet adheaiveness vmm corrected 
for F#* However this relationship became normal in the majority of 
patients after correction#
The results obtained before correction for PO? probably reflect 
mi overall picture in uraemia where platelet adhesiveness is 
diminished at least partly as a result of low MV# The increased 
adhesiveness in patients with chronic renal failure on dialysis is
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imïmovm ; orne might speculate that this ie the result of frequent 
exposure to the dialy.sii’ig membrane#
7# Platelet factor.^ 3 availability
111 Chapter 7 the results are desoribed of platelet factor-»^  
availability in aoiitro3. subjects mid uraemio patients using the 
method described by Spaet and Cintron (1965)• In normal subjects 
there was no aignifieant corre3.ation between the platelet ooimt and 
the *5typven* tlim? a].though there was a tendency for S^typven.^  time 
to be prolonged in tlie presence of a low platelet ecamt# When this 
test was done in coiijmotion with ADP^ induced platelet a|^ gi*egation? 
the S^typven^  times were significantly correlated with percentage 
disaggregation but not with platelet aggregation*
ihe raoan value of the iStypven^ times in uraemic patients was 
significantly longer than the mean value from normal controls*
A significant correlation existed between the *8typven* times in 
uraemic patients and the platelet count*
The normal relationship between the ’Stypven^ tioie and percentage 
disaggregation was absent in uraemic patiente* The majority of 
patients showed either prolonged ^Stypven* time or diminished 
disaggregation or both* HaemodiaXysis had no effect iJhere plate3.et 
faotor^3 availability was normal? but tended to reBiore normality 
in patients i^ ith reduced platelet factor™3 availability#
8* The offset of uxea* uric acid* creatinine and p^ uanidlnosucciziio 
acid on ADP^lnduced platelet aggrof
In Chapter 8 the results are described of the above mentioned 
chemical substances on platelet aggregation in vitro#
Urea caused j^ihibltion of ADP-^ ijidueed p3.atelet aggregation in a 
filial oonoentratioa ranging from 200^ 800 rag per 100 ml platelet^ rieh 
plasma? but the aaihibition was not correlated with the urea concentration. 
However? the degi’oes of itahibition of percentage disaggregation by added 
urea were correlated with the corresponding urea concentration # The 
effect of urea on ADP^ induoed platelet aggregation was similar to the 
findings obtained from patiente with uraemia :l#e# diminished aggregation
gaid disaggregation#
Urio acifl in a ooneentratioa of 5 mg# per 100 ml* platelet-rich 
plasma caused slight diminution in platelet aggregation and slight 
inoreaae in disaggi?egation. Creatinine when added in a final 
concentration of 10 mg. per 100 ml* had no effect on platelet 
aggregation but slightly increased disaggregation. Guanidine 
succinic acid inhibited platelet aggregation but increased platelet 
disaggregation.
In conclusion, the evidence suggests that the haemostatic 
defect in uraemia be due in part at least to a qualitative 
platelet abnormality# This abnormality could arise from inability 
of the uraemic platelets to react with or release ADP possibly as 
a result of intracellular ensymatio inhibition# In this way an 
explanation can be found for the low platelet aggregation, 
disa<Bgrogation and low factor 3 availability# The normal results 
obtained in assessment of platelet adhesiveness after correction 
for haematocrit could be a balance between diminished reactivity to 
ADP and diminished platelet disaggregation.
The defect in platelet function can be corrected by haemo— 
dialysis in most patients with chronic renal failure but not in 
acute uraemia# .
à & m ùm ,
:k igai. m m i ia  o f  n sâm ao  im 'Ib h 's  m  miom
8Tm)i3ia immi#
Forty patients with uraemia were studied lu this thesis| the 
blood urea levels mu^^ed from 85 to 920 %# per 100 ml. Of these 
31 patients were outferiug from ohronio renal failure and 9 from 
acute lîraeiïiia* There were 20 males and 20 females and their ages 
ranged from 13 to 06 years# Some of these patients v/ero studied 
more than onoo during the oourso of their lllmsa* The patients 
included in this study were either attending the renal oXiMo, 
treated in the wards or under treatment by haemodialysis#
Of these patients, eleven were bleeding at the time of the 
study.
Seven patients with ohronle renal failm?e were emminecl before 
and after haemodlaïyais# In all patiente the pre-diaiyais aample 
vms taken in the afternoon from the arterlo-Tenous shunt, before 
starting the dialysis and before hepaiîin was administered# The 
poot-dlalyaia sample v/ae collected by a clean venepuncture the 
next morning and between six to seven hours after the end of 
dialyele# None of the patients wore under oral anticoagulant 
therapy at the t%m of the study.
Six patients were dialvsed for 10 hours by a "ohron-a*coil" 
twin coil (Baxter) in a Travenol twin coil artificial kidney# The 
seventh patient (Id# 40) was dialyeed for the same period usinai a 
^bhroR-a-ooil" twin coil (Bawdier) i?i a recirculating single pace, 
artificial kidney imchlm.
Seven patients Buffori^ ig from aomte uraemia ?/ere also examined 
before and after dialysis, The pre-dia3ysis samples were taken at 
different times of the day, and the post-rlialysia on the day after#
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All seven patienta were dlalyaecl by a rotating-drum artificial kidney 
(made by Üeifroid of France, a modification of their Weaker hospital 
model, Incorporatimg suggestions by Dr* B.H* Parsons of Deeds)* The 
Xmtients are described Ira the chronological order in which they were studied< 
Casa No* ll Hale? age 20 yearsc This patient presented two years 
prior to investigation with a 3 month history of tiredness and exertional 
dyspYioea* At that time his haemoglobiïi was 7*3 gm, per cent and hie 
blood urea was 200 mg per 100 ml, Retrograde pyologrmii showed very 
small kidneys and was diagnosed provisionally as olironic renal failure 
due to congenital hypoplasia of the kidney, In August I966 haemo^ 
dialysis was started and the patient has been maintalnecl cm this form 
of treatment ever since, His platelet studies were performed before 
mid after single treatments by liaemodialysis.
Case Ho, 2t Hale, age 33 years0 For 7 years this patient has been knovm 
to have heavy album:lnm'ia? high blood urea and radiological flndrlngs 
suggestive of chronic nephritis, Microscopy of urine showed granular 
casts and occasional red blood cells but the urine was sterile on 
culture, This patient has been treated by dialysia since the beginning 
of 1967 and Was e^mmined for platelet function on tvio occasions before 
and after liaomodieOLysia, In the results section the figures quoted 
were on an occasion when the blood urea was 150 mg per 100 ml before 
haesodlalysis and 35 mg per 100 ml at the end of haomodlalyais,
Case wo* 3^  Male, age 31 years $ This male patient had been knoxm to 
have albiuisiiraxda si^ xoe 3,948 and was later diagnosed eis chronic glomerulo« 
nephritis* In 196$ he was placed on haeffioclialysis treatment. He was 
examined 3 times for platelet function before and aftm? haemodialyels*
In the results section the flgiu^ es quoted were on an occasion when the 
blood urea was I68 mg per 100 ml before haemodialysis and 52 mg per 
100 ml after haemodialyeis*
Case Ho, 4I Female, age 30 years: This patient had a history of
nephritis at the age of 15 years* She had persisting renal impairment 
end had superimposed toxaemia of pi^ ogïumoy duramg her only pregnancy 
1950, In the past few months she developed headachee, general
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malaise and blurring of vision and on admission to hospital she v/as 
diagnosed as suffering from chronic glomerulonepl'irltis plus ma].ignamt 
hypertension* She weus given treatment for her hypertension and 
deoislon taken to give her regular dialysis treatment* Her platelet 
atndiaa were performed before atart^ aig dialysis v;hen the blood 
urea v;as 27? mg par 100 ml*
Case No# 5$ Femal.0, ago 24 years : In the yem* prior to admission
to hospital in Igb? this yomig vmman. had suffered from bouts of 
"Indigestion" with vomiting# For several raontîis she had become 
l\iore£is5ngly clyspnoeio? had intermittent ankle sv/elllng and occasional 
transient ej)istajcls# (m admission she had anaemia and hxypertension 
and v/as found to have chronic renal failux^ e possibly due to 
congenital renal anoma];^ # She was started on haemodialysla 
treatment ;md ims examined for platelet fimotion before and after 
haemodialysis# iliere was great difficulty in nmintain:liig the 
patient on regular haemodialysis because of trouble with her arterlo»* 
venous shunt and she was maintained by peritoneal dialy’sis* T&io 
patientas general condition gradually deteriorated and following 
oonvulaione she died* Ite blood urea levels before and after liaemo- 
dialyols were 155 mg per 100 ml and 22 mg per 100 ml. z'espeotively# 
Autopsy showed îiypoplaBia of the kidneys*
Case Ho# 6t Male, age 59 yearss This patient vîae admitted to the 
artificial kidney unit with a severe degree of acute renal failure 
(blood urea 540 mg per 100 ml)# The primm% cause for uraemia was 
not o3.eax‘ but v/as possibly due to septicaemia secondary to pneumonia, 
Ih© patient v;as haemodlalysed on six occasions over a period of two 
v/eeks* His renal function improved to a great extent and he v/aa 
discharged with a blood urea of 82 mg per ICX) ml* Platelet studies 
were carried out before and after the third haeoiodlaXyeis#
Case Mo* ?: Female? age 62 yeai^ s . : This patient v/as admitted to the
artificial kidney unit having a severe degree of acute renal failure 
vjlnlch had followed perforation of a peptic ulcer six days before.
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lïaeraodlalyois wae oarrlecl out Ob the following day. Blood urea 
before haeniodialyaia Was 340 mg per 100 ml and after haemodiûïlysia 
154 mg per 100 ml* iUi iiitraperitonoal drain was inserted with the 
aspiration of a copious amount of dark fluid ooataining some altered 
blood* Baotériological examination of this fluid showed a profuse 
growth of monilia# A further haemodialyaia was carried out three 
days later* Cn both occasions platelet studies were done before and 
after dialysis* Follovdng the first haemodialyeie there was a fall.in 
platelet count and the patient developed ecchymosio at venepuncture 
alto* After the second haemodialyais there was a further drop in 
platelet count with profuse upper alimentary and peritoneal bleeding 
as judged by the aspiration from these sites* Her blood urea before 
the second haemodialysis was 343 mg per 100 ml; this fell to I9O mg 
per 100 ml at the end of liaemodialysiG, Tlie patient’s general 
condition deteriorated and she died 9 claya after admimsion*
Case Ko* 8î Female, age 53 years: Tliera was a history of profuse 
diarrhoea for two weelcs before admission followed by right-aided 
abdominal pain* On adridsaion to the renal mit the patient was 
deïiydrated* .pgr^^^al and subsequently noted to be oliguric* Marked 
haematwiu was also present* îlaemodialyais was Cforried out on three 
occasions# A percutaneous ki#ey biopsy showed changes compatible 
with acute tubular necrosis* !&e patient was discharged 39 days 
later with a blood urea of 48 mg per 1Û0 ml#
JnVestigations at a later date suggested that the patient was 
suffering from cholangitis or cholecystitis# The platelet function 
of this patient was investigated before and after her second liaemo- 
dialysis* Blood urea was 310 mg per 100 ml before haemodlalysie and 
130 mg per 100 ml after haeiaodialysis.
Oase No# 9t Male, age 13 years? TMs ^mtimt had a life*-»long history 
of enuresis, polydypsia and urinary frequency* H© also had spina 
bifida# Froteus urin^ ary infection was demonstrated at the age of 5 
weeks* Blood urea was not markedly increased, rmging from 4i to 
85 mg per 100 ml in the previous 5 months* The urine was sterile 
on several occasions before and on the day of the platelet studies#
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üam No# 10: Fmmie, age 25 joarat ïn 1965 this patient \wà hoon 
Buffering from a left periiiephrio aboma# She wao also found to  
have à right steghom oalamliis, impaired remi funotlon with a non- 
funotloning loft kidney# She vim admitted to hospital h W a m o  of 
progreoaive v/eakneao, tiroêmeas, vomiting and oliguria* Her blood 
imm on admission waa 310 mg* per 100 ml* Treatment wm #ven 
for dehydration and pyolonephritlo* Her platelet studies vmm 
àoïiB five daya after adiïileaion when the blood urea was 131 mg* per 
100 ml*
Oase Ho* 11% FoisaXo, ago 57 yeara: This patient wan suffering from 
ohronio pyelonepteltia with ohromia ranal failure, l^pertemlon and 
ïïyxoodema* This haa been aaeoolated with frequent episode# of 
©piotajdLs* Platelet studies were earried out 6 months after the 
last epintaKis* At that time her blood urea was 122 mg* per 100 ml*
Oaea Ho* 12# Peimle, age gO yearn* This fermle patient had long 
standing rheumatoid i^thritia with ohronio renal failure, poseibly 
on the basis of renal myloid. She was adîiîtti'êâ to hospital 
beoauee of inoreastng tirecbiess, breathleosnoB© and ankle swelling* 
Purpuric spots on the faoe were seen on the day of the platelet 
atudies* She had a low v/hite ooll count (l,30D/o#m* ) and later 
developed a gum infeotlon possibly as a oonsequence of the 
Egrauulooytosio (SOO/o*m)# Her b^ood urea vim 87 wg* per 100 ml* 
Two months later the patient died*
Oas0 Ho* 13* Fgimle, ago 35 years# At the age of seven years this 
patient had acute glomerulonephritis and themfter recurrent episodes 
of acute pyelonephritis* The last episode vim 4 months before she 
vma examined for platelet fuiiotlon* She had spontaneous bruising 
on the limbs partioular2y the lower IMob. Her blood œoa was 
180 mg* par 100 ml# on the day her platelet studies were performed*
Oas© No# 14* &le, age 58 years# For 44 years this patient had been 
known to have ohronio renal imuffioienoy clue to hydronephrosis
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resulting from etenoseâ urotluîa following' a fractured pelvis# He 
was adîBittôâ as an emergency because he hlecl profusely from the 
lower gastrointestinal tract. The source of bleeding was sought 
and may have occurred from colon cllvertiom].! demonstrated by 
barium enema, The platelet studies wore done 17 days after the 
onset of blooding. After adndssion his blood urea rose slightly 
from 186 to 203 per 100 ml.
Oase Ho, 15* Female, age 42 years* This patient was suffering
from ohronio renal fmlure and pyelonephritis due to B.ooli and 
B, proteus. Bha bruised easily but had no history of other bleeding 
and was never jaundiced. This patient was examined for platelet 
function when she was on out-patient surveillanee (blood urea 
169 mg. per 100 ml.) and again when she was put on regular 
haemoclialysis treatment*
Oaae No. 16* Female, age 37 years* This patient was investigated
in 1961 for renal tuberculosis and although no certain diagnosis was 
made at that time, she received antituberoulous treatment for 18 
months. A past history of t#erculosls of the hip was also 
obtained. She had Intermittent frequency of micttarition, loin pain 
and headache. She had a creatinine clearance of 30 ml. per minute 
and the urine culture v?as positive for B.ooli. The platelet 
studies were done while the patient was on out-patient at tendance at 
the renal clinic. Her blood urea was usually mintaiaed around 
100 mg. per 100 ml.
Oase No. 17* Male, age 4I ye. rat This patient had been known to 
be suffering from chronic renal failure secondary to polycyetic kidney 
disease since the age of 9 years. Brine culture was repeatedly
sterile. His blood urea was 2 #  mg’, per 100 ml. at the time of
study.
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OasG No, iB: Female, ago 50 years: This patient was suffering from 
ohronio renal ineuffioimcy duo to el/ronic pyelmepM'itis. She had 
a history of renal calculi in 1965 and neplireotomy in 1966.
Thereafter she developed chronic pyolonopîxritis duo to B, qoli infection^  
Her blood urea was stable aromid 100 ïBg per IGO ml mid was 116 mg 
per 100 ml whoa her platelet studies were dcme#
Case No* 19? Female, age 37 years* This woman’s history started 
with a left pyelolithotomy for calcu3,i in 1950* ^he has had bilateral 
renal calculi since that time* In the two progiiPBCiês (1958 and 1959) 
she had toxaemia of pregnancy and recurrent pyelmepWitis * In the 
six months prior to study she developed exertional dyspnoea and was 
found to be î^pertensive with cardiovascular clianges m â  albuminuria* 
intravenous pyelograp% showed poor right renal fbnctioE and aortogram 
revealed right renal artery stenosis# Her condition rapidly 
deteriorated with imcontrollablo liypertenaion, loft ventricular failure 
and tensive eacaphalopatliy* Her skin showed a yellowish hue.
Her blood urea rose steadily to l80 m$ per 100 ml and she rapidly 
deteriorated and died* Her platelet studies were done a few hours 
before death*
Case No* 20s Male, age 32 yeai'a# This patient had been suffering 
from chronic renal failure duo to polycystio kidney diseme reoognised 
since the age of 26, He also had clironio pyolonephidtio with urine 
culture positive for B, coll* %  was studied for platelet function 
wMle mder in-pationt treatment for acute pyelonepWltis * His blood 
urea was 120 mg par 100 ml at the time of study*
Case Ho* 21: Female, a #  34 years: This patimt had been Imown to 
have ohronio rensl, failure and maXignont hypertension for two years 
before admission* She was treated for the hypertension and was put 
on regular haemodiëdlysis treatment since m e  year* Platelet studies 
were done before and after haemodi-alysls. Her blood urea was 262 mg 
per 100 ml before haemodialyais and 112 mg per 100 ml after 
haemodialysis,
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Case No* 22s Female, age 13 ymwat This patient vim admitted to 
hospital in 1963 with acute glomerulonephritis* ’ Her condition 
deteriorated in the five months mxlor to admission with vomiting, 
wealmcsB end oedema with chronic renal failure, the blood urea 
increasing from 24? to 603 mg per 100 ml* The latter was the 
blood urea value on the day her platelet studies wore done.
Case No* 33% ^Wie, ago 43 yearss Ih.ia patient developed acute 
renal failure following post-operative peritonitis and septicaemia*
The platelet studies wox'o done before and after iiaeraodialysis at one 
week after operation* The prediajyais blood urea was 3G5 mg per 
IGO ml and the postdialysis blood urea was 140 mg per 100 ml*
Case Ho* 24# Female, age 53 years; This female patient had 
oîironio renal failure resulting from chronic pyelonephritis in a
solitary left kidney. ïïrine culture was positive for Klobseilla
organism* Bhe had no history of abnormal bleeding*^ The blood urea 
was 162 mg per 100 ml at the time of examination.
Case Ho* 25* Female, age %  years: This patient was admitted as an
emergency with acute renal failure following delivery. Other features 
include haomatemesis, melaena and jaundice* Her serum bilirubin was 
4*6 mg per lOO ml*, direct bilirubin 3*1 mg per 100 ml; alkaline 
phosphatase 15 K*A. units per 100 ml* Her blood urea was 121 mg 
per 100 ml at the time the platelet studies were carried out.
Case Ho* 26# %le, age 28 years; ^ght months before study this 
patient developed irontal headache and was found to have l^pertension* 
It was not possible to control hie liypertension and he developed 
chronic renal failure and left ventricular failure. His blood urea 
was 188 mg per IGO ml on the day of the study*
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Gaee No. 2?î l&le aga 59 yoera# Five month© before stut^ thia 
patient had a respiratory xnfeotlon followed by an acute - 
proliferative glornemlouephritls$ thia passed in to the neplirotlo 
phaae. There wao evidence of marked renal failure m  ehown by 
protêlnuroa and haematuria, oreatinim olearanee and Gotiaiatloii of 
blood urea.
Three days before the platelet studies were done, the patient 
Was admitted as an emergomy with rigors, pyrexia, delirium and 
abdominal pain, Bacteraemlc shock and gma-negatlvo septioaoîîia 
were diagnosed and the patient was treated accordingly. However, 
his condition deteriorated steadily, he became amrio, began to 
bleed from his nose and mucous membranes and died 4 days after 
admission* Biood culture Immediately bof ,re death showed the
of Wwo%tlc strapt'ooooous* His blood urea was 220 rag. 
per 100 ml; ha had thrombopytopaenia on the day the platelet 
studies were performed.
Oaso Ho. 28$ female, aged 32 years# This patient developed acute 
renal failure following septic abortion. Bleeding per vagina 
continued and later a ptsrpurio rash apjpeared on the abdomen, 
fellov/lng the first dialysis the vaglml bleeding and purpura 
disappeared but the patient remained anurlo. Hor platelet count 
was low (6 1,500/0.am.) before the first dialysis but improved 
steadily afterwards. Her platelet studies were carried out on 
several occasions before and after dialysis.
Oase No* 29$- Female, age 33 years: This patient was admitted as 
an ©mergemy bleeding per urethra and with ammla* She was found 
to have an ëx^enaive tumour of the vault of vagina and base of 
the bladder. Although urethrostomy was performed, the patient’s 
general condition deteriorated with little drainage of urine and
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gradually rising blood urea. Her platelet studies were done on the 
4th post-operative day and the patient died 10 days later.
Case No, 30* Male, age 53 yocre* This patient was admitted as an 
emergency. He was in ooma and had epistoxxsf aoute renal failure 
resulting from prostatio enlargement with obstruction was diagnosed,
The patient had a blood urea of 650 mg. per 100 ml.,.haematuria but 
m  caste, Platelet studies were done just after admiasion and 
repeated one week later, that is ? days after the obstruction had 
been relieved. The blood urea foil to 45 per 100 ml. before 
discharge.
Oaae Ho, 31* !&le, age 86 years* This patient developed acute renal
failure supervening on top of ohr nic failure as a consequence of urinary 
retention due to phimosis. He had a history of myocardial infarction. 
ÏÜS blood urea was the highest in the group (920 i%* per 100 ml.) The 
kaolin cephalin clotting time was 72.5 seconds, om«sk\ge pa?otlirombin 
time was 37*9 seconds (control 28 seconds). ProtteomMn assay was 
40,8 per cent and factor X assay was #  por cent.
Oase lo, 32* Bfele, age 49 years: This male patient was admitted as
an emarganoy one day before his platelet studies were done. Three 
months before he had experienced inoreasing fatigue, anorexia, nausea , 
vomiting and loss of weight. The diagnosis of otoonic renal failure 
clue to polycystic disease of kidnoye was established. The patient 
also had pyelonephritis due to a mizmd growth of B, ooli, B, protons 
and streptococcus faecalis. Following admission his condition 
deteriorated, he became oomatosed and died five days later. His blood 
urea at the time of the study was 350 per 100 ml.
Oaao No, 33* Female, age 88 yeh^ rs* This patient gave a four year
hiotos?y of rocurroiit attacks of right loin pain associated with 
dysuria. Bim weeks before admission she had noticed deterioration in 
her vision, became breathless anddevaloped polyuria with nocturia.
She had a past history of pulmonary tuberculosis and had received
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therapy for this# She was in left ventricular* failure with bilateral 
pleural effusion at the time of admission. She was also foimd to bo 
hypertensive with Grade IV retinopathy# lier blood urea on 
admission was 154 Big# per 100 ml. A diagnosis of chronic renal 
failure secondary to maligngmt hypertension was made. She was not 
bleeding at the time her platelet studios were made but ecoliymosis on 
the legs was noted 10 days later#
Case Ho# 34* Male, age 55 yearss This male patient was admitted 
as an emergency with bronchopneumonia, bronchial carcinoma and acute 
chronic renal failure. His blood urea was 435 mg# per 100 ml. on 
admission, this became 234 mg# per 100 ml* when his platelet studies 
were done and fell to 52 mg# per 100 ml. on discharge#
Qase Ho. 35* Male, age 31 years; This patient was suffering from 
chronic renal failure of unknown aetiology. The blood urea on the day 
of the study was 250 mg. per 100 ml.
Case Ho. 36* Male, age 51 years* This male patient had congenital 
bilateral duplex ureter and had developed chronic renal failura with 
clironio pyelonephritis since 1962* He had no history of bleeding* 
Urine culture was positive for B.ooli. He was admitted as an 
emergency and was found to have hypokalaemic alkalosis and a blood 
urea of 370 mg. per luO ml. at the time of the platelet studies.
Case No. 57* Female, age 38 years; She was admitted with acute 
renal failure following incomplete abortion and Clostridium Welohii 
septicaemia# She was jaundiced, pyrexic and oliguric* Her serum 
bilirubin was I4 mg per 100 ml. and her urine contained methaemoglobin 
ajrid bilirubin. She had a positive direct antihuman globulin (Coombs) 
test to a titre of I/32O# Her platelet count was 50fO0O/c*mm# on 
admission and she had eecliymosis on the anterior tibial area, before 
dialysis and bruising at venepuncture sites after dialysis# Haema- 
turia and haemoptysis were also features* The blood urea fell from 
347 to 161 mg. per 100 ml. after dialysis*
Case Mo# 38* Male, age 42 yearss This patient was suffering from 
epidermolysis bullosa and acute renal failure# He v/as investigated 
because he had epistaxis and haemateraosis# The blood urea on the 
day of the platelet studies was 190 mg per 100 ml*
Case No# 39* Male, age 32 years: Tvio months before investigation
this patient developed acute renal failure with thrombotic 
microangiopathy and jaundice# He also had uncontrollable 
malignant hyper tension • There was a history of ilngestloa of 
analgesics# The patient was treated by haemodialysis on several 
occasions; platelet function was examrlnod before and after 
haemodialysis# The blood urea before haemodialysis was 300 mg per 
100 ml and 219 mg per 100 ml after haemodialysis#
Case No# 40: Male, age 23 yesu's: This patient had acute nephritis
at the age of four and frequent attacks of sore tliroat which 
culminated in tonsillectomy at the age of twelve# On admission he 
Was found to be anaemic, liypertensive and he had a blood urea of 
143 mg per 100 ml# Urine cultures were repeatedly negative# He 
was treated by regular haemodialysis and his platelet studies 
were done before mid after dialysis#
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The bleeding tendency in uraemia has been under investigation 
in recent years. It has been attributed to vascular fragility, 
thrombocytopenia and abnormalities in plasma coagulation factors.
A qualitative platelet defect has also been suggested as being partly 
responsible for the haemostatic failure in uraemia.
In this thesis an attempt has been made to define the defect in 
platelet function in uraemia, to assess the effect of haemodialysis 
on the defect and to demonstrate by in vitro tests the effect on the 
reactivity of platelets to adenosine diphosphate of certain substances 
Imov/n to be present in increased amounts in uraemic plasma.
The discovery of platelets, their morphology and the role they 
play in haemostasis and thrombosis is described.
An historical account is given of the progress of knowledge on 
the bleeding tendency in uraemia and the evolution of ideas on 
aetiology and methods used in these studies.
An account is given on the materials and methods used to study 
some of the properties of platelets in normal controls and uraemic 
patients. These include a method for estimation of platelet 
aggregation by addition of calcium and calcium plus adenosine 
diphosphate (ADP) in an artificial circulation system (the Chandler 
tube technique), and by a turbidimetric method. Platelet aggregation 
with ADP and its reversal was studied by a turbidimetric system. The 
ability/
ability of platelets to adhere to glass surfaces was measured by a 
modified Hellem's glass bead column method. Platelet factor 3 
availability was estimated by determining the 'Stypven* time of 
kaolin activated platelet-rich plasma (the method of Spaet and 
Cintron). A brief outline of the basis of each method and a 
discussion of some of the possible sources of error in the basic 
techniques are given with each method. Experiments on the effect 
of factors influencing the results of some of the tests were also 
described.
The addition of ADP to platelet-rich plasma in the Chandler tube 
system resulted in significant shortening of the platelet 
aggregation time.
When calcium and calcium plus ADP were added to platelet-rich 
plasma in turbidimetric system, a significant positive correlation 
was obtained between the platelet-i'ich plasma platelet count and the 
platelet aggregation time, duration of platelet aggregation and the 
fall in optical density occurring just before clot formation. A 
similar correlation was found with the clotting time and the platelet 
count.
The addition of ADP as well as calcium significantly prolonged 
the duration of platelet aggregation occurring just before clot 
formation.
When the results from normal controls and uraemic patients were 
compared, no difference was obtained in the mean aggregation time and 
clotting time, although uraemic patients had a significantly lower 
■platelet count. However, the duration of platelet aggregation 
occurring before clot formation in the calcium plus ADP experiment 
Was found to be prolonged in most of the uraemic patients examined. 
This may be a reflection of a qualitative platelet defect in uraemia 
resulting in inability of the platelets to release a normal amount of 
ADP in response to thrombin*
ADP/
ADP-induced platelet aggregation in normal control and uraemic 
patients was also investigated by the turbidimetric system. In normal 
controls a positive correlation was found between platelet dis­
aggregation and the platelet count, but not between the count and 
platelet aggregation. However, when the results of experiments in 
which the platelet count was diluted with platelet-poor plasma were 
included, both aggregation and disaggregation were significantly 
correlated with the platelet count. A positive correlation also 
existed between platelet aggregation and disaggregation. Because of 
these correlations with the platelet count, the results from normal 
subjects and uraemic patients were grouped into four ranges of 
platelet count and the mean values compared. Platelet aggregation 
and disaggregation in uraemic patients were significantly lower than 
in normal controls.
The effect of haemodialysis on ADP-induced platelet aggregation 
was assessed. In chronic renal failure there was an insignificant 
increase in platelet aggregation following dialysis but the increase 
in platelet disaggregation was both constant and significant, usually 
reaching normal levels.
In acute uraemia, the effect of dialysis on platelet aggregation 
and disaggregation was not constant; in this respect these patients 
differed from those with chronic uraemia. In uraemic patients with a 
haemostatic failure, the time taken by their platelets to disaggregate 
was prolonged in the majority of cases, their ability to aggregate 
being more diminished than the rest of the uraemic group.
Platelet adhesiveness to glass was studied in normal subjects 
and uraemic patients. A significant correlation existed between 
platelet adhesiveness and the haematocrit value, both in normal 
controls and when the packed cell volume was varied in vitro. A 
negative correlation was obtained between the percentage disaggregation 
and percentage platelet adhesiveness.
When/
When no correction was made for the haematocrit value, the 
majority of uraemic patients showed low adhesiveness, while after 
correction their mean value was not significantly different from the 
normal mean.
Haemodialysis increased platelet adhesiveness consistently in 
chronic uraemic patients but not in the patients with acute renal 
failure.
Most uraemic patients had an abnormal relationship between 
disaggregation and adhesiveness. However, this relationship became 
normal in the majority of patients when the results of platelet 
adhesiveness were corrected for haematocrit.
Platelet factor 3 availability was studied in normal controls 
and uraemic patients. The 'Stypven' tim% of normal subjects were 
not correlated with the platelet count but were significantly 
correlated with the ability of platelets to disaggregate following 
the addition .of ADP in the turbidimetric system. The mean value of 
the 'Stypven* times in uraemic patients was significantly lower than 
the mean value from normal controls and was also correlated with the 
platelet count. The normal relationship between the 'Stypven* time 
and percentage disaggregation was absent in uraemic patients.
Haemodialysis had no effect where platelet factor 3 availability 
was normal, but tended to restore normality in patients with reduced 
platelet factor 3 availability.
The in vitro effect of urea, creatinine, uric acid and guanidino 
succinic acid on ADP aggregation was assessed. Urea caused a 
diminution in both aggregation and disaggregation, an effect 
similar to the findings obtained from uraemic patients. Percentage 
disaggregation v/as significantly correlated with the corresponding 
urea concentration added to the plasma.
Creatinine, uric acid had a negligible effect on aggregation 
and disaggregation while guanidino succinic acid caused an 
insignificant/
insignificant diminution in aggregation and an increase in 
disaggregation•
The thesis concludes with a summary of the work.
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Figures 1-45
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Table 1. The effect of adding ADP on the "snow storm" time 
in the Chandler tube method* .
Subject Ho
1
2
3
4
5
6 
7
Control (calcium)
Snow storm
484 
381 
542 
475 
446 
465 
400 
456.14 
"54
Test (Calcium t ADP)
First snow 
storm
60
46
50
54 
44
60
62
53.5
-7.43
Second snow 
storm
379
404
370
399
440
366
396
393.4
±25.2
Platelet
count/c.nm.
450.000
412.000
423.000
445.000
444.000
423.000
363.000
422,857 
±29,930
Table I shows the effect of ADP on the "snovf storm" time of 
reoalcified platelet-rich plasma in the Chandler tube technique. 
The mean "snow storm" time when ADP was added with the calcium 
chloride was significantly shorter than when calcium chloride 
was added alone (t = 2,782, QD2 > P > 0,0l).
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Table 6, Optical density readings of caloium-platelet aggregation 
in a normal control#
Turbi dimet ri o me thod.
mwft-'nT' » f 1". 1^ Jirw.Tmcfr m#»~9ps JO itrvT^r-
1 Optical'Time Optical[ Time Time | Opticali Time ;Opticalj
(seconds) density |(seconds)|density (seconds)| density! (seconds) density I
Start 0.600 155 1 0.565 310 i 0.560 I 465 0.545
0.565 160 1 0,565 315 0.560 470 0.540
10 j 0,560 165 1 0.565 320 0,560 I 475 0.530 ‘
: 15 0.565 170 1 0.565 325 0.560 j 480 0.520 (
; 20 1 0.565 175 i 0.565 330 0.565 1 485 0.510 i
: 25 0.565 180 . 0.565 335 0.565 490 0.495 }
30 0.565 185 1 0.565 340 0.565 495 0.480 i
35 0,565 190 I 0.565 345 1 0.565 j 500 0.470
40 0.565 195 1 0.565 350 0.565 505 : CLOT
45 0.565 200 0.565 355 0.565
1 50 : 0.565 205 0.565 360 0.565
; 55 0.565 210 0.565 365 0.565
60 0.565 2X5 f 0.565 ; 370 0.565 1 ;
65 0.565 220 1 0.565 375 0.565
: 70 0.565 225 1 0.565 1 380 0.565 !
: 75 0.565 230 0.565 385 1 0.565
80 0.565 235 0.565  ^ 390 0.565
85 0.565 1 240 0.565 ; 395 0.565
90 1 0.565 1 245 0.565 400 0.565
I ^95 0.565 S 250 0.565 405 0,565 ;100 ! 0.565 255 1 0.565 410 0.565 1
105 0.565 1 260 I 0.565 415 0,565
110 I 0.565 1 265 ! 0.565 j 420 0,565 !
1115 0.565 270 i 0.565 ! 425 
i 430
0.565
j 120 0.565 i 275 1 0.565 0.565 1 I
125 0.565 280 0.565 435 01565
130 0.565 ! 285 1 0.565 440 i 0.565 1
135 0.565 290 1 0.565 1 445 : 0.565
140 0.565 295 1 0.565 ! 450 0.565 1
1145 0.565 ; 300 1 0.565 455 0.565
150 0.565 1 305 10.565 ( 460 0.565
j------- 1
Table 6 shows the optical density readings in the turbidimetric iiBthod 
after reoalcifioation of diluted platelet-rich plasma. This is a 
representative experiment in a normal control (experiment No, 16, 
table 2, figure 7)0
Table 7* Optical density reading of calcium plus ADP platelet
aggre
Turbi
gation in a normal 
dimetric method
control.
i m ‘ ^\ Time ^Optical\ Time 1Opticalj Time .Optical! Time I Optical 1
f (seconds)j density |(seconds)! density | (seconds) density! (seconds)' densitys tajiinvTPX—
TI Start t 0.600 I 155 i 0.460 1 310 i 0.535 1 465 0,565 1
1 5 1 0.580 ;■ 160 I 0.460 I 315 1 0.535 i 470
i 0,565 1
10 0.580 \ 165 0,460 i 320 1 0.540 1 475 ! 0,555
15 0.580 ! 170 ! 0.460 i 325 î 0.540 , 480 0.555
20 ' 0.580 [■ 175 0.455 ! 330 ; 0.540 ; 485 1 0,550
i 25 ; 0.575 - 180 0.460 : 335 1 0.545 1 490 ïf 0,545
1 30 1 0*575 185 0.455 1 340 i 0.545 1 495 0.540
I 35 1 0,565 i 
0.560 1
190 0.460 ! 345 ; 0.550 500 1 0.535
s 40 ' 195 1 0.460 [' 350 0,550 • 505 f 0.525
: 45 ; 0.540 : 200 0.460 j 355 > 0.550 : 500 t 0.520
I 50 0.540 j 205 1 0.460 360 ! 0.555 • 515 i 0.510 1
1 55 1 0.540 ■ 210 [ 0.465 365 ; 0.560 : 520 0,500 f
60 1 0.540 i 215 ! 0.470 ' 370 j 0.560 ; 525 ' 0.490 1
: 65 1 0.535 1 220 0.470 1 375 0.560 ' 530 0.475
■ 70 I 0.530 j 225 0.475 380 0.560 î 535 0.470 1 
0.455 11 75 1 0.520 1 230 j 0.480 385 0.560 i 540 1
80 ! 0.515 i 235 1 0.480 1 390 1 0.560 / 545 Î CLOT 1
85 : 0.510 1 240 : 0.480 j 395 0.560 t 1
90 i 0.505 i 245 i 0,485 ! 400 1 0.560 S J l
95 1 0.500 ; 250 ! 0.490 I 405 1 0.560 ' j
100 ! 0.495 1 255 [ 0.490 410 0.560 1 f
105 I 0.490 1 260 i 0.495 415 1 0.560 1 1
110 1 0.485 (' 265 1 0.500 420 0.560 1
115 i 0.480 : 270 ; 0.500 i 425 0.560 \ tf 1
120 I 0.480 : 275 1 0.510 1 430 0.565 ; ! î
1?5 1 0.470 ; 280 j 0.510 j 435 î 0.565 I 1f
130 1 0.470 i 285 i 0.515 Î 440 ; 0.565 1 f
135 I 0.470 ! 290 Î 0.520 i 445 ! 0.565 1 î î
140 ' 0.470 1 295 ; 0.520 1 450 : 0.565 ! f
145 i 0.465 ! 300 1 0,525 1 455 ! 0.565 ; t '
150 I 0.465 1 305 1 0.530 1 460 1 0.565 j tf i
Table 7 shows the optical density readings in the turbidimetric method 
after addition of calcium plug ADP to diluted platelet-rich plasma. 
This is a representative experiment in a normal control (experiment 
No, 16, table 3) figure 9)*
Table 8» Optical density reading's of oaloium-platelet aggregation
in a uraemic patient*
Turbidimetric method»
Time Optical Time Optical Time Optical
a tie totm'Arw*! A 3 !1 r«t ti .S’1 jTh Mf
Time
inti 4-' Sfu .fTOi
Optical
1 (seconds) density (seconds) density (seconda) density 'seconds) density
j Start 0.600 155 0.590 310 0.590 ' 465 0.600
! 5 0.585 160 0,590 315 0.590 470 0,600
10 0.585 165 0.590 320 0.590 475 0.600
15 0,585 170 0,590 325 0.590 480 0.600
20 0,585 175 0.590 330 0.590 485 0.600
: 25 0,590 180 0.590 335 0.590 490 0.600
30 0.590 185 0.590 340 0.590 495 0.600
35 0.590 190 0.590 345 0.590 500 0.600
40 0.590 195 0,590 350 0.590 505 0.600
45 0.590 200 0.590 355 0.590 510 0.600
50 0,590 205 0.590 360 0.590 ' 515 0.600
: 55 0.590 210 0.590 365 0.590 520 0.600
60 0.590 215 0.590 370 0.590 525 0.600
65 0,590 220 0.590 375 0.595 530 0.595
70 0,590 225 0.590 380 0.595 535 0.595
75 0,590 230 0.590 365 0.595 540 0.595
80 0.590 235 0.590 390 0.595 545 0.585
85 0.590 240 0.590 395 0.595 550 0.580
90 0.590 245 0.590 400 0.595 555 OÎ575
95 0,590 250 0.590 405 0.595 560 0.575
100 0.590 255 0,590 410 0.595 565 CLOT
105 0 0.590 260 0.590 415 0.595
110 0.590 265 0.590 420 0.595
115 0.590 270 0.590 425 0.595
120 0,590 275 0.590 430 0.595
125 0.590 280 0,590 435 0.595
130 0.590 285 0.590 440 0.595
135 0,590 290 0.590 445 0.600
140 0.590 295 0.590 450 0.600
145 0.590 300 i 0.590 455 0.600
150 0.590
«n*" .S 'SlïcOf I*> «*1 rfair.:
305
.j>,j,«4rAFinrnu
0,590 460
It l-i
0.600
A Ui 1L lt4UT?lX=-CI ^ “C tV 7
Table 8 shows the optical density reading in the turbidimetric method 
after recalcification of diluted platelet-rich plasma» This is a 
representative experiment in a uraemic patient (patient No. 205 table 4, 
figure S).
Table 9, Optical density readings of calcium plus âDP-platelet
aggregation in a ux'aemic patient
Turbidimetric method
Time
(seconds)
Optical
density
Time
(seconds)
Optical
density
Time
(seconds)
ALU .1 u *iVm
Optical
density
Time
(seconds)
I j n' wMB
Optical
density
Start 0.600 155 0.585 310
, , . . .
0.595 465 0.585
5 0.600 160 0.585 315 0.595 470 0.585
10 0.600 165 0.585 320 0.595 475 0.580
15 0.600 170 0.585 325 0.595 480 0.580
20 0.600 175 0.580 330 0.595 485 0.580
25 0.610 180 0.580 335 0.595 490 0.580
30 0.610 185 0.580 340 0.595 495 0.575
35 0.610 190 0.580 345 0.595 500 0.570
40 0.610 195 0.580 350 0.600 505 0.570
45 0.610 200 0.580 355 0.600 510 0.570
50 0.605 205 0.580 360 0.600 515 0.565
55 0.605 210 0.580 365 0.600 520 0.565
60 0.600 215 0.580 370 0.600 525 0.560
65 0.600 220 0.580 375 0.600 530 0.555
70 0.600 225 0.580 280 0.600 535 0.555
75 0.600 230 0.580 385 0.600 540 0.55580 0.600 235 0.580 390 0.600 545 CLOT
85 0.600 240 0.580 395 0.600
90 0.600 245 0.580 400 0.600
95 0.595 250 0.585 405 0.600
100 0.595 255 0.585 410 0.600
105 0.595 260 0.585 415 0.600
110 0.590 265 0.585 420 0.600
115 0.590 270 0.585 425 0.595
120 0.590 275 0.585 430 0.595
125 0.590 280 0.585 435 0.595
130 0.585 285 0.590 440 0.595
135 0.585 290 0.590 445 0.590
140 0.585 295 0.590 450 0.590
145 0.585 300 0.590 455 0.590 1
150 0.585 305 0.590 460
«mw# ■iwin n.aum
0.585
taeiîiB.srABseasaBegf*e¥,«=rti«ViL _ _ _
Table 9-shows the opticaldensity readings in the turbidimetric method
after addition of Calcium plus ADP to diluted platelet-rich plasma. This 
is a representative experiment in a uraemic patient (patient No. 20, table 
5, figure lo).
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Table 23. Heaiilts of ABP-induced platelet aggregation and the 
corresponding platelet count in normal controls.
•u4^e«»vrf
Platelet aggregation [
Experiment
Noo
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20 
21 
22
23
24
25
26
27
28
29
30
31
32
33
34
30-60_
0.025 
0.010 
0.020 
0.020 
0.030 
0.030 
0.045 
0.100 
0.050 
0.090 
! 0.085 
0.065 
0.105
30-90 Maximum
0.050 0.110
0.025
0.040 Î
0.050 I
0.050
0.065 I
0.065
0.150
0.180
0.140
0.150
0,115
0.150
0.060 0.120 
0.120 0.180 
0.120 I 0.180 
0.170 I 0.230
10.115
10.115 
0.110 
10.105 
0.090 
0.180 
0.130 
0,190
i 0 .1 60
jo. 125 
jo. 115
j0.065 
jo. 185 
jo. 120 
IO.I65 
O.I65
jo. 145
0.190 
0.195 
0.17b 
0.170 
0.130 
0.280 
0.170 f
0.300 I
0.240
0.185 i
0,145 '
0,115 !
0,275 ! 
0.195
0.240 1
0.240
0.215
0.050
0.105
0.110 
0.100
0.150
0.170
0.320
0.280
0.240
0.245
0.200
0.275
0.210 
0.380
0.365
0.425
0.315
0.320
0.320
0.290
0.230
O.48O
0.310
0.485
0.415
0.300
0.290
0.200
0.450
0.380
O.48O
0.380
0.410
10.130 i 0.190 I 0. ;
Percentage 
dis 'ggregation
45.4 
30
47.6 
50
45 
40 
50
39.1
28.6
70.8
59.1
62.5
67.3
59.5
51.3
46.5
87
50.8
46.8
43.7
72.4 
76
41.6
72.6
81.4
74.7
76.6
86.2
62.5
57.8 
: 65.1
i 47.9
I 86.8
65.8
! 44.7
Platelet
count/c.mm,
100,000
72.000
126.000
90.500
90.000
93.000
114.000
236.000
177.000
194.000
240.000
212.000
223.000
185.000
301.000
345.000
340.000
255.000
268.000
340.000
279.000
350.000
360.000
375.000
400.500
369.000
432.000
442.000
380.000
435.000
442.500
390.000
425.000
422.000
315.000 ■! > PT'.W It
Table 23 shows the results of AÏ)P-induced platelet aggregation in 
35 normal experiments® Fifteen experiments were carried out after 
diluting the platelet-rich plasma with platelet-poor plasma® All 
parameters of platelet aggregation and disag'gregntion were 
significanbcorrelated with the plateletcount (Chapter 5)*
Table 24. ADP-induoed platelet aggregation in 19 normal
controls.
Optical density readings.
8 9 ' 10 1 11
0.600|0.600:0.600|0.600 
0.525io.4 5 5jo.560: 0.480
I
* C
I 1 i 2 I 3 : 4 ! 5 j 6 5 7
Start i 0.600( O.6OO|o.60o|0.600[0.600|0.600jO-^OO 
30 I 0.4301 0.480)0.470 0.510(0.44010.4801 0.460
1 i 0.310| 0.360 ;0.290! 0.380|0.270|0.290[ 0.3001 O.4OO |0 .340 |0 .495 ! 0,295
1.30 1 0.250! 0.340 f0,190!0.340[0.210|0.180 0.220! 0. 340 |0.310 jo.445!0.205
2 0.220| 0,270 p. 160! 0.300!0,180 0.140[ 0.190! 0,305 [0.345 |0.420|0.170
2. 30 i 0.235! 0,250 |o. 130! 0.290 p. 17510.115: 0.185! 0.300 10.425 10.405 jO. 155
3 j 0.275! 0.235 :0.12010.295[0.23010.120; 0.200! 0.305 [0,495 lO.40OiO.i5O
3.30 1 0.310; 0.245 p. 125| 0.31510.295:0.160! 0.230; O.32O |0.530 |0.405i 0,195
4 I 0.3501 0.250 i0.130|0. 34510.360:0.225Î 0.2701 0.350 io. 550 10.410[ 0.210
4.30 1 0.375: 0.260 p. 14510,38010,44510.290; 0.310! 0.385 I0.560 O.425 0.250
5 i 0.395Î 0.280 O.I80I 0.415:0.49010.35010.360: 0.420 |o.56010.445,0.295
5.30 ; 0.4001 0.30010.195|0.445:0.520;o.41o!o.4051 0.450[0.560!o.46510.335
6 ; 0,4101 0.330Î0.23010.47010.530[0.45010.440I 0.480 10.560 lo.48OlO.5iO
6.30 ; 0.4101 0.360 p.250I 0.495:0.540[0.480} 0.465: O.505 Io.56ojo.50olo.390
7 j O.415I 0.375 ;0.280l 0.505!0.540!0.495! 0.4801 O.520 |0.560 0.510:0.400
7.30 I 0.415: 0.390 p. 300| 0.51510.545ÎO.510:0.495i0.530 lo.560 lo. 52010.405
8 ; O.420I 0,405 p.320- 0.52oio.545lo.52010.500! 0.540 [0.560:0.525! O.410
8.30 ; 0.4251 0.415 io.340:0.525l0.550i0.520l0.5051 0,540:0.56010.530:0.415
9 ; 0.4351 0.420 |0.360:0.525I0.550:0.52olo.5051 0.545 [0.560 :0.530:0.425
9.30 ! 0.440: 0.430 |o. 375: 0.525|0.550|0.520[ 0.510! 0.550 io.560 p.530:0.440
10 i0,440; 0.440jO.385; 0.525|0,550!0.520:0.510 0.550 0.560i0.530[0.460
Table 24 (continued)*
l'kA'nMl k» t> tviMk B . A ^ tst n >X HJ ÿowKTirtikinijiynî-.iVTfye-r«l-<4&£v»i,AiTU;»i ikfl jaju&US .
12 13 14 15 16 17 18 19
Start 0.600 0.600 0.600 0.600 0.600 0.600 0*600 0.600
30 0*560 0.525 0.465 0.540 0.460 0.510 0.465 0.450
1 0.475 0.405 0.300 0.425 0*295 0.420 0.320 0.320
1*30 0*410 0*330 0,225 0.350 0.220 0*380 0.250 0^260
2 0*375 0.290 0.185 0.315 0*225 0*370 0.215 0.235
2.30 0.360 0.275 0.160 0.295 0.295 0*390 0.190 0.225
3 0*355 0.270 0.140 0.285 0.395 0.420 0.190 0.220
3.30 0.355 0.275 0.130 0.285 0*480 0.460 0*205 0.230
4 0.370 0.300 0.125 0.290 0.530 0*490 0.230 0.255
4.30 0*390 0.330 0.120 0.295 0.550 0.515 0.265 0*275
5 0.410 0.360 0.130 0.315 0.555 0.520 0*295 i 0.295
5.30 0.430 0.395 0.140 0.340 0.560 0.535 0*335 i 0.315
6 0.450 0.425 0.160 0.360 0.560 0.545 0.380 0.325
6*30 0.465 0.450 0.180 0.385 0.550 0.545 0*415 0.350
7 0.475 0.465 0.210 0.405 0.545 0.545 0.440 0*365
7.30 0*485 0.475 0.230 0.425 0.545 0.545 0*460 0*375
8 0*495 0*495 0.260 0.445 0.545 0.545 0*470 : 0.390
: 8*30 0*500 0*490 0.295 0.455 0.545 0*545 0*480 0.400
|9 0*500 0.500 0.320 0.465 0*545 0.545 0,490 0.410
[9.30 0*505 0.510 0.350 0.475 0*545 0.545 0*500 ; 0*415
1 0.510 0.500 0.370 O.48O 0.545 0.545 0.500 1 0.420«■•»W4nz»T<rt*j»cs-w«ejiÈ*
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Table 26* ADP-induoed platelet aggregation in normal controls
optical density readings in Gronp 2«
9MLV»*-
Time 
Minutes
Lw#LAi,«:' Î
-îi» ftl.
Start 
30 
1
1*30 
2
2.30
3
3.30
4
4.30
5
5.30
6
6.30
7
7.30
8
8.30
1
0.600 
0.4301 
0.3101 
2501 
220 
235 
2751
b,
r
p,
b.
I
I
p.4351
310Î 
3501 
3751 
395 j 
4001 
4101 
410 i 
4151 
4151 
4201 
425
9.30 p,
10 D.
4401 
440 s
0.600
0.480
0.360
0.300
0.270
0.250
0.235
0.245
0.250 
0.260 
0.280 I 
0.300 j
0.330 
0.360 I
0.375 I
0.390
0,405 I
0.415
0,420
0.430
0.600 
0.440i 
0.2701 
0.210 
0. 180
0.175j 
0.23
0.600
0.540
5
0.600
0.520
0.600j 0.600! 
0.4901 0.505
0.425 0.4051 0.380 0.400 
0.350 0.325 1 0.3201 0.335 
0.315 0.2901 0.295] 0.310 
0.295 0.280) 0.280 0.310
0.285 0.280! 0.280 0.310
0.295! 0.2851 0.3101 0.290 ! 0.330 
0.360 
0.445
0.490 0.315
0.6001 0 .
0*510 I Oe 
0*420 0 
0.380! 0* 
0.370 
0*390 
0*420 
0.460
0.5201
0.530
0.540 I
0.540]
0.545
0.5451
0.550
0.550]
0.550]
0. 
0. 
0.
0.290 j 0.350! 0.3051 0.3651 0.490 | 0.
0.295* 0.375! 0.330 0.4051 0.5151 0.
0.395* 0.355] 0.440 
0*375 0.475
0.395 0.500, _
0,405 0.515 0.545
0,405] 0.430 j 0.415
0.425 0.430Ï 0.420 
0.445] 0.440] 0,425
0.340 0,410 
0.360 0,420 
0.3851 0.420
0.520
0.535
0.545
0. 
0. 
0. 
0.
0.520] 0.545 ! 0.
0.530
0.535
0,440 I 0.550
■1
0.455 ] 0,450] 0.425 
0.4651 0.450 0.430 
0.475 0.455 I 0.430 
0.4801 0,460 0.435
0.545 I 0.
, 0.545 I 0. 
0.540] 0.545 0.
0.540} 0.545 0. 
0,540 0,545 I 0. 
0.5401 0.545 I 0
600
450
320
260
235
225
220
230
255
275
295
315
325
350
365
375
390
400
410
415
420
Table 2?« AbP-induoed platelet aggregation in normal
control optical density readings in Group 3»
0.600
0.480
0.300
0.330
0.295
0.280
0.280
0.280
0.290
0.300
0.320
0.340
0.360
0.375
0.390
0.405
0.410
0.420
0.420
0.425
0.430
0.600
0.510
0.460
0.330
0.320
0.335
0.360
0.380
0.390
0.390
0.390
0.395
0.395
0.400
0.400
0.405
0.420
0.420
0.430
0.430
0.440
0.600
0.510
0t420
0.370
0.360
0.270
0.410
0.450
0.485
0.510
0.520
0.525
0.530
0.530
0.530
0.530
0.530
0.530
0.530
0.530
0.530
0.600
0.560
0.475
0.410
0.375
0.360
0.355
0.355
0.370
0.390
0.410
0.430
0.450
0.465
0.475
0.485
0.495
0.500 
0.500 
0.505 
0.510
0.600
0.560
0.495
0.445
0.420
0,405
0.400
0.405
0.410
0.425
0.445
0.465
0.480
0.500
0.510
0.520
0.525
0.530
0.530
0.530
0.530
0.600
0.510
0.405
0.360
0.330
0.325
0.335
0.355
0.380
0.410
0.440
0.465
0.480
0.495
0.500
0.510
0.510
0.515
0.520
0.520
0.520
0.600
0.530
0.450
0.410
0.395
0.390
0.395
0.410
0.435
0.460
0.480
0.495
0.500
0.505
0.510
0.515
0.520
0.520
0.525
0.525
0.530
Table 28* ADP-induced platelet aggregation in normal control,
Optical density reading’s in Group 4*
Turbidimetric method*
IH 4. Æ f -7?
1 2 1 3 1 4
M4 ^1 g' H*. <4^ 1 nÿ ■‘-LT.IrfU.tZ'-.rf
5 ! 6 7
wm «'tu «*'»* } v'f vTf/ rj .a T-PiM.fcv» M.j*.4,|s,rw
! Start 1 0.600 1 0.600 1 0.600 j 0.600 1 0.600 ! 0.600 0.600
I 30 j 0.510 1 0.580 0.565 Î 0,510 1 0.565 1 0.565 ! 0.570
S 1 1 0.545 0.570 ! 0.545 ; 0.550 1 0.535 ! 0.535 i 0.525
1 1.30 1 0*520 f 0.555 ; 0.525 j 0.520 j 0.515 ! 0,500 j 0.485 i
2 i 0*500 5 0.560 ! 0.510 i 0,500 i 0.505 I 0,480 0.460
1 2,30 1
1
0.490 i 0.555 : 0,500 i 0.495 0.500 j 0,465 0.450 i
S 3 0*490 1 0.550 i 0.495 0.495 1 0.510 1 0.455 1 0.470
: 2.30 J 0.495 t 0.555 1 0.500 i 0,490 1 0.520 0,455 1 0,440
: 4 : 0.500 Î 0.557 : 0.515 *i 0*490 0,525 1 0,450 0.435
: 4,30 ! 0.510 \ 0.560 : 0,520 s 0.495 s 0.525 1 0.450 0.430
: 5 i 0*520 » 0,560 1 0*530 = 0*500 1 0.540 1 0,455 1 0.435
: 5,30 0*530 1 0.560 : 0,540 i 0*505 1 0.540 i 0.455 j 0.440
: ^ 1 0*535 1 0,560 1 0*540 * 0.515 : 0.540 1 0.460 I 0.445
1 6*30
1
0.540 & 0.565 1 0*545 I 0*520 j 0.545 < 0.470 1 0.455
i 7 0*540 i 0,565 1 0.545 f 0,530 i 0.545 1 0.480 t 0.470
: 7,30 1i 0*545 0,565 1 0*545 i 0.530 1 0.545 ! 0.485 ! O.48O
1 8 ? 0.545 1 0.570 ! 0.545 i 0,540 ; 0.550 ; 0.495 1 0.495
i 8*30 i 0*545 1 0.570 1 0*545 ; 0*545 1 0.550 0.505 0.500
; 9 0.545 0.565 1 0*550 I 0.550 ; 0.550 1 0.510 i 0,505
: 9,30 1 0*545 i 0,565 1 0,550 0.560 1 0.550 i 0.515 ; 0.515
jio
,.l.0.545 1Li» «Ht W l/T »■»»«•
0.565
< 3 t :' ou»»*/li
0.550 I 0*560
-»LA'V,n w mrir«.Lp.‘i.>'r<4' i
i 0.550
v3.'
! 0.520 1 0.520
Table 29. ADP-induoed platelet aggregation in uraemio patients 
Optical density readings Group 1 (platelet count
350,000 - 450,000/o.mm).
Subject number
Time
(minutes)
Start
30
1
1.30
2
2.30
3
3.30
4
4.30
5
5.30
6
6.30
7
7.30
8
8.30
9
9.30
10
3
0.600
0.550
0.465
0.405
0.375
0.370
0.370
0.385
0.410
0.435
0.465
0.480
0.495
O.5O0
0.510
0.53D
0.520
0.52Ô
0.520
0.520
0.520
ra;*eienTaWn»nA1»rc»«fb»BK* W
0.600
0.540
0.470
0.405
0.365
0.350
0.340
0.330
0.330
0.335
0.340
0.350
0.355
0.370
0.390
0.400
0.410
0.420
0.430
0.440
0.450
0.600
0.560
0.520
0.465
0.420
0.395
0.375
0.370
0.365
0.360
0.365
0.370
0.375
0.385
0.400
0.410
0.420
0.430
0.440
0.450
0.455
8
0.600
0.520
0.380
0.290
0.240
0.190
0.180
0.170
0.175
0.175
0.185
0.210
0.230
0.250
0.280
0.290
0.305
0.315
0.325
0.330
0.340
29
0.600
0.525
0.395
0.330
0.285
0.270
00255
0.255
0.260
0.280
0.295
0.320
0.350
0.385
0.410
0.430
0.450
0.455
0.470
0.475
0.480
Table 30. ABP-induced platelet aggregation in uraemio 
patients.
Optical density readings Group 2 (platelet 
count 250,000 “ 350,000/c.mm*).
Subject number
Time
(minutes) 1 3 6 10 11 14 16 15 28
Start 0.600 0.600 0.600 0.600 0.600 0.600 0.600 0.600 0.600
30 0.510 0.510 0.530 0.530 0.530 0.570 0.460 0.545 0.550
1 0.425 0.420 0.415 0.425 0.450 0.510 0.290 0.475 0.470
1.30 0.350 0.350 0.345 0.360 0.410 0.430 0.220 0.420 0.405
2 0.250 0.325 0.315 0.315 0.360 0.380 0.180 0.365 0.375
2.30 0.215 0.320 0.305 0.300 0.370 0.340 0.200 0.340 0.365
3 0.205 0*330 0.310 0.290 0.350 0.320 0.260 0.325 0.365
3.30 0.195 0.350 0.330 0.285 0.345 0.310 0.330 0.310 0.400
4 0.190 0.370 0.360 0.285 0.340 0.290 0.400 0.300 0.430
4.30 0.190 0.395 0.375 0.290 0.340 0.270 0.450 0.295 0.460
5 0.190 0.405 0.385 0.295 0.345 0.270 0.470 0.290 0.480
5.30 0.190 0.415 0.390 0.310 0.330 0.265 0.480 0.290 0.490
6 0.195 0.420 0.390 0.315 0.340 0.260 0.480 0.285 0.500
6.30 0.205 0.425 0.395 0.340 0.345 0.260 0.485 0.285 0.505
7 0.215 0.435 0.395 0.360 0.350 0.250 0.490 0.285 0.510
7.30 0.225 0.440 0.400 0.305 0.355 0.250 0.490 0.285 0.510
8 0.240 0.445 0.410 0.400 0.360 0.250 0.495 0.285 0.515
8.30 0.260 0.450 0.415 0.405 0.370 0.250 0.495 0.285 0.515
9 0.270 0.460 0.420 0.435 0.380 0.245 0.495 0.290 0.520
9.30 0.275 0.470 0.425 0.450 0.390 0.240 0.500 0.290 0.520
10 0.285 0.470 0.430 0.450 0.400 0.240 0.500 0.295 0.520
10.30 - — - - 0.400 — - 0.29511 — — - — — - - 0.295 -
Table 30 (continued)
Subject number
Time
(minutes) 29 30 31 32 35 38 34 40
Start 0.600 0.600 0.600 0.600 0.600 0.600 0.600 0.600
30 0.555 0.525 0.570 0.570 0.555 0.560 0.575 0.540
1 0.485 0.420 0.540 0.540 0.530 0.520 0.540 0.465
1.30 0.430 0.360 0.495 0.495 0.485 0.480 0.495 0.425
2 0.405 0.330 0.460 0.465 0.450 0.455 0.460 0.410
2.30 0.390 0.320 0.435 0.450 0.415 0.440 0.415 0.410
3 0.385 0.320 0.425 0.440 0.400 0.430 0.400 0.420
3.30 0.385 0.320 0.415 0.435 0.380 0.430 0.395 0.445
4 0.395 0.335 0.415 0.440 O.37O 0.425 0.385 0*475
4.30 0.405 0.355 0.420 0.455 0.365 0.425 0.385 0.505
5 0.415 0.390 0.435 0.485 0.355 0*425 O.38O 0.525
5.30 0.435 0.420 0.450 O.48O 0.355 0.430 0.380 0.540
6 0.450 0.450 0.460 0.495 0.355 0.435 0.380 0.540
6.30 0.455 0.475 0*470 0.505 0.355 0.440 0.385 0.540
7 0.465 0.490 O.48O 0.515 0.365 0.445 0.385 0.540
7.30 0.470 0.500 0.490 0.525 0.360 0.445 0.390 0.540
8 0.475 0.505 0.495 0.530 0.360 0.460 0.395 0.545
8.30 0.475 0.510 0.505 0.535 0.365 0.470 0.400 0.545
9 0.480 0.515 0.505 0.535 0.370 0.480 0.405 0.545
9.30 0.480 0.520 0.510 0.535 0.375 0.485 0.410 0.545
LO 0.480 0.520 0.510 0.540 0.380 0.490 0.415 0.550
L0.30 - - —
11 — — — - - — - -
Table 31# ADP-induoed platelet aggregation in uraeinio 
patients
Optical density readings Group 3 (platelet count
150,000 - 250,000/o.imn}
Subject number
Time
(minutes) 2 4 7 9 12 14 15 17
Start 0.600 0.600 0.600 0.600 0.600 0.600 0.600 0.600
30 0.500 0.580 0.540 0.555 0.580 0.580 0.570 0.540
1 0.370 0.555 0.480 0.465 0.570 0.550 0.520 0.500
1.30 0.270 0.520 0.425 0.410 0.550 0.500 0.460 0.435
2 0.230 0.500 0.390 0.375 0.530 0.465 0.420 0.380
2.30 0.205 0.490 0.360 0.360 0.515 0.440 0.390 0.355
3 0.190 0.490 0.340 0.350 0.500 0.425 0.380 0.330
3.30 0.185 0.485 0.335 0.335 0.490 0.415 0.360 0.315
4 0.175 O.48O 0.325 0.330 0.48-5 0.405 0.350 0.305
4.30 0.175 0.480 0.320 0.325 0.480 0.400 0.345 0.295
5 0.180 0.475 0.325 0.320 0.470 0.395 0.340 0.295
5.30 0.180 0.475 0.330 0.315 0.470 0.395 0.330 0.285
6 0.195 0.470 0.335 0.315 0.465 0.395 0.325 0.280
6.30 0.200 0.470 0.340 0.310 0.465 0.395 0.320 0.260
7 0.215 0.470 0.345 0.305 0.465 0.400 0.320 0.280
7# 30 0.230 0.470 0.350 0.305 0.465 0.400 0.320 0.280
8 0.240 0.470 0.355 0.300 0.465 0.405 0.320 0.280
8.30 0.250 0.470 0.355 0.300 0.465 0.410 0.320 0.275
9 0.260 0.490 0.360 0.300 0.465 0.415 0.320 0.270
9# 30 0.275 0.470 0.360 0.295 0.465 0.420 0.320 0.270
10 0.285 0.470 0.365 0.295 0.465 0.425 0.320 0.270
Table 31 (continued)
Subject number
Time
(minutes) 20 21 22 24 25 26 33 35
Start 0.600 0.600 0.600 0.600 0.600 0.600 0.600 0.600
30 0.555 0.560 0.570 0.545 0.570 0.585 0.575 0.530
1 0.465 0.505 0.520 0.490 0.540 0.570 0.520 0.450
1.30 0.410 0.450 0.450 0.425 0.500 0.535 0.480 0.400
2 0.375 0.420 0.415 0.385 0.465 0.500 0.455 0.370
2.30 0.360 0.405 0.395 0.355 0.455 0.480 0.440 0.355
3 0.350 0.400 0.380 0.330 0.435 0.465 0.430 0.340
3.30 0.335 0.400 0.370 0.325 0.430 0.455 0.425 0.330
4 0.330 0.405 0.365 0.315 0.425 0.455 0.425 0.325
4.30 0.325 0.420 0.365 0.315 0.425 0.455 0.430 0.325
5 0.320 0.435 0.365 0.315 0.420 0.455 0.440 0.320
5.30 0.315 0.445 0.365 0.320 0.420 0.465 0.455 0.3256 0.315 0.460 0.370 0.325 0.415 0.475 0.465 0.330
6.30 0.310 0.470 0.375 0.325 0.420 0.480 0.480 0.335
7 0.305 0.475 0.385 0.330 0.420 0.485 0.490 0.3357.30 0.300 0.480 0.390 0.340 0.420 0.495 0.495 0.3408 0.300 0.485 0.400 0.350 0.420 0.500 0.500 0.3458.30 0.300 0.490 0.405 0.360 0.420 0.505 0.505 0.355
9 0.295 0.495 0.415 0.370 0.420 0.510 0.505 0.3559.30 0.295 0.495 0.420 0.370 0.420 0.515 0.505 0.36510 0.295 0.495 0.430 0.380 0.420 0.515 0.505 0.370
Table 32. AbP-induced platelet aggregation in uraemic 
patients
Optical density readin^ s^ of group 4 (platelet 
count 509000 ~ 150;000/c,mm)
Time
(minutes)
I Start 
I 30 
1
1.30 
2
2.30
3
3.30
4
4.30
5
5.30
6
6.30
7
7.30
8
8.30 
|9
9.30 
10
10.30
Subject number
7*Al -.1 I
0.600
0.580
0,580
0,570
0.560
0.560
0.560
0.550
0.550
0.550
0.550
0.550
0.555!
0.560
0.560
0.560
0.560
0.565
0.565
0.565
0.565
■j
13
0.600|
0.5401
0,5251
0.5001
0,490
0.4901
0o500|
0.5051
O.5IO!
0.5201
0.525
0,530
0.535
0.540
0,545!
0,545
0.550
0,555
0.560!
0,560
0.560
23 27 28
0.600
0.590
0.590!
0.590)
0,590'
0,590
0.590
0.590
0.590
0,590
0.590
0,590
0,590
0.590
0.590
0.590
0,590
0.590
0,590
0.590
0.590
0.600 I
0.560
0.540
0.525
0.515
0.510 
0,505 
0,505 
0,505 Î 
0.505 !
0.510 ! 
0.515
0,520
0.525
0.530
0.535
0,540
0.540
0,540
0.540
0.540
0.600
0.585!
0.585
0.585
0.585
0.580
0.580
0.580 I
0.580
0. 580 I
0.580
0.580
0.500
0.580
0.580
0.580 I
0.575 !
0.580 1
0.580 j
0.580 I
0.580 I
0.600
0.585
0.575
0.570
0.565
0.565
0.565
0.565
0.565
0.565
0.565
0,565
0.565
0.565
0.565
0.565
0.565
0,565
0,565
0.565
0.565
37
0.600 
0.570 
0,570 
0.565 
0,565 
0.562 
0.560 
0.560 
0.560 
0.560 
0.560
0.557 
0.557 
0.557 
0,557 
0,557
0.557
0,557
0,560 
0,560 
0.560 
0.560
39
0.600
0.575
O4560
0.545
0.525 
0.510 
0.500 
0.485 
0.475
0.470
0,465
0.460
0.460
0.460
0.460
0,460
0.465
0.465
0.465
0.465
0.470
0.470
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Table 35# The effect of varying the stirring speed and 
the incubation temperature on ADP-induoed 
platelet aggregation*
Turbidimetric method.
Platelet aggregation Di s aggregation
Experiment 30-60 30-90 Maximum MAT Time Percentage
1 High speed 0.090 0.150 0.285 120 150 78.9
Ordinary
speed 0.160 0.225 0.41 150 180 71.9
Low speed 0.180 0.265 0.47 210 240 29
2 High speed 0.040 0.075 0.150 120 150 96.7
Ordinary
speed 0.130 0.205 0.400 150 180 85
Low speed 0.090 0.140 0.220 180 210 81.8
3 Room temp­
erature 0.130 0.190 0.315 150 180 74
37 0 0.030 0.23 60 90 76
Table 35 shows that when the stirring speed was increased, 
less platelet aggregation and more complete disaggregation 
occurred. With lov/ speed, although the effect on 
aggregation was not constant in comparison to the results 
from ordinary speed, yet less and more delayed 
disaggregation resumed.
The results from an experiment carried out at 37^0 showed 
diminished aggregation and early and more complete 
disaggregation as compared to an experiment done at room 
temperature*
Table 36,
j Subject 
! No.
1 
2
3
4
5
6
7
8
9 
10
f «A'9w.»Ar^
The kaolin oephalin 
clotting time in 
normal controls.
Clotting
Time
53*6
51
55
50.5
56
54.8
40.6
43.6
55.8 
48.3
Table 36 shows the kaolin cephalin clotting times in 10 normal 
controls. The test was carried out in duplicate and the result: 
shown are the mean clotting time of 2 readings.
The mean clotting time v/as 50.9 - 5*3 seconds the range was 
40a3 " 61.5 seconds.
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Table 4I. Platelet adhesiveness in normal controls 
Modified He Hem's method.
Subject
No,
Percentage adhesiveness Percentage 
Packed cell 
volume Platelet coun"uncorrected corrected
1 60,8 56.5 43 214,500
2 60.7 58,2 42 232,500
3 53.5 51 42 224,500
4 53.2 50.7 42 241,250
5 62,4 59.9 42 163,750
6 53.8 56,7 39 163,000
7 33.3 47 32 141,750
8 49.4 55.5 44 167,500
9 46.7 52.8 44 211,750
10 55.8 61.9 44 157,250
11 52,6 53.7 40 122,500
12 55.3 49.2 44 208,500
13 51 52.1 40 220,250
14 59.1 53 44 199,500
15 50.6 46.3 43 219,750
16 31.6 43.3 33 157,250
17 45.4 50.1 38 315,000
16 45.4 48.3 39 211,000
19 44.2 48.9 38 127,750
20 50.7 53.6 39 281,750
21 43.2 46.1 39 159,500
22 59.3 60.4 40 161,000
23 50.2 51.3 40 205,000
24 46.6 42.3 43 152,500
25 52,7 48,4 43 243,750
26 36.9 34.4 42 156,500
27 50.9 55.6 38 189,000
mm.
Table 41 shows the results of percentage platelet adhesiveness of 
citrated whole blood in 27 normal controls# The mean percentage 
adhesiveness was 50*2 - 7*8 and the packed cell volume was 40,6 - 3,1,
A significant correlation existed between the packed cell volume and 
percentage adhesiveness (r « O.65I , P < O.OOl), as shown in
figure 32. The platelet counts presented in this table are in 
citrated blood. This table also shows the results of percentage 
platelet adhesiveness after beihg corrected for variation in PCV,
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Table 45* Relationship between platelet adhesiveness and the 
packed cell volume in vitro.
I Citrated blood ml,
j Platelet-poor plasma ml
I Packed cell volume 
per cent
■ Percentage 
I adhesiveness
f 1
i '
I °
F
\ 40Î
F
' 54.4
4.5 1 4 i 3.5 : 3
33 28
38.1 I 38.5 1 29.9 23.4 15*4 U.4| 1.2
Table 45 shows the effect of changing the POV in vitro on platelet 
adhesiveness. The results of platelet adhesiveness were 
significantly correlated with their corresponding PCV values 
(r = 0.989 F<'O.OOl). A correction factor was obtained from the
curve (figure 33). For every 1 per cent reduction in POV, the 
platelet adhesiveness was increased by 1,8 per cent*
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Table 59» The effect of urea on ADP-induced platelet
aggregation (optical density reading
Tu-rhid line trie method#
I
I Start
I 30
I 1
I 1.30 
2
! 2.30 
I 3 
I 3.30
I 4 
I 4.30 
! 5
I 5.30 
1 6 
I 6,30
1 77.30 
8
1 8.30 
9
9.30
I 10
Test
0*600
0*490
0*405
0.350
0.327
0.320
0.332
0.357
0*380
0*390
0*400
0*407
0*407
0*407
0,407
0.402
0.405
0.405
0.405
0*405
0.405
, . ±
Control I
i
Î
0,600 
0.430 I 
0.320 I 
0.260 Î
0.235 I 
0.220 ; 
0.215 ‘ 
0.235 f 
0.265 I 
0.305 I 
0.330 . 
0.355 Î 
0.380 ; 
0.400 j
0.405 ; 
0.410 [
0.415 [
0.415
0.415
0.420 i 
0.420
fCvuwi
Table 59 shows the optical density readi.ngs of a representative 
experiment (Ho* 4? table 56) in which urea was added in a 
concentration of 500 rajg* per 100 ml* of plasma* The optical 
density reading's of the test are the mean values of 2 test 
experiments done before a.nd after the saline control#
s
4)
rH
E4
(M
OA
*ë
Ô
rH
S
"S
ô
I icaKtmar.ui
+)
CO
s
«
O
•P
CO
8
VO IT\ ^  rn (M OJ CM CM CMOCr^^corv-»mrnocoC(>Oroon
o o o o o o o o o o o o o o o o o o o o o
g  "^90ri^\oir\Lf\vo co o  m  ir\vo co oo o\ o\ o\ o\ ov
VO LO\ vj' rn <~0 oo oo oo '<h 'çÿ" Tzj-
• • • ♦ • • • ♦ • • *  V* * • « • • • • « •
O O O O O O O O O O O O O O O O O O O O O
+3 Om O(D VOEA
O
rHP OA o*P VOCî *
Ô o
VO '^oooorocvi CM CM CMCOrOOOfOrOonoO'^t-'^'^'i^f--*;}- ♦ • • • • • • • • • • • • ♦ • • • • • ♦ ♦
o o o o o o o o o o o o o o o o o o o o o
t>-ocMOLr>QCMCMtr\omi>-c^D^cMirM>-ojirMr\
— ^  ^  _  H  CM m i n v o  i> -co o \ o o
i r \ " ^ f C r n r n n i n i r o r n n i r n r n r n r r i ' < j ' ^
o O O O O O
rH rH rH '=cr
O O O O O O
%
g  o  o  O  
o  m  CM o  . . _ .LT\ m  m  rn rn m  
# # » $ # #
o  o  o  o  o  o
Q^Q!£^*^O^C>OOOLrMrMr\o rHmQ'^c^cr\C7vcr\o\cr\ovoooocDco
o o
*xj*. • «
o  o  o
s
'=5' • •
o O
VO in'<f'^ sf'^ -<fimir\Lr\inLr\Lr\if\ir\ir\inir\ir\Lr\Lr\ 
O O O O O O O O O O O O O O O O O O O O O
g g o g o Q Q o o i r N o o o o m t n o L r v o i o i   — rçt>_rHir\omvoa3cr\ocMcMmmÔ C5V CM LTM-j o
VO cl CM rH rH rH rH rH 
# CM
o o o o o o o o o o o o o o o o o o o o o
SOCMOl£\t>-t>-CMir\t^CMI>-OlfM>-OOOt>-t>-OCM QVO (3\vg vq COrH-^COrHLnl^-OOOrH CM CM CM Cl Cl 
•^CMrHrHrHiH CMCMCMClcimci'^i-'sJ-'^'^'-^-^Kj-
• • «
O O O O O O O O O O O O O O O O O O O O O
43
-p
CO
o
Cl rH
O
Cl
CM
O  g  O  O  O  Oc> m  Cl m  Cl m• * • • • •
CM C lC l'^ '^ ir\Lr\VD VD  ^-I>-CO
^  R♦ • O00 CT\ 0\ rH
1
•H
IO
0 VO
Q)
I— \
1
A
*8O
O
rH
P 0A 0-P VO
£3 «
0 00
VO
m
-p
I
O O Q O O O O O O Q O O O O O O i r v O i r M T M r v  
o i > r ^ o o v o v o  o v c v i m c o  o  M  ou c i c i T ; i ' ^ i r \ L r \ i r \ u r \
VO •^CIOJ OJ OJ OJ ^
OOOOOOOOOOOOOOOOOOOOO
< ^ Q O O C > O O Q Ç 0 g Q O i r \ p t f V O O O Q O O  o O V O N C l t H  O J ^ C O  o Cl*^VOVOt>*l>-GOOD CO CO CD 00
# * • * • • • •  » # * # * !» * * * # , .«# #
o o o o o o o o o o o o o o o o o o o o o
^OtnoooOLnoirMrv
C O C M O C V J O v - ^ t — O V O O O  _________ ___cirocicici'=^ '^ *’^Lrvir\LrvtrvLr\ir\Lnir\Lr\LnLPi
g g o g o O O o o o o o O o
o o o o o o o o
o o o-LTMfMTvt^o Lfit^O O >-ir\ir\ir\Lr\u-\Lr\Lmr\S CVJCMC^ VOCr\*^ OliHCMrnrrjCVJ<MOJCV)C\J(MCMCMCM ir\'^ rnmci'<j'^ ir\Lf\ir\Lr\ir\ir\ir\Lr\ir\LrvLr\ir\Lr\
o o o o o o o o o o o o o o o o o o o o o
rH
P 0 m m
A 0 m  ^-p VO Cl• • •
8 000
VEtatiSJ*
-P 0 0 m(0 0 00 t—<3) Vû Cl
Eh • • *
000
CM CM*
cnc—i-H Tf LT\ irwo VO voCl cl v:f *>:J- "sj- ■*îj* vj- 'çj- "<]' *<î* ■4;^
Lfic—i>-^-ù~ir\ir\t>-Lr\irvLr\CM cm cm cm oo O 
r-lOlO'ï^-CyNClVOC^COOOOQOOCOOOOOCDCOCO
ce OJ Cl rn Cl xj" ^  '=:t* k}* *sJ'
# $ * » # * * # # # # # * , # * # #
OOOOOOOOOOOOOOOOOOOOO
- P
-P O  
CO Cl rH
0 0 0 0 0 0 0Cl Cl Cl Cl m  ro Cl 
iH  CM CM ClCl'<j-';j-ir\ir\VOVO t^i>-co
%
• • o
co O l  C J lrH
8,
*
CQ
4) P
Æ 0)
EH Q)
P
• CMOî
-p tp
G 0 •
0 m
0 CQ ^
♦H 0
A q 0
<3> rH A
P i cd p
X ï> ho<D •iH
q <H
t-- Cd
<D P
a 0 g
•H P
0 A
m A  P
2Pp 0n G
•H 0 0
rü A ü
cd 0
0) 0
A P  P
w
>a (D n3
P p 0
•iH 0
m 0 Gq s i
0 p 0
n] A
<A ra
rH 0
cd 0
ü ra rH
•H hOrÛ
P G cd
■H p
0Tï
0
0 0 •H
S i A Jdp P
>3
g P G
& •rl •H
0 0
x i G 0
Ü1 0 P
rcJ rH
0 P
VO rH 0
cd 0
0 ü A
rH *H
S3 P 0
cd
Eh 0 EH
TO
0
•H
I,
Ü
%
§
«H
O
05
P
c6
'cd
•S
q
o
»
r-l
VD
'§
cd 
•H 
%0
1
•H
rp
00iH
pq
K*‘ r-»*J " .^4'
Oj
*H0
0
1
+
‘aià *Ws.w#« 4«fl AWU'
I 1 1
Ch i 1
G •iH 'H
A A
cd -G G
'H P a Pi
0 0 0
03 G G
rH O O
Pr rH iH
O G
Pi A
>5 0 0
XX S a
O G
iH rH rH
Cd hO ho
p
•H O ü
G •H •H
0 G G
hp O G
G A A
O .G G
O ü ü
C-* 1 1
0 0 Q)
A A
G G
r-l rH 1—1
•H •H •H
Cd 0
(K, Ch <H
rH iH rH
ce 0 0
G G G
0 >i 0 0
A 0 A A
G
ü *t5 ü G
I
P4s
0
rH
1
he
o
‘S0
1
%
cO
•H
0CdrH
Pi
0 P-.
rH
Cd
p
1
I
3
rH
I
A
O
ÜC-.
q .M G 
o  o  A 0 A roÆ  Æ[ Æ! -H 
O  P  O  P
» . w- m*, w .P»
I
g
CQ
8
Clrr\
g
C
A ra 
O  P
rHC)
§
*Hm 
G 
0 
P
0 A 0 
A 0 A
Cd r~i
S G•H 0
rt ^
Ü B
•d
1
4 4-1 1 I I l f !
I + I
A0
O«H
G
O
I + + +  4* I
"if *»M,'ar* r* rw,- "•«* •.*♦« -fa* •v.f * fl -«*- # frj* ,f*"w4A*fLu
IrooO *X3q MA 0
g g
CM
0 •H
•fH P G
G Pi GG 0 0
S P, 0
0 "G •H
G 0 PP4 H-3■dO 0 hoG A G
ü O 0G Ch rH
O A O
A 0 G
G P-i O
t 1 1
0 0 0
î-l A A
G G GrH rH rH
•H •H •H
0 0 0
<H Ch Ch _
1—1(—1fH ■
0 0 0 ■G G G '
0 0 0
A A A
0 0 0
P P P  <
G G Gü ü ü .
4^
CT\ CM Cl
ra m m
•fH *H •H
P P p a>
•rH •iH *H •iH
A A A P
G G G •riPi Pi p.! A
0 0 0 G
G G G P
O O O A
rH rd G 0
0 m 0
>, •G
Pi Pi Pi •r!
O
G o O P
*iH •H •H 0
G G G S
O O O G
A A A 0
G G G G
O O O A
1 1 1 t
0 0 0 0
A A A A
G G G G1— i G 1—1 1—!
-H •H •rH •H
0 0 0 0
Ct-I CiHt,H Ch
rH iH rH I—ï
0 0 0 0 0
G t5 G G G
0 f|H 0 0 ^ 0
A Ch A A 0 A
w *H a>Ï O rO Ü Ü 0
O *H *H *H Od
G  CÔ G  G  0  
H O G O O O
O A -H A A M
€ ë  ë-Sê &
'd
O § ü 
G r-t G 
A G A
ô g a
m m
•ri •fH
P
•ri •fH ra
A A •H
G G W
Pi Pi O
0 0 rH
G m G G
O •rH O ü
rH m r"4 A
0 O 0 0
b A >i GPi G P i G
Pi p
O 0 o
•H G •rH 1—i
G O G 0
C A O G
A nd A 0
G E>iG A
O G Ü C-
1 1 1 1
0 0 0 0
d 5 G G
i~l rH r—1 rH
•H •r! •fH •H
0 0 0 0
Ch C|H Ch CfH
rH rH r—11—[
0 0 0 0
G G G G
0 0 0 0
A A A A
ü ü o
‘H *H *rf 
G G G
c e o
A A Aëêê
LT\VD LT\
Cl tr\ D— 
OJ m
co
m
m  co OJ c^  re Ul re
.-J.*;,' fit- kd i
►T* i-Aj* » r.-k-TW*"
PÜ0
•O
rO &
G O 
CQ ^
CM Cl '=^J- IT\ VO O* CO <T\ O  rH CM C) LT\ VO 
«H rH t—I I—! I—1 r™t i—i
' . î«»' f* "f»
* I*'#
03
•H
CO
•HX>
i
&
I I I + I 1 t t 1 + I
p^r^rrr; ■•ir detye*wlUwi«BtA1*J«»fim**=.n3*.*i.*^ <r -
•H
%
0
rH
m
I i I
XÙ
•g
Oc
A
G
i
ÿ
co
ü
r-t
VO
0 i—t
'S
Ed
g
CQ
Ü
0
■O
I
«
o
m
•iH 03
P  •r-t
•H 0 3
 ^ A O 
>3 G, G
0 pi 0
G 0 P 
rp G 0 
•rt O
® & 
o >a œ
•rt Pi P  4-3 A 
0 ü cé
&''d .4
â
0 G  0 
P. O A
1 I I
0 0 0 
S S S
1—I rH I—I 
•rt *rt «rtCd 0 0 cA Ch Ch
taie
G G 0 0 
A A
ü Ü
• d e
P P
ê ê
(a
•H
P
I
ë
O
r-t0
î>5
Pi
ü
'd
0
1
0
rH
'Ü
Ch
I t
b#inr*4iXBt *1*1 n J-w»-
•H 
G A
O G 
•rt p4m 0 
G G 
0 O 
P  I—I
0 SPi 0
rH
p  hD 
G
0 Ü 
G •rl 
hû G 
•rt O 
rH A
0 G 
S O
t I
0 0 
A A 
G G
G  rH 
>5 *rt -H 0 0 0 
G Ch Ch
I + I f f  I f
rH rH
0 G 0 
G o G 
0 •H 0 
A 0 A 
G
Ü 0 Ü 
•H P  *H 
G A G
8
oî
i
ïH
I
0
A
O 
•H
Pm
&
^?g  ,
PiO O
ü
G
•ri
P
•ri
G
O
P
•rt
A
Q>
P-r
0
•iH
P
g0
Pi
O
P
030 
P4
1
*s
Ch
03
s i
A G  
G A 
Pi A 0 O
g I
r-l cd
0 G
>3 ^
Pi g
ü P  
•rl A
G 0
A
'g -g
O1 Pi
G
O
•H 0 
0 î> 
G 'iH0 4-^ 
P  cd 
A A 0 0 
P-( CiH
k'33
o
P  A
G Pi 
0
G 0 
ho P  
•H Gt—i o
0 0 
S G
1 0
'S
G S 
O A 
•H
P  P
0 A 0 
•H o o
a G Pi 
0 0 
0 0 
O O P  
•H *tH G 
P  P  QPi Pi 0 0 0 
03 03 I
;
(—1
3
I 0 I i I 0
fH
Cd
rH 0 G 
Cd -H 0
g g ^
A Cd Ü
o - r i
•H G 
P  P  O 
G Pi A 
Ü 0 G
0
4-i <£j 0 O
0 G 
A >—t
a - g
•d Ch 
0
Ch r4
cd
rH G
0 0
g ^
A ü 
•H 
0 G 
P  O
g a•< o
0 0 0 p 
A *H A I—! 
p p  p -HrH «H rH 0 
•A A  *rt Ch0 Xl 0 
Ch Pi Ch rH 
0 0
i-l G rH G 
0 O 0 0 
G r-l G A 
0 G 0 
A p A o 
A 'H
0 0 0 G
ü rH ü G
•"X hD <tî O
- 4JH—
0 1-10 0-
hj) f -A- LT\ ro
CM
rn
T0 m  
rn G
rn
'=d-
m v o  co o\
LT\ CM LTv
CM rn r^i LT\
g
A
P
03
0 
Pi
1
0
I
3
I—{
G  G 
O 0 
•H A
ü O
8 
4-^ C
CO u
■Sê
g
(6
G0
A
4-3
03
0
Pi
0
1
0
iP
•H
0
Ch
"d
G G 
O 0 
•ri A 
4-3
ü O
g 'dp c
03 A
g g
&
G
rO
5
ü
•ri
P
03
6 
î>3 rH
O
Pi
0
r-i
"cd
Ch
m
VO O
ro
G G 
O 0 
•A A
g  o
g 'd  
'g 8 
g g
I.*# f. 4:*
C3V
0 -  CO o \
1—1 rH (—1
rH CM 
(M CM
rn
CM
"cj- m  VO o-
CM CM CM CM
CO o \  
CM CM % jpHrn CMm
. i9'-rj"vw*
''G
i
•H
§
O
I—I
VO
0
r-l
g
B
P 0
0 GPi O
P  0
ro PiG Pi
W Pi
G Ü0 A
0 0 
I I
H *H 0 0 <H «H
0 0 
II
H *H0 0 C(H
0 0
O  
G  
H 
O
r - i  r - t  A  0 0 0 
C  G  0 0 
A A rH 
0
ü  ü  *H
d'dg
o o G
.§ -G A 
O  O  O
r-I 0
H Cf-[
0 0
A A
P  0
ü  Ü
G G
O  O
O  o
a»-» *iir«*wt>*k'P'
I +
+  I
0ra
o
rH
rH
g
ro
■H
0
i-S
A P  
0 O"G rO
•H a 
Pi o
0 A XX
1 P
0  I
9 0
I—I A 
•H y
0  rH 
^  *rH
,03
r-l CjH 
. (6 
03 G rH 
■H 0 0 
S A G  0 0 
0 O  A 
Ü  *A  
■H G 0 
p o p  
Pi U G 
0 XI O 0 O <
1
•rt
A
XX 
P.
:
0rH
d
1I—\
ho
0
' d
g
X  
ü
1
0
A
rd
0
P  rH 
0 0 
Pi G 
O 0 
•H A
G Ü 
0 -H 
O G
o S m
'âgi3
0 I CO LT\ 
^  I CM VO 
<
rH rH
m  LT\
CO
m
LT\ CM rnm rn CM
r-*WMÎH •4 «ÎT* It^trt l*
O I m  -Kt l rn rn
t. rm>„'#
irwo 
rr) rn
ET-
rn
CO o\ 
m  rn 9-
F U N C T I O N  O F  P L A T E L E T S  IN H A E M O S T A S I S
1. P l a t e l e t  p lug
2 .  V a s o c o n s t r i c t i o n  -  5 - H T  r e l e a s e
3 .  C o n t r i b u t i o n  to c o a g u l a t i o n
4 .  C lo t  r e t r a c t i o n
5. C a p i l l a r y  i n t e g r i t y
Figure 1 shows the functions of the platelet in haemostasis.
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Figure 2 illustrates schematically the mechanism of haemostasis 
(Luscher, 19^7)•
Figure 3 shows an artificial thrombus made in a Chandler tube 
by rotation of I5 ml. whole blood for 1 hour. The white head 
and the fibrin tail can be seen.
%  ^  -J »  f _ TÎ *»V
I
Figure 4 shows a longitudinal section through a Chandler 
thrombus. The contrast between the platelet head and the 
fibrin tail can be seen. Original magnification x 300. 
Stain - Piero Mallory (Photomicrograph prepared by 
Dr F. Walker)
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Figure 5 shows an EEL titrator and a galvanometer (EEL, 
type 20, Evans Electroselenuim, Ltd., England). This 
apparatus was used in the study of platelet aggregation 
by the turbidimetric method.
5Figure 6 shows the apparatus used for the determination of 
latelet adhesiveness by a modified Hellem's technique 
Hirsh et al., 1966). It consists of a glass bead column 
through which blood is forced by an electrically driven 
mechanical pump.
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Figure 7 illustrates the optical density changes that took 
place after recaloifioation of diluted platelet rich 
plasma in the turbidimetric system# This is a 
representative experiment in a normal control (experiment 
No* 16, table 2)* The optical density readings are 
given in table 6)#
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Figure 8 shows graphically the optical density changes 
after recaloifioation of diluted platelet-rich plasma 
in the turbidimetric system* This is a representative 
experiment in a uraemic patient (patient No* 20, table 
4)* The optical density readings are given in table 8*
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Figure 9 shows the optical density changes a fte r the 
addition of calcium plus to diluted p la te le t rich  
plasma in  the turbidimetric system* This is a 
representative experiment in  a normal control 
(experiment Ho*16, table 3)* The optical density 
readings are given in  table 7*
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Figure 10 shows the optical density changes after the 
addition of calcium plus ADP to diluted platelet rich 
plasma in the turbidimetric system* This is a 
representative experiment in a uraemic patient (patient 
No. 20, table 5)* The optical density readings are 
given in table 9*
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Figure 11 illustrates the relationship between the platelet 
count ancl the optical density fall in phase 5 following 
recaloification in the turbidimetric system. The results 
from all uraemic patients except one (Wo. 22) fell within 
the 95 per cent confidence limit of normal controls. The 
results from normal controls are shown in table 2, and from 
uraemic patients in table 4#
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Figure 12 shows the relationship between the platelet count 
and the optical density fall in phase 5 following the 
addition of calcium and ADP in the turbidimetric system*
The results from two uraemic patients (Nos. 18, 22; fell 
outside the normal 95 cent confidence limit# In two 
patients (Nos* 35 and 36) the fall in optical density 
could not be determined because of failure of their 
platelets to disaggregate in phase 2* The results from 
normal controls are given in table 3 and those from 
uraemic patients in table 5*
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Figure 13 shows the relationship between the platelet count 
and the aggregation time in phase 5 following recalcifioation 
in the turbidimetric system. The results from two uraemic 
patients fell outside the 95 per cent confidence limit of 
normal controls (los. 21, 38). The results from normal 
control are shown in table 2, and those from uraemic patients 
in table 4*
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l’igure 14 showa the relationship between the platelet 
count and the aggregation time in phase 5 when calcium 
and ADP were added in the turbidimetric system. The 
results from two patients (Nos. 21, 38) fell outside the 
95 per cent confidence limit of normal controls* The 
results from normal controls are shown in table 3 and 
those from uraemic patients in table 5»
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figure 15 ahows the relatiomsbip between the platelet 
count and the duration of phase 5 following 
recalcifioation in the turbidimetric system# All 
uraemic patients shows normal results except one 
(patient No. 35)* The results from normal controls 
are presented in table 2 and those from uraemic 
patients in table 4*
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Figure 16 shows the correlation between the platelet count 
and the duration of phase 5 when calcium and ADP were added 
in the turbidimetric system* The results from three 
uraemic patients (Nos* 18, 20  ^2l) showed normal relation­
ship and the rest (Nos* 12, 15, 17> 35, 38) were outside the 
normal 95 per cent confidence limit* The results from 
normal controls are shown in table 3 and those from 
uraemic patients in table 5*
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Figure 17 shows the relationship between the platelet count 
and the clotting time after recalcifioation in the 
turbidimetric system. All uraemic patients showed normal 
results except 3 (Nos. 15, 21,38})* The data for normal 
controls are shown in table 2 and those from uraemic 
patients in table 4*
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Figure 16 illustrates the relationship between the platelet 
count and the clotting time when calcium and ADP were added 
in the turbidimetric system (r = 0*768, P < O.OOl)* All 
uraemic patients showed normal results except two (Nos* 21 
and 38)* The figure is constructed from the data in tables 
3 and 5*
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Figure 19 shows the mean optical density changes in ADP- 
induced platelet aggregation in normal controls (black 
line), and uraemic patients (white line). The optical 
density readings are the mean values from 12 normal 
controls and 5 uraemic patients - one standard deviation. 
The platelet counts of both normal controls and uraemic 
patients ranged between 350,000 - 450,000/c.mm. (group l). 
The optical density readings from normal controls are 
presented in table 25» and those from uraemic patients 
in table 29.
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Figure 20 shows the mean optical density change in ADP-induced 
platelet aggregation in normal controls (black line), and 
uraemic patients (white line). The optical density readings are 
Jhe mean value of 9 normal experiments and 17 uraemic patients 
- one standard deviation. The platelet counts of both normal 
controls and uraemic patients ranged between 250,000 - 350,000/c.xnm. 
(group 2). The optical density reswîings from normal controls 
are presented in table 26 and those from uraemic patients in table
30.
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Figure 21 shows the mean optical density changes of ADP- 
induced platelet aggregation in normal controls (black 
line), and uraemic patients (white line). The optical 
density readings are the mean values 7 normal 
experiments and 16 uraemic patients - one standard 
deviation. The platelet counts of both normal controls 
and uraemic patients ranged between 150,000 - 250,000/c.mm. 
(group 3)« The optical density readings from normal 
controls are presented in table 27 and those from uraemic 
patients in table 31#
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Figure 22 shows the mean optical density changes of ADP- 
induced platelet aggregation in normal controls (black 
line); and uraemic patients (white line). The optical 
density readings are the mean value from 7 normal 
experiments and 8 uraemic patients - one standard 
deviation. The platelet counts of both normal controls 
and uraemic patients ranged between 50,000 - 150,000/c.mm. 
(group 4)* The optical density readings of normal 
controls are presented in table 28, and those of uraemic 
patients in table 32.
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Figure 23 shows the relationship between the platelet 
count and 30-60 platelet aggregation In the 
turbidimetric system* The results from 35 normal 
experiments are presented in this figure, and are 
shown in table 23*
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Figure 24 illustrates the relationship between the platelet 
count and percentage disaggregation after ADP has been 
added to platelet rich plasma in the turbidimetric system. 
The results from 35 normal experiments are presented in 
this figure and are shown in table 23*
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Figure 25 shows the relationship between 30-60 platelet 
aggregation and percentage disaggregation in the 
turbidimetric system* This figure is compiled from 
the data of 35 normal experiments and these are shown in 
table 23.
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Figure 26 ghov/s the effect of haemodialysis on 30-60 
platelet aggregation in chronic and acute renal 
failure patients* The results are given in tables 
20 and 21.
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5’igure 27 illustrates graphically the effect of 
haemodialysia on percentage platelet disaggregation 
in chronic and acute uraemic patients* The results 
are shown in tables 20 and 21#
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Figure 28 shows the effect of haemodialysia on 30-60 
platelet aggregation and disaggregation in 7 acute 
uraemic patients# Results are presented in 4 groups 
according to their platelet count and in relation to 
the normal mean values - 2 standard deviations in each 
group# This figure is compiled from data shown in 
table 21#
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Figure 29 shows the effect of haemodialysis on ADP- 
induced platelet aggregation* The mean optical 
density readings from 7 chronic uraemic patients before 
and after haemodialysis were used to construct the 
curves and are given in table 33.
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Figure 30 illustrates the relationship between 30-60 
platelet aggregation and the corresponding blood urea 
level before and after haemodialysis in ohronio renal 
failure* The figure is constructed from data in 
table 20#
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Figure 31 shows percentage platelet adhesiveness in 27 
normal controls (table 41) and 39 uraemic patients 
(table 43)* The results are presented without 
correction for the packed cell volume. The mean 
percentage platelet adhesiveness in the uraemic 
patient is significantly lower than the mean value of 
normal controls (t « 7*483, P < O.OOl).
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Figure 32 illustrates the relationship between the 
percentage platelet adhesiveness and the packed cell 
volume in 27 normal controls# The figure is 
constructed from data In table 41#
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Figu3?e 33 illustrates the correlation between percentage 
platelet adhesiveness and the haematocrit values when the 
packed cell volume was lowered in vitro hy addition of 
platelet-poor plasma to whole ci trated blood. The results 
are shown in table 45*
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Figure 34 shows the percentage platelet adhesiveness 
in normal controls and uraemic patients after 
correcting the resultsfor the packed cell volume. The 
mean percentage platelet adhesiveness in uraemic 
patients is not significantly different from the mean
value of normal controls (t « I.63O P>0.1). The
results from normal controls are shown in table 4I» and 
those from uraemic patients in table 43#
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Figtire 35 shows the relationship between percentage 
platelet adhesiveness and the percentage platelet 
disaggregation after addition of ADP in the 
turbidimetric system. The results of percentage 
platelet adhesiveness are not corrected for the 
haematocrit. The figure is compiled from normal 
data shown in table 42. The results from uraemic 
patients are given in table 44# Both normal controls 
and uraemic patients fell within the same range of 
platelet count (365,970 - 62,690/c.mm.)
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Figure 36 shows the relationship "between percentage platelet 
adhesiveness and the percentage platelet disaggregation 
after addition of ADP in the turbidimetric system, The 
results of percentage platelet adhesiveness presented in this 
figure are corrected for variations in haematocrit* The 
figmre is compiled from normal data shown in table 42* The 
results from uraemic patients are given in table 44* Both 
normal controls and uraemic patients fall within the same 
range of platelet count (365, 910 - 62,690/c.mm*)
THE EFFECT OF HAEMODIALYSIS ON PLATELET ADHESIVENESS
CHRONIC RENAL FAILURE
60-
w
30-
10-
ACUTE RENAL FAILURE 
7 patients
«
&
I
Figure 37 illustrates the effect of haemodialysis on 
percentage platelet adhesiveness in patients Y/ith acute 
and chronic renal failure* The results are not 
corrected for variations in packed cell volume. The 
figure is constructed from data in tables 46 and 47*
r*0-623 
0-02 >P >0-01
0) 40 
T3
30
CL 10
50 100 150 200
Blood urea mg/100ml.
250
Figure 38 shovm the correlation between the percentage 
platelet adhesiveness and the corresponding blood urea 
levels before and after haeraodialysis in chronic 
uraemic patients# The results are given in table 
45.
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Figure 39 shows the results of platelet factor 3 availability 
tests in normal controls and in uraemic patients (method of 
Spaet and Cintron, I965)* The "Stypven times" of 23 normal 
controls are presented in table 49# The results from 31 
uraemic patients shown in this figure (table 50) include all 
patients regardless of the platelet count or the abnormality 
in their Kaolin oephalin clotting time. The "Stypven times" 
of 13 uraemic patients with a platelet count within the normei 
mean value - 2 standard deviations, and having a normal Kaolin 
oephalin clotting time are also shown in this figure#
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Figure 40 shows the relationship of "Stypven" times in relation 
to the platelet count in normal controls. There is no 
significant correlation between the platelet count and the 
"Stypven" time (r = 0.131, P>0*l); the correlation is still
insignificant when the results from 8 experiments are 
included in which the platelet-rich plasma was diluted with 
platelet-poor plasma (r = 0.298, 0.1>F>0.05)*
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Figure 4l shows the relationship between "Stypven" times and the 
platelet count in uraemic patients. V/hen the results from uraemic 
patients with prolonged Kaolin oephalin clotting time are excluded, 
there is a significant correlation between the "Stypven" time and 
the platelet count (r = -0.462, 0.02 > P > O.Ol). The results from 
uraemic patients are presented in table $0.
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Figure 42 illustrates the relationship between the "Stypven time" 
in the platelet factor-3 availability test and the percentage
disaggregation after ADP has been added to platelet-rich plasma
in the turbidiraetric system* A significant correlation was 
obtained between the "Stypven time" and percentage disaggregation 
in 10 normal controls (r = 0,655, 0.05 > P> 0.02). The results
from 12 uraemic patients are shown in this figure. These
uraemic patients had normal Kaolin oephalin clotting times and a 
platelet count within the normal range. The results of 8 uraemic 
patients fell outside the normal 95 per cent confidence limit 
around the regression line. The results of normal controls and 
uraemic patients are given in table 52*
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Figure 43 shows a significant correlation between 
the percentage platelet disaggregation and urea 
concentration in vitro* The figure is 
constructed from data in table 5 ,^
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Figure 44 shows the effect of urea on ABP-induced platelet 
aggregation# This is a representative experiment (No. 4, 
table 56). The optical density readings of the test are 
the mean values of two tests done before and after the 
saline control. The concentration of urea added was 500 mg. 
per 100 ml. of plasma. The test shows a diminution in 
both aggregation and disaggregation as compared to the 
control. The optical density readings are giyen in table 
59*
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Figure 45 illustrates the effect of guanidino 
succinic acid on ADP-induoed platelet aggregation. 
The optical density readings of the test and the 
controls are the mean values of 7 experiments and 
are shown in table 60,
